Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),0.844354657691492,2.5813783999201876,0.0,0.0,0.0,17/29,4.70%,GRIA2;GABRB3;GABRA5;GRIA4;GABRB1;GABRA2;GRID1;GRID2;GABRG3;GABRA3;GRIK1;GABRA4;GABRB2;GRIN2D;GLRA3;GRIK2;GRIK5
prerank,glutamate receptor activity (GO:0008066),0.8780819712771107,2.420817859247991,0.0,0.0,0.0,13/19,4.70%,GRIA2;GRM5;GRIA4;GRM7;GRM1;GRID1;GRID2;GRM8;GRIA1;GRIK1;GRIN2D;GRIK2;GRIK5
prerank,ligand-gated channel activity (GO:0022834),0.7700084493055704,2.3959922544577315,0.0,0.0,0.0,14/29,7.23%,GRIA2;GRIN1;GRIA4;GABRB1;GRID1;GRIN2A;GRID2;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;GRIA3
prerank,ligand-gated ion channel activity (GO:0015276),0.7679893295142757,2.3844806387529704,0.0,0.0,0.0,14/30,7.23%,GRIA2;GRIN1;GRIA4;GABRB1;GRID1;GRIN2A;GRID2;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;GRIA3
prerank,ligand-gated cation channel activity (GO:0099094),0.6428399927312944,2.344268649593677,0.0,0.0,0.0,23/75,8.25%,GRIA2;GRIN1;GRIA4;KCNJ3;ASIC2;KCNJ6;GRIN2A;KCNN2;ASIC4;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;KCNJ11;KCNN1;ASIC1;TRPM2;KCNJ10;GRIA3;KCNN3;KCNK1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.7558857169111586,2.301093605891884,0.0,0.0,0.0,11/28,8.68%,GABRA5;GABRA2;GRID1;GRID2;GABRG3;GABRA3;GRIK1;GABRA4;GRIK2;GRIK5;GABRG2
prerank,GABA-A receptor activity (GO:0004890),0.8396435412969516,2.29629762621586,0.0,0.0,0.0,10/18,8.68%,GABRB3;GABRA5;GABRB1;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRD;GABRG2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.8372007567591433,2.2660357873158965,0.0,0.0,0.0,12/17,10.33%,GRIA2;GRIN1;GRIA4;GRIN2A;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;GRIA3;GRIN3A
prerank,ligand-gated anion channel activity (GO:0099095),0.8325128214817042,2.2594813569567798,0.0,0.0,0.0,12/17,9.58%,GABRB3;GABRA5;GABRB1;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;GLRA3;GABRG2;GLRA2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.8115995173130446,2.2394366324489936,0.0,0.0,0.0,11/19,8.68%,GABRA5;GABRA2;GRID1;GRID2;GABRG3;GABRA3;GRIK1;GABRA4;GRIK2;GRIK5;GABRG2
prerank,voltage-gated cation channel activity (GO:0022843),0.5785056012333919,2.230356834108868,0.0,0.0,0.0,33/97,11.77%,KCND2;HCN1;CACNA1A;GRIN1;KCNH7;CACNA1B;KCNQ3;KCNC2;GRIN2A;KCNH5;KCNH8;CACNA2D1;GRIN2B;GRIN2D;CACNG2;KCNJ11;HCN2;CACNA1E;KCND3;KCNH1;KCNC3;KCNQ5;CACNB2;KCNC1;LRRC55;KCNK1;CACNG3;OPRM1;GRIN3A;KCNQ2;CACNB4;CACNG8;KCNA2
prerank,GABA receptor activity (GO:0016917),0.7873872121010567,2.2279815559295764,0.0,0.0,0.0,10/21,8.68%,GABRB3;GABRA5;GABRB1;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRD;GABRG2
prerank,potassium channel activity (GO:0005267),0.5766507793560905,2.1474423520673818,0.0,6.559020917908135e-05,0.001,27/89,8.25%,KCND2;HCN1;KCNH7;KCNQ3;KCNC2;KCNN2;KCNH5;GRIK1;KCNH8;KCNMB2;KCNMB3;GRIK2;GRIK5;KCNJ11;KCNN1;KCNK13;KCNMB4;KCNK10;HCN2;KCND3;KCNH1;KCNC3;KCNQ5;KCNK9;KCNC1;LRRC55;KCNK1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.8645246320149889,2.137425235835012,0.0,6.09051942377184e-05,0.001,9/12,8.68%,GABRB3;GABRA5;GABRB1;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRG2
prerank,chloride channel activity (GO:0005254),0.602294362470833,2.126098891782631,0.0,0.00022737939182081534,0.004,18/59,10.96%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;GLRA3;TTYH2;ANO5;GABRD;GABRG2;ANO4;GLRA2;CLCN1
prerank,cell adhesion mediator activity (GO:0098631),0.7400921813335942,2.122401062644562,0.0,0.0002131681798320144,0.004,17/24,14.65%,DSCAM;BSG;LRRC4C;PLXNB3;CNTN6;ROBO4;DSCAML1;NPTN;VSTM2L;ESAM;NINJ1;NTNG1;ROBO3;CNTN4;CNTN2;JAM3;BCAM
prerank,retinoid binding (GO:0005501),-0.7356726826398703,-2.0919933584917154,0.0,0.0011343263761315597,0.001,7/22,5.63%,NR2F2;ALDH1A2;PTGDS;RBP1;CYP26B1;RBP4;ABCA4
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.8291885995848917,2.0757162657497106,0.0,0.0003009433127040203,0.006,9/13,9.58%,GABRA5;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GLRA3;GABRG2;GLRA2
prerank,platelet-derived growth factor binding (GO:0048407),-0.8798276502313608,-2.074312373125342,0.0,0.0011343263761315597,0.002,7/11,3.42%,COL1A2;COL3A1;COL5A1;COL1A1;PDGFRA;PDGFRB;COL6A1
prerank,voltage-gated potassium channel activity (GO:0005249),0.5622665714767565,2.073741401259151,0.0,0.0003315949464053557,0.007,22/80,8.25%,KCND2;HCN1;KCNH7;KCNJ3;KCNQ3;KCNC2;KCNJ6;KCNN2;KCNH5;KCNH8;KCNJ11;KCNN1;HCN2;KCNJ10;KCND3;KCNH1;KCNC3;KCNQ5;KCNN3;KCNC1;LRRC55;KCNK1
prerank,amyloid-beta binding (GO:0001540),0.5602081528492325,2.053075525287925,0.0,0.00040389760389223777,0.009,28/79,13.14%,GRIA2;CACNA1A;ITM2A;GRIN1;GRIA4;CACNA1B;NLGN1;MAPK8IP2;GRIN2A;GRIA1;APBB1;GRIN2B;APBA2;PFDN5;APBB3;TGFB2;TLR2;CLU;FZD6;PFDN6;ATP1A3;GRIA3;ITM2C;APBB2;FZD4;ITGAM;CD36;SORL1
prerank,anion channel activity (GO:0005253),0.578590932896242,2.052244680345968,0.0,0.00038370272369762584,0.009,18/61,10.30%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;LRRC8B;GABRB2;GLRA3;ANO5;GABRD;GABRG2;ANO4;GLRA2;VDAC2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.7003273045874077,1.9949481474471134,0.0,0.0018271558271315518,0.038,3/21,3.12%,GRM5;GRM1;GRIA1
prerank,histone acetyltransferase activity (GO:0004402),-0.64480845427623,-1.951544695651375,0.0,0.019283548394236513,0.047,15/30,16.42%,KAT2B;EP300;KAT6B;BAZ1A;CREBBP;HAT1;ATF2;TADA3;MCM3AP;KAT14;EPC2;KAT8;BRCA2;EPC1;ARRB1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.8279975758929292,1.939627458791707,0.0,0.004340879298397384,0.091,6/10,8.68%,GABRA5;GABRA2;GABRG3;GABRA3;GABRA4;GABRG2
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.7357863666355946,1.9217833833692797,0.0,0.0052936764658283566,0.12,6/16,2.94%,PTPRG;PTPRB;PTPRN2;PTPRD;PTPRR;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.7357863666355946,1.9217833833692797,0.0,0.0052936764658283566,0.12,6/16,2.94%,PTPRG;PTPRB;PTPRN2;PTPRD;PTPRR;PTPRT
prerank,Toll-like receptor binding (GO:0035325),0.7950508149365292,1.8734452673961977,0.002044989775051125,0.011698669709180948,0.261,7/11,12.99%,TIRAP;S100A9;S100A8;TOLLIP;TLR2;DAB2IP;CD36
prerank,protease binding (GO:0002020),-0.48718061681525937,-1.8697234827224067,0.0,0.05841780837077532,0.169,39/99,20.17%,COL1A2;COL3A1;TIMP3;STIM1;COL1A1;ITGAV;CFLAR;CCBE1;PRKN;GSK3B;ITGB1;LCOR;DPP4;ANXA2;TRIP4;BCL2;F3;ADAMTSL4;LDLR;LONP2;SELENOS;CHMP3;RHBDD2;RIOK3;FN1;SRI;FAP;BRCA2;BDKRB2;ECM1;BFAR;SERPINE1;DERL1;SYVN1;VCP;PARK7;ITGB3;TIMP2;CARD16
prerank,glycine binding (GO:0016594),0.7815653964763276,1.8671451503795857,0.0,0.012265369116488211,0.281,6/11,10.33%,GRIN1;GLRA1;GRIN2B;GLRA3;GLRA2;GRIN3A
prerank,sodium channel activity (GO:0005272),0.5784011851570859,1.840461893983589,0.0021141649048625794,0.01733767862633717,0.388,12/37,8.29%,HCN1;SCN1A;ASIC2;ASIC4;GRIK1;GRIK2;GRIK5;ASIC1;SCN4B;HCN2;KCNK1;SCN3A
prerank,calcium-activated potassium channel activity (GO:0015269),0.7527715083580679,1.8217660821596604,0.006289308176100629,0.020768671235061972,0.459,6/11,7.94%,KCNN2;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNN3
prerank,SUMO transferase activity (GO:0019789),-0.6829915155218915,-1.8067488270097698,0.003838771593090211,0.11933113476904009,0.381,8/16,15.33%,PIAS1;HDAC4;RANBP2;NSMCE2;PIAS3;UBE2I;PIAS4;TOPORS
prerank,glutamate receptor binding (GO:0035254),0.6767482010183292,1.8059612738701945,0.004301075268817204,0.023933641156311684,0.52,9/17,10.43%,CAMK2A;IGSF11;SHISA6;SHANK3;HIP1;SHISA7;HOMER1;SHANK2;HOMER2
prerank,R-SMAD binding (GO:0070412),-0.6741972034051018,-1.7977768797185976,0.0,0.11267642002906826,0.416,11/18,18.75%,SMAD3;LDLRAD4;SMAD6;DDX5;SMAD2;PMEPA1;JUN;SMAD4;PPM1A;SMURF1;RANBP3
prerank,semaphorin receptor binding (GO:0030215),0.612145784962694,1.7673393829306703,0.004273504273504274,0.035357495428136786,0.673,8/23,4.59%,RIT2;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,ankyrin binding (GO:0030506),0.633980053348816,1.7637956188237285,0.008928571428571428,0.03567472635382228,0.693,8/19,11.18%,SLC4A1;SPTBN4;SPTB;SLC8A1;KCNJ11;NRCAM;KCNQ2;SPTBN1
prerank,amino acid binding (GO:0016597),0.5815886714959525,1.7541712962839597,0.002105263157894737,0.037997228055056564,0.726,9/31,10.33%,GRIN1;GRM7;AARS2;GLRA1;GRIN2B;GLRA3;NOS3;GLRA2;GRIN3A
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.5560843213080018,-1.7460525491876422,0.003875968992248062,0.18359882630815103,0.646,17/33,25.53%,PCF11;SCAF8;DHX9;AR;CTR9;TBP;RPRD2;WDR43;GTF2B;HNRNPU;CDC73;WAC;DRAP1;CCAR2;AGO1;RTRAF;RECQL5
prerank,androgen receptor binding (GO:0050681),-0.5851880760955358,-1.742139078886195,0.001976284584980237,0.16830567605852018,0.663,16/25,25.57%,FOXP1;DDX5;EP300;TGFB1I1;NSD1;PRPF6;PRMT2;WIPI1;KDM3A;RNF14;PARK7;ARID5A;RNF6;TRIM68;KDM1A;ZBTB7A
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6759379657480814,-1.7418240536904883,0.0019193857965451055,0.1498571179133805,0.664,6/15,20.81%,ALDH1A1;ALDH1A2;ALDH2;ALDH1L1;ALDH7A1;ALDH4A1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.6891446561715275,-1.741079801990657,0.0076045627376425855,0.1365728956862398,0.669,4/13,2.60%,BMP6;BMP5;BMP7;BMP4
prerank,inward rectifier potassium channel activity (GO:0005242),0.6057975537233741,1.7369446680933547,0.0064516129032258064,0.04449401280857318,0.787,8/24,8.25%,KCNJ3;KCNJ6;KCNN2;KCNJ11;KCNN1;KCNJ10;KCNN3;KCNK1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6363434156114255,1.7346920404837365,0.01079913606911447,0.044313902795666986,0.792,5/19,5.29%,NRG3;GRM5;NRG1;GAS6;CD24
prerank,ion channel activity (GO:0005216),0.46915110474571087,1.7345542796942823,0.002008032128514056,0.043096515442609534,0.792,18/80,7.23%,GRIA2;GRIN1;GRIA4;GABRB1;GRID1;GRIN2A;GRID2;ASIC4;GRIA1;GRIK1;GRIN2B;GRIN2D;UNC80;GRIK2;GRIK5;TMEM63B;TRPM2;GRIA3
prerank,chemorepellent activity (GO:0045499),0.5915448335240666,1.7319924981102142,0.004201680672268907,0.04287048949954955,0.797,9/25,4.59%,NRG3;SEMA3C;SEMA6A;NRG1;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6428691207433865,-1.7263540957635948,0.0038095238095238095,0.14622498194132288,0.726,7/18,7.90%,PDLIM5;BAIAP2L1;ANXA2;RAB10;TMOD3;ANXA1;CNN3
prerank,histone demethylase activity (GO:0032452),-0.5790261221664609,-1.7177562949130152,0.007312614259597806,0.14935297285732202,0.761,11/27,16.10%,KDM7A;KDM4B;PHF8;KDM5B;KDM6A;PHF2;FBXL19;KDM3B;KDM3A;JARID2;KDM2A
prerank,cAMP binding (GO:0030552),0.7125589726523822,1.7111396016909863,0.00847457627118644,0.051367770037357846,0.853,6/11,12.83%,HCN1;PDE4B;PDE10A;PDE2A;PDE4D;PDE4A
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6927980995372469,-1.6979007288942172,0.006048387096774193,0.17311565617269342,0.839,6/13,20.81%,ALDH1A1;ALDH1A2;ALDH2;ALDH1L1;ALDH7A1;ALDH4A1
prerank,BMP receptor binding (GO:0070700),-0.6891462680007302,-1.6963415182919277,0.013358778625954198,0.16318095153778292,0.843,4/12,2.60%,BMP6;BMP5;BMP7;BMP4
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.39917109521265765,-1.6915687626626286,0.0,0.16099872365227272,0.859,58/188,16.99%,ZBTB20;PBX1;BNC2;SMAD3;TCF7L2;SOX5;NFKB1;CREB3L2;PRDM5;SMAD6;FOXC1;PER3;FOXO3;HDAC4;BCOR;NCOR1;TFEB;TBL1X;BRD7;TBL1XR1;YAP1;KMT2D;HMGB1;GABPB2;STAT3;FOXC2;DHX9;REST;RUNX1;AR;DHX36;FOXK1;TBP;NFYC;CHD3;JUN;NR1H3;GABPA;SMAD4;GLIS2;CALCOCO1;MEF2C;ZBED4;TBX18;ARID5B;SOX13;IRF1;ATF6;SOX6;GLI1;HINFP;RXRA;KLF15;SFPQ;VSX1;FOXK2;SIX1;NFYB
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5443941488056432,1.685280575163472,0.006329113924050633,0.06439922906504013,0.925,8/32,11.77%,KCNQ3;KCNC2;KCNH1;KCNC3;KCNQ5;KCNC1;KCNQ2;KCNA2
prerank,transforming growth factor beta binding (GO:0050431),-0.59133303692058,-1.6849624535681298,0.007590132827324478,0.16376837055399393,0.883,12/23,16.18%,TGFBR3;TGFBR1;LTBP1;ITGAV;TGFBR2;THBS1;TWSG1;CD109;ACVR1;LRRC32;TGFB3;VASN
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.3490707157650844,-1.6642733477031941,0.0,0.19537103701842393,0.932,185/732,18.50%,ZBTB20;NFIA;PBX1;FOXP2;FOXP1;HLF;NR2F2;ZIC4;PKNOX2;NFAT5;ZIC1;SMAD3;GLI3;TCF4;TCF7L2;ZBTB7C;MAF;SOX5;TEAD1;FOXD1;PRRX1;NFKB1;PRDM5;HOXB6;ZNF148;ZKSCAN2;HIVEP2;RBPJ;THRB;ZNF423;GLIS3;HOXC6;GLI2;FOXP4;NR1D2;ZFHX3;RARB;FOXC1;ZEB1;KLF9;ZIC2;FOXO3;CREB5;HDAC4;NR3C2;ARNT;TFEB;MXI1;MEOX2;HOXB3;NFIB;ELF1;FOXN3;KCNIP3;NR6A1;TOP1;RREB1;NFIX;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;ZNF182;HOXA5;SMAD2;PRRX2;ZBTB16;TBX15;SKI;PBX3;ZIC5;TEF;HOXA7;STAT3;JDP2;NSD1;DNMT3A;FOXC2;ELF4;HOXC4;SKIL;HIVEP3;DHX9;HOXA3;REST;CEBPG;HOXB5;ZBTB37;RUNX1;GTF2IRD1;AR;DHX36;FOXK1;ZNF496;SP2;NFYC;ZEB2;MAFG;ZBTB1;KDM6A;CHD2;HOXB4;ATF2;ZFAT;TEAD3;ZNF467;RFX2;UBP1;ZNF569;JUN;NR1H3;GABPA;HIF1A;SMAD4;GLIS2;CALCOCO1;ZBTB24;MEF2C;NFATC4;NRF1;TEAD2;HES1;TBX18;TFCP2;IRF9;ZNF692;BHLHE41;TCF3;TCF7L1;ZBTB34;SOX13;PATZ1;IRF1;ATF6;SOX6;SIX5;GLI1;CCAR1;HINFP;MKX;MED8;ZSCAN18;CC2D1B;STAT1;RORA;ZNF367;ZNF18;HDAC1;ZNF697;HOXB9;CARF;HOXC5;RXRA;ZKSCAN1;KLF15;MNT;SNAPC3;ATOH8;IKZF2;PRDM15;ZNF112;FOXL1;SALL1;FOXK2;KLF6;MYBL1;NR4A1;SIX1;NFYB;HEYL;TBX2;RUNX2;STAT5A;NR4A2;HNRNPU;NFIC;CC2D1A;STAT5B;POU6F2;ZFHX4;ZKSCAN7;TFCP2L1;NFATC3
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.384426828136207,-1.6639660400522027,0.0,0.18489519930944426,0.932,73/232,20.68%,RNF220;PDZRN3;RNF152;PELI2;SMURF2;CBLB;RNF43;UBR2;TRIM44;PIAS1;KCMF1;PRKN;ARIH1;WWP2;RNF115;TRIP12;HUWE1;RNF217;UHRF2;RBBP6;UBR5;RC3H1;MEX3C;UFL1;SH3RF1;DTX4;NSMCE2;RNF19A;WWP1;ASB2;TRAF3IP2;RNF8;CDC42;RNF145;HLTF;RNFT1;PIAS3;XIAP;RNF216;HERC2;UBR1;GID4;RFWD3;TRIM5;UBR3;TRIM11;PIAS4;TRIM25;CUL3;NHLRC3;DTX3L;SH3RF2;TRIM39;SMURF1;TOPORS;UBR4;MSL2;HECTD1;RNF181;SH3RF3;BFAR;SYVN1;TRAF6;MYLIP;AREL1;RNF14;LRSAM1;UBE2D3;NFX1;COP1;DTX2;TRIM63;RNF11
prerank,poly-pyrimidine tract binding (GO:0008187),-0.584447899246054,-1.6621812874426003,0.013232514177693762,0.1786862549348294,0.937,8/23,6.30%,RBMS1;RBMS3;ATXN1;HNRNPH1;DIS3L2;KHDRBS1;RBMS2;U2AF2
prerank,calcium ion binding (GO:0005509),0.3696803046719147,1.6595671063212327,0.0,0.07938601650974812,0.96,59/323,9.92%,SPOCK2;ADGRL3;SPOCK1;GRIN1;NRXN1;CDH12;CDH8;SYT1;PCLO;SYT6;S100A16;RASGRP3;MMP12;KCNIP4;SYT7;CDH19;CDH20;CDH7;S100A9;S100A8;S100G;DNER;SYT12;SYT11;CDH18;RYR2;MCTP1;CDH2;RYR3;MMP13;SNCA;MEX3B;KCNIP1;SLC8A1;ENPP2;RCN2;CDH10;SLC25A23;HSPA5;PITPNM1;PCDHB6;SLIT3;SLIT1;TRPM2;CPNE1;THBS3;SYT10;MELK;TUBB4A;CIB2;S100A2;DYSF;TPT1;ARSA;GALNT3;DCHS1;ASTN2;AIF1;PVALB
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.34753169346686624,-1.6574252393077784,0.0,0.17820267369026804,0.942,186/731,18.50%,ZBTB20;NFIA;PBX1;FOXP2;FOXP1;HLF;NR2F2;ZIC4;PKNOX2;NFAT5;ZIC1;SMAD3;GLI3;TCF4;TCF7L2;ZBTB7C;MAF;SOX5;TEAD1;FOXD1;PRRX1;NFKB1;CREB3L2;PRDM5;HOXB6;ZNF148;ZKSCAN2;HIVEP2;RBPJ;THRB;ZNF423;GLIS3;HOXC6;GLI2;FOXP4;NR1D2;ZFHX3;RARB;FOXC1;ZEB1;KLF9;ZIC2;FOXO3;CREB5;HDAC4;NR3C2;ARNT;TFEB;MXI1;MEOX2;HOXB3;NFIB;ELF1;KCNIP3;NR6A1;TOP1;RREB1;NFIX;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;ZNF182;HOXA5;SMAD2;PRRX2;ZBTB16;TBX15;SKI;PBX3;ZIC5;TEF;HOXA7;STAT3;JDP2;NSD1;DNMT3A;FOXC2;ELF4;HOXC4;SKIL;HIVEP3;DHX9;HOXA3;REST;CEBPG;HOXB5;ZBTB37;RUNX1;GTF2IRD1;AR;DHX36;FOXK1;ZNF496;SP2;NFYC;ZEB2;MAFG;ZBTB1;KDM6A;CHD2;HOXB4;ATF2;ZFAT;TEAD3;ZNF467;RFX2;UBP1;ZNF569;JUN;NR1H3;GABPA;HIF1A;SMAD4;GLIS2;CALCOCO1;ZBTB24;MEF2C;NFATC4;NRF1;TEAD2;HES1;TBX18;TFCP2;IRF9;ZNF692;BHLHE41;TCF3;TCF7L1;ZBTB34;SOX13;PATZ1;IRF1;ATF6;SOX6;SIX5;GLI1;CCAR1;HINFP;MKX;MED8;ZSCAN18;CC2D1B;STAT1;RORA;ZNF367;ZNF18;HDAC1;ZNF697;HOXB9;CARF;HOXC5;RXRA;ZKSCAN1;KLF15;MNT;SNAPC3;ATOH8;IKZF2;PRDM15;ZNF112;FOXL1;SALL1;FOXK2;KLF6;PRMT5;MYBL1;NR4A1;SIX1;NFYB;HEYL;TBX2;RUNX2;STAT5A;NR4A2;HNRNPU;NFIC;CC2D1A;STAT5B;POU6F2;ZFHX4;ZKSCAN7;TFCP2L1;NFATC3
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.7098711150966948,-1.6527685951669875,0.01486988847583643,0.17808924105265492,0.954,7/10,22.01%,SETD5;NSD1;NSD3;SETD3;SETD2;ASH1L;PRDM9
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6955668271877771,1.648890123794489,0.0175054704595186,0.08565097465650337,0.971,2/11,6.33%,HCN1;HCN2
prerank,I-SMAD binding (GO:0070411),-0.6775327447345081,-1.6484448027395748,0.01125703564727955,0.17845016308142403,0.963,10/13,21.47%,SMAD3;TGFBR1;SMAD6;TGFB1I1;SMAD2;AXIN1;SMAD4;SMURF1;SMAD9;SMAD1
prerank,thyroid hormone receptor binding (GO:0046966),-0.5444764017567595,-1.6408142220642243,0.018975332068311195,0.18366223585712732,0.972,18/28,27.03%,NCOR1;TRIP12;MED17;NSD1;MED12;NCOA6;MED1;PRMT2;GTF2B;TRIP6;MED16;HMGN3;ARID5A;MED13;GTF2H1;TAF7;JMJD1C;GAS2L1
prerank,poly(U) RNA binding (GO:0008266),-0.5982928170039136,-1.6400287881728266,0.013539651837524178,0.17742755066657812,0.973,7/20,5.14%,RBMS1;RBMS3;ATXN1;HNRNPH1;DIS3L2;KHDRBS1;RBMS2
prerank,G protein-coupled receptor activity (GO:0004930),0.37869938567398076,1.6358850807238188,0.0,0.0943139215159205,0.986,50/239,16.76%,ADGRL4;PAX8;GRM5;ADGRL3;ADGRB3;MTNR1B;HCAR2;GRM1;ADGRB1;GRM8;ADRB1;S1PR5;HCRTR1;GPR101;GPR149;LGR5;MTNR1A;GPR35;P2RY1;ADGRA1;APLNR;ELOVL4;GPR26;GPR176;GPR17;ADRA1D;ADRA1A;TRHR;ADGRL2;GPR75;HCRTR2;MRGPRE;OPRM1;CELSR2;F2RL2;F2R;CNR1;GRPR;GPR85;RORB;OPRK1;GRM3;ADGRG1;OPRL1;NPFFR2;ADCYAP1R1;NPR1;CALCRL;GPR45;ADGRE1
prerank,glucose transmembrane transporter activity (GO:0005355),0.6118179506503723,1.6322569898401031,0.017241379310344827,0.09513391339931614,0.986,4/17,4.35%,SLC2A1;SLC2A3;SLC2A5;SLC5A11
prerank,DNA-binding transcription factor binding (GO:0140297),-0.3908707332967727,-1.631911516995646,0.0,0.18371549987826744,0.977,52/189,13.79%,FHL2;SMAD3;TCF7L2;PRRX1;PRDM5;RBPJ;PIAS1;EP300;HDAC4;NCOR1;RERE;WWP2;RBBP8;GSK3B;YAP1;MEF2A;HMGB1;CBX5;SMAD2;SKI;NBN;CREBBP;STAT3;DHX9;BCL2;AR;CRTC3;TBP;PIAS3;RUNX1T1;DACT1;CHD4;ATF2;MIER1;EIF4E;TEAD3;JUN;GABPA;HCFC1;ID2;TLE4;CRTC1;MEF2C;TLE1;HES1;RB1;SIK1;PIAS4;BHLHE41;TCF3;CGGBP1;TCERG1
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.6115212697831403,-1.6269254363648047,0.02095238095238095,0.18472068755927015,0.979,6/18,5.49%,TGFBR3;SMAD3;TGFBR1;SMAD6;TGFBR2;SMAD2
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.5140811249178037,-1.6239409749960745,0.00946969696969697,0.18241648611715675,0.984,19/33,33.23%,PCF11;SCAF8;DHX9;CTR9;RPRD2;WDR43;SPTY2D1;GTF2B;HNRNPU;CDC73;WAC;CCAR2;AGO1;RTRAF;RECQL5;RRN3;ZNF326;ELOF1;URI1
prerank,ubiquitin protein ligase activity (GO:0061630),-0.37516771579797886,-1.617631757032244,0.0,0.1863941305921895,0.987,70/228,20.68%,RNF220;PDZRN3;RNF152;PELI2;SMURF2;CBLB;RNF43;UBR2;TRIM44;KCMF1;PRKN;ARIH1;WWP2;RNF115;TRIP12;HUWE1;RNF217;UHRF2;RBBP6;UBR5;RC3H1;MEX3C;SH3RF1;DTX4;RNF19A;WWP1;UBE4B;ASB2;TRAF3IP2;RNF8;CDC42;RNF145;UBE2K;HLTF;RNFT1;XIAP;RNF216;HERC2;UBR1;GID4;RFWD3;TRIM5;UBR3;TRIM11;TRIM25;CUL3;NHLRC3;DTX3L;SH3RF2;TRIM39;SMURF1;TOPORS;UBR4;MSL2;HECTD1;RNF181;SH3RF3;BFAR;SYVN1;TRAF6;MYLIP;AREL1;RNF14;LRSAM1;UBE2D3;NFX1;COP1;DTX2;TRIM63;RNF11
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.33584962447184213,-1.6156747171709185,0.0,0.18293946417818294,0.988,203/831,18.50%,ZBTB20;NFIA;PBX1;FOXP2;FOXP1;HLF;NR2F2;AEBP1;ZIC4;PKNOX2;NFAT5;ZIC1;SMAD3;GLI3;TCF4;TCF7L2;ZBTB7C;MAF;SOX5;TEAD1;FOXD1;PRRX1;NFKB1;PRDM5;HOXB6;ZNF148;ZKSCAN2;HIVEP2;RBPJ;THRB;ZNF423;GLIS3;HOXC6;GLI2;FOXP4;NR1D2;ZFHX3;RARB;FOXC1;ZEB1;KLF9;ZIC2;FOXO3;CREB5;HDAC4;NR3C2;CUX1;OSR1;ARNT;TFEB;MXI1;MEOX2;HOXB3;NFIB;ELF1;KCNIP3;NR6A1;TOP1;RREB1;NFIX;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;ZNF182;HOXA5;SMAD2;PRRX2;ZBTB16;TBX15;SKI;PBX3;ZIC5;TEF;HOXA7;TFDP2;STAT3;JDP2;NSD1;HOXC8;DNMT3A;FOXC2;ELF4;HOXC4;SKIL;HIVEP3;DHX9;HOXA3;REST;VEZF1;CEBPG;HOXB5;ZBTB37;RUNX1;GTF2IRD1;AR;ZBTB8A;DHX36;FOXK1;ZNF496;CDC5L;SP2;TBP;NFYC;ZEB2;MAFG;ZBTB1;KDM6A;CHD2;HOXB4;ATF2;ZFAT;TEAD3;ZNF467;RFX2;UBP1;ZNF569;JUN;NR1H3;GABPA;HIF1A;CREBRF;SMAD4;GLIS2;CALCOCO1;ZBTB24;MEF2C;NFATC4;NRF1;TEAD2;HES1;RB1;TBX18;TFCP2;IRF9;ZNF692;BHLHE41;TCF3;TCF7L1;ZBTB34;SOX13;PATZ1;IRF1;ATF6;SOX6;SIX5;GLI1;CCAR1;ZFP3;HINFP;MKX;MED8;ZSCAN18;CC2D1B;STAT1;RORA;ZNF367;ZNF18;HDAC1;ZNF697;HOXB9;CARF;HOXC5;RXRA;ZKSCAN1;KLF15;PRDM2;MNT;SNAPC3;BBX;ATOH8;IKZF2;PRDM15;TRPS1;ZNF112;FOXL1;SALL1;GTF2B;FOXK2;KLF6;MYBL1;NR4A1;SIX1;NFYB;HEYL;ZFP37;TBX2;RUNX2;TWIST2;STAT5A;NR4A2;HNRNPU;NFIC;CC2D1A;STAT5B;POU6F2;ZFHX4;ZKSCAN7;TFCP2L1;ZNF436;NFATC3
prerank,nuclear receptor binding (GO:0016922),-0.40962264168283924,-1.6129480880565459,0.0,0.18171908545627588,0.988,58/111,27.07%,FOXP1;SMAD3;TCF7L2;DDX5;EP300;NCOR1;TRIP12;PPARGC1B;TGFB1I1;BAZ2A;LCOR;BCAS3;MED17;DCAF1;TRIP4;NSD1;MED12;PRPF6;PPARGC1A;NCOA6;NCOA1;MED1;JUP;PRMT2;TADA3;HIF1A;WIPI1;MMS19;STAT1;LATS1;KDM3A;RXRA;GTF2B;NR4A1;CNOT1;NR4A2;STAT5B;RNF14;PARK7;TRIP6;MED16;TACC2;HMGN3;PPID;ARID5A;RNF6;SMARCD3;MED13;MED14;GTF2H1;TRIM68;PHB2;KDM1A;ZBTB7A;TAF7;JMJD1C;GAS2L1;ESR1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5956655460231505,-1.6124582216379668,0.011472275334608031,0.17640604707516933,0.988,5/18,3.19%,TGFBR3;TGFBR1;BMPR1A;LTBP1;TGFBR2
prerank,SH2 domain binding (GO:0042169),-0.524858572973842,-1.5998359424636792,0.018832391713747645,0.1923392161528076,0.994,8/31,7.54%,AFAP1;DAG1;SH3PXD2B;ABL1;PAG1;IRS1;KHDRBS1;INPPL1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.5212748625883854,1.5919993455529837,0.018480492813141684,0.12827767026356288,0.997,8/30,11.88%,SLC39A10;SLC40A1;SLC39A2;SLC30A1;SLC25A37;SLC30A3;SLC39A8;SLC30A5
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.5091788169338803,-1.5895851296081374,0.011811023622047244,0.20610366519044945,0.997,15/34,15.74%,GAB2;FCHSD2;ADAP2;MYO1B;GBF1;ARAP1;MAPKAP1;CYTH3;ZFYVE1;DAPP1;IQGAP2;KIF16B;PARD3;OGT;ZFYVE16
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.44693668146911597,-1.5796947956590772,0.009689922480620155,0.21752376389346378,0.998,18/60,15.44%,LRRK1;CTDSPL;PPM1D;PPM1E;LRRK2;CDC14A;PPP4C;CAMK2G;SSU72;PPP2CB;PPM1H;PPM1M;MTMR3;PPM1A;DUSP1;CTDSPL2;CDC14B;PPP1CB
prerank,vinculin binding (GO:0017166),-0.669433608401677,-1.5760425866170344,0.01858736059479554,0.21915185586861735,0.998,5/11,15.53%,DAG1;CTNNA1;TLN1;SYNM;SORBS3
prerank,cyclic nucleotide binding (GO:0030551),0.5591533236135071,1.573173129036219,0.029880478087649404,0.14466367840418065,0.997,8/21,12.83%,HCN1;PDE4B;PDE10A;PDE2A;PDE11A;KCNH1;PDE4D;PDE4A
prerank,ubiquitin-specific protease binding (GO:1990381),-0.5768365753565519,-1.568474728881399,0.009900990099009901,0.22818865599846544,0.998,9/19,19.17%,PRKN;LCOR;SELENOS;CHMP3;RHBDD2;DERL1;SYVN1;VCP;PARK7
prerank,calcium activated cation channel activity (GO:0005227),0.5955393128815271,1.5660399192598455,0.026200873362445413,0.1498998640578725,0.999,6/17,5.92%,KCNN2;KCNMB2;KCNMB3;KCNN1;TMEM63B;KCNMB4
prerank,ligand-gated calcium channel activity (GO:0099604),0.5612991242027092,1.556326893958253,0.030434782608695653,0.1574849439871995,0.999,7/19,6.44%,GRIN1;GRIN2A;RYR2;RYR3;GRIN2B;GRIN2D;TRPM2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.6217198213762938,-1.5550908745555627,0.040152963671128104,0.24985837744519493,0.999,6/14,19.41%,CYB5R4;NOX4;AIFM1;CYBA;MICAL1;NCF2
prerank,frizzled binding (GO:0005109),-0.4981571261591442,-1.5523041359620202,0.015533980582524271,0.24910404233731226,0.999,15/34,25.71%,WNT4;LRP6;RNF43;WNT5B;WNT6;RYK;WNT9A;FZD7;WNT5A;MYOC;FZD1;DVL3;WNT16;ZNRF3;DVL2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.32871601747636703,-1.545737412432452,0.0,0.25624141983894977,1.0,111/597,13.59%,ZBTB20;PBX1;BNC2;FOXP1;HLF;ZIC4;PKNOX2;NFAT5;ZIC1;SMAD3;GLI3;TCF4;TCF7L2;MAF;SOX5;TEAD1;NFKB1;CREB3L2;PRDM5;HOXB6;THRB;SMAD6;GLI2;NR1D2;RARB;FOXC1;PER3;FOXO3;CREB5;HDAC4;BCOR;NR3C2;ABL1;NCOR1;CUX1;OSR1;ARNT;TFEB;MBNL2;MEOX2;NFIB;TBL1X;ELF1;BRD7;TBL1XR1;NR6A1;NFIX;YAP1;GMEB1;RARG;KMT2D;HMGB1;NR3C1;KLF3;HOXA5;PRRX2;TBX15;GABPB2;ZIC5;TEF;HOXA7;STAT3;JDP2;HOXC8;FOXC2;ELF4;HOXC4;DHX9;KDM5B;REST;CEBPG;HOXB5;ZBTB37;RUNX1;AR;DHX36;FOXK1;SP2;MBD2;TBP;NFYC;MAFG;HOXB4;ATF2;CHD3;RFX2;UBP1;JUN;NR1H3;GABPA;SMAD4;GLIS2;CALCOCO1;MCM9;MEF2C;ZBED4;NFATC4;TEAD2;HES1;TBX18;TFCP2;IRF9;ARID5B;BHLHE41;TCF7L1;SOX13;IRF1;ATF6;SOX6;YBX1;GLI1
prerank,AMP binding (GO:0016208),-0.662805821913605,-1.5449124278708395,0.03910614525139665,0.25156523206657666,1.0,6/11,21.81%,PRKAG2;MPPED2;PFKP;PRKAG3;PFKM;PFKL
prerank,voltage-gated sodium channel activity (GO:0005248),0.5429843806845805,1.5446304498628796,0.02159827213822894,0.1682667972716539,0.999,9/22,15.88%,HCN1;SCN1A;SCN4B;HCN2;SCN3A;SCN2A;CACNA1I;SCN2B;SCN8A
prerank,carboxylic acid binding (GO:0031406),0.4837454211258897,1.5400502954663846,0.024291497975708502,0.17025031962583548,0.999,11/38,12.72%,GRIN1;GRM7;MAG;GLRA1;GRIN2B;GLRA3;NOS3;RTN4R;GLRA2;GRIN3A;EPDR1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4641992317392855,1.5386872794512134,0.006185567010309278,0.16837675984118947,0.999,12/49,7.94%,SYT1;PCLO;SYT6;SYT7;SYT12;SYT11;MCTP1;CPNE9;CPNE8;CPNE1;SYT10;DYSF
prerank,metalloendopeptidase activity (GO:0004222),-0.41838212837334665,-1.5354788529619714,0.009541984732824428,0.26435337863261105,1.0,22/76,14.04%,TRABD2B;ADAMTS2;ADAMTS10;THSD4;ADAMTSL3;ADAMTS12;ADAMTS6;ADAMTSL5;ADAMTS5;ECE1;ADAMTSL4;ADAMTS9;NRDC;ADAM9;MBTPS2;MMP14;ADAM19;ADAMTS15;ADAM33;NLN;MMP2;ADAMTS17
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5403647899696997,1.5249145663584645,0.027559055118110236,0.1811588459484391,0.999,5/22,6.44%,SYT1;AP2M1;APBB1;APBB3;CLU
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.6381245685330716,-1.518691780888672,0.04572564612326044,0.2932233682300082,1.0,7/12,21.62%,GAB2;IRS1;SHC1;FRS2;SH2B1;BLNK;PIK3R1
prerank,hexose transmembrane transporter activity (GO:0015149),0.6253556762849507,1.5168932720961248,0.04782608695652174,0.18844067097150072,0.999,3/12,2.70%,SLC2A1;SLC2A3;SLC2A5
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.5203266235355379,-1.5168086648587318,0.02819548872180451,0.29078324753716706,1.0,8/25,10.54%,GAB2;PLEKHA2;FCHSD2;ADAP2;MAPKAP1;ZFYVE1;DAPP1;KIF16B
prerank,acetyltransferase activity (GO:0016407),-0.48828796981144545,-1.5145196332641901,0.030710172744721688,0.2888665237398665,1.0,11/31,16.20%,KAT2B;EP300;KAT6B;CREBBP;PAFAH2;SAT1;PAFAH1B2;KAT8;ESCO1;NAA15;GTF2B
prerank,RNA polymerase II complex binding (GO:0000993),-0.49192438530924193,-1.5133601387266282,0.029644268774703556,0.2846150913978098,1.0,14/32,25.53%,PCF11;SCAF8;DHX9;CTR9;RPRD2;WDR43;GTF2B;HNRNPU;CDC73;WAC;CCAR2;AGO1;RTRAF;RECQL5
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6372947051816931,-1.5110527178252335,0.03364485981308411,0.28365557184002893,1.0,5/12,3.19%,TGFBR3;TGFBR1;BMPR1A;LTBP1;TGFBR2
prerank,peptidoglycan binding (GO:0042834),0.6613543606949003,1.5105392868157406,0.05183585313174946,0.19332714155534228,0.999,5/10,21.01%,PGLYRP1;TLR2;NOD1;NOD2;RNASE7
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.33644760415740105,-1.5084738822718669,0.0,0.28283342131671807,1.0,105/346,21.57%,RNF220;PDZRN3;RNF152;PELI2;SMURF2;UBE2N;CBLB;RNF43;UBR2;UBE2E2;TRIM44;KCMF1;PRKN;BCOR;BIRC6;FBXW8;ARIH1;KLHL13;BTRC;WWP2;RNF115;TRIP12;RNF146;HUWE1;RNF217;UHRF2;RBBP6;UBR5;RC3H1;RNF213;MEX3C;SH3RF1;DTX4;RNF214;RNF19A;WWP1;ASB2;UBE2H;TRAF3IP2;RNF8;FBXO10;CDC42;RNF145;UBE2K;HLTF;RNFT1;DDB2;MAEA;XIAP;FBXO3;ANAPC4;TNFAIP1;RNF216;HERC2;UBR1;RNF103-CHMP3;TRAF2;UBE2R2;GID4;RFWD3;TRIM5;UBR3;TRIM11;TRIM25;CUL3;NHLRC3;DTX3L;SH3RF2;UBE2B;TRIM39;SMURF1;CUL2;TOPORS;ERCC8;UBR4;MSL2;TRAF3;UBE2E1;HECTD1;RNF181;SH3RF3;BFAR;RNF20;UBA7;UBE2S;FBXO22;SYVN1;TRAF6;FBXW11;MYLIP;AREL1;RNF14;LRSAM1;UBE2D3;NFX1;PML;COP1;DTX2;TRIM63;RNF11;SHARPIN;TTC3;ANAPC11;CUL1;ARIH2
prerank,glycerophospholipid flippase activity (GO:0140333),0.6249447063624093,1.50778850499884,0.05197505197505198,0.19341191380682843,0.999,7/11,11.06%,ATP8A1;ATP11A;ATP10A;ATP10B;ATP11C;ATP8A2;ABCB4
prerank,neuropeptide binding (GO:0042923),0.5592023028937101,1.50606780280796,0.04831932773109244,0.1920566349108734,0.999,5/18,15.25%,GPR149;OPRM1;SORL1;OPRK1;OPRL1
prerank,potassium channel regulator activity (GO:0015459),0.44080891613925505,1.5022738571734715,0.022964509394572025,0.19364972612957757,0.999,12/49,8.42%,DPP10;KCNIP4;KCNIP1;WNK2;KCNMB2;KCNMB3;KCNMB4;DPP6;KCNAB1;AKT1;LRRC55;SGK3
prerank,histone methyltransferase activity (GO:0042054),-0.4878100102160939,-1.5016093114094844,0.02862595419847328,0.2920417782548711,1.0,16/32,22.01%,SETD7;KMT5B;KMT2C;NSD3;SMYD3;SETD2;PRMT2;N6AMT1;SETDB1;EHMT1;PRMT5;PRMT8;NTMT1;KMT5A;EZH2;PRDM9
prerank,cell-cell adhesion mediator activity (GO:0098632),0.45828759080083636,1.4976335340333937,0.030120481927710843,0.1963126673267258,0.999,14/42,12.08%,DSCAM;BSG;LRRC4C;PLXNB3;CNTN6;ROBO4;DSCAML1;NPTN;VSTM2L;ESAM;NTNG1;ROBO3;CNTN4;CNTN2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.6197269680951822,-1.4940091166834326,0.055658627087198514,0.3025873482125636,1.0,7/12,26.57%,CYFIP2;LARP1;GEMIN5;EIF4E;EIF4E3;NCBP3;NCBP2
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.6172879732385294,-1.491009613545846,0.05350553505535055,0.3036137978353733,1.0,6/12,16.56%,SULF1;GNS;SULF2;ARSK;ARSI;GALNS
prerank,single-stranded DNA binding (GO:0003697),-0.38896779761389294,-1.4894280255334373,0.003669724770642202,0.30090787338595826,1.0,48/93,32.79%,RBMS1;RAD23B;RBBP8;TOP1;HMGB1;SMC6;WDR48;TDP2;MLH1;DHX9;RAD51B;DHX36;PCBP2;FUBP1;SSBP2;MCM9;RTF1;RAD51D;NABP2;APTX;BRCA2;MCM6;MSH3;CTC1;DMC1;SPRTN;HNRNPU;WBP11;POLR2H;PARK7;STN1;SSBP1;ERCC1;CRY2;LONP1;MCM4;POLR2D;MCMDC2;SAMHD1;IGHMBP2;TWNK;NEIL3;RPA2;PCBP1;RNF138;CDC45;RAD51;POLA1
prerank,FAD binding (GO:0071949),-0.5173609472535935,-1.48777919769861,0.04609218436873747,0.2985023486727743,1.0,11/24,17.96%,MICAL3;DDO;MICAL2;MTHFR;AIFM1;SQOR;PRODH;KDM1B;MICAL1;NQO2;SQLE
prerank,potassium:proton antiporter activity (GO:0015386),-0.6615570971534077,-1.4850293953339724,0.03636363636363636,0.29852045838269803,1.0,3/10,6.00%,SLC9A1;SLC9A8;SLC9A2
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6420883132037034,1.484889198124556,0.07709251101321586,0.21044561079837037,1.0,5/10,9.00%,IGSF11;SHISA6;SHANK3;SHISA7;SHANK2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.4784209710192575,-1.4833886398592404,0.03718199608610567,0.2968784198864321,1.0,16/32,29.56%,FTO;KDM7A;KDM4B;PHF8;TMLHE;EGLN3;BBOX1;ALKBH1;TYW5;KDM2A;JMJD4;TET2;EGLN2;TET3;PHYHD1;HSPBAP1
prerank,sialyltransferase activity (GO:0008373),0.5270031267530662,1.4804915442622577,0.046610169491525424,0.2128594535026025,1.0,7/20,12.38%,ST6GALNAC3;ST8SIA4;ST3GAL6;ST8SIA1;ST8SIA6;ST8SIA3;ST6GAL2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5809809580316891,1.4777153619489456,0.06374501992031872,0.21332715271188912,1.0,7/15,7.12%,HS6ST3;HS3ST6;HS3ST5;HS3ST2;HS6ST2;NDST4;HS3ST4
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.4727304843622826,-1.4773716138249742,0.02857142857142857,0.3045356958174293,1.0,17/34,26.15%,STK3;FAM20A;CCNT2;CAB39L;CCNT1;IGF2;MAP2K1;CCNK;RICTOR;DDX3X;MTCP1;CAB39;TAOK1;ALS2;DBF4;IRGM;INCENP
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.42939510548378607,-1.4750499104068056,0.0321285140562249,0.3040197246314032,1.0,27/53,27.57%,MICAL3;AOX1;DDO;MICAL2;POR;NOX4;MTHFR;AIFM1;SQOR;PRODH;KDM1B;PPOX;DPYD;MICAL1;NQO2;SQLE;ACOX1;SDHA;NOS1;ILVBL;ACOX3;CRY2;GSR;KDM1A;MTO1;ACADVL;GFER
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.3557922909276129,-1.4748264515243068,0.004282655246252677,0.2991238554321662,1.0,46/173,18.50%,ZBTB20;FOXP2;FOXP1;AEBP1;NFKB1;PRDM5;ZNF148;FOXP4;ZFHX3;ZEB1;FOXO3;MXI1;KCNIP3;ZKSCAN3;NR3C1;ZBTB16;SKI;JDP2;SKIL;REST;ZBTB37;GTF2IRD1;FOXK1;SP2;ZEB2;ZBTB1;JUN;NFATC4;HES1;TBX18;ZNF692;BHLHE41;TCF3;ZBTB34;SOX13;PATZ1;PRDM2;MNT;TRPS1;FOXK2;HEYL;ZFP37;TBX2;CC2D1A;ZNF436;NFATC3
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.6172040439384352,-1.4702206353923777,0.048327137546468404,0.30333451885862917,1.0,6/12,24.60%,SLC9A1;SLC9A8;SLC9A2;LETM1;SLC9B2;SLC9A9
prerank,rRNA binding (GO:0019843),0.44166316848025317,1.469903253463997,0.026490066225165563,0.22095592400187727,1.0,18/42,18.77%,RPL23;RPF2;RPLP0;MRPS18A;RPL12;MRPS7;RPL5;ERI1;RPS3;FASTKD5;RPS14;UTP23;RPS5;MDM2;PPAN;RPS9;CIRBP;MRPL18
prerank,regulatory RNA binding (GO:0061980),-0.45173412955414227,-1.4684504919374095,0.03007518796992481,0.30182694540490435,1.0,8/38,8.06%,DICER1;PUM2;ZC3H7A;RC3H1;DHX9;PUM1;TUT4;RBM10
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.6112324829562701,1.4660698179727787,0.06976744186046512,0.22330240477484783,1.0,3/11,12.95%,KCNJ3;KCND3;KCNJ8
prerank,carboxy-lyase activity (GO:0016831),0.508963149909583,1.4631066400125807,0.05203619909502263,0.22360654425088525,1.0,6/23,10.63%,FAHD1;DDC;PISD;MVD;UXS1;GAD1
prerank,hexosaminidase activity (GO:0015929),-0.6057937401331138,-1.4614815478649843,0.054844606946983544,0.311353684808511,1.0,6/12,19.84%,CEMIP;OGA;HEXD;CEMIP2;HEXA;NAGA
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.5502945844174614,1.4610618634299288,0.07643312101910828,0.21907027381111327,1.0,4/16,8.84%,ANO3;TTYH2;ANO5;ANO4
prerank,intracellular chloride channel activity (GO:0061778),0.5502945844174614,1.4610618634299288,0.07643312101910828,0.21907027381111327,1.0,4/16,8.84%,ANO3;TTYH2;ANO5;ANO4
prerank,alanine transmembrane transporter activity (GO:0022858),0.5983565457407982,1.4604571537987567,0.0824295010845987,0.21638210008178935,1.0,4/12,15.95%,SLC6A6;SLC7A8;SLC36A1;SLC3A2
prerank,metal ion binding (GO:0046872),0.31460970076624567,1.4593194829699894,0.0,0.214485946761885,1.0,91/477,12.68%,SPOCK2;ADGRL3;SPOCK1;GRIN1;NRXN1;CDH12;CDH8;SYT1;MT2A;PCLO;SYT6;S100A16;RASGRP3;MMP12;KCNIP4;SYT7;CDH19;CDH20;CDH7;S100A9;S100A8;S100G;DNER;SYT12;SYT11;CDH18;RYR2;MCTP1;CDH2;PDE2A;PGP;RYR3;MMP13;SNCA;MEX3B;KCNIP1;NUDT3;SLC8A1;ENPP2;RCN2;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;CDH10;SLC25A23;HSPA5;PITPNM1;PCDHB6;CSGALNACT1;SLIT3;SLIT1;NUDT12;TRPM2;CPNE1;THBS3;SYT10;MELK;HPRT1;TUBB4A;CIB2;S100A2;DYSF;IDH3G;TPT1;ARSA;TPPP;ACVR1C;GALNT3;DCHS1;ASTN2;PIF1;AIF1;PVALB;IMPA1;SYT2;APEX1;BRSK2;CALM1;PCDHA4;SNN;HACL1;RET;SPARCL1;CDC42BPA;SNCB;HMGCLL1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.43685952023162583,-1.4574682590869243,0.029013539651837523,0.3155100921938389,1.0,14/48,18.00%,TRPM3;PIEZO2;NALCN;ATP6V1B2;SLC41A1;TRPM6;SLC12A7;CALHM2;SLC12A2;PKD2;TRPM4;CALHM5;TRPV2;TRPM7
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5922538178181825,-1.4530573367547766,0.05555555555555555,0.32053867919072465,1.0,8/13,19.34%,PDGFRA;PDGFRB;PDGFC;ERN1;VEGFA;VEGFD;ITGA5;ITGB3
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6012319871524048,-1.4520651470405084,0.07984790874524715,0.31793547856716003,1.0,6/12,14.81%,KDM7A;KDM4B;PHF8;PHF2;KDM3B;KDM3A
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.6130590555634274,-1.4486678444968246,0.08148148148148149,0.32044720125716564,1.0,5/11,28.90%,UBR5;UBE4B;UBE2K;ANAPC11;RBX1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.333277240408582,-1.447652659996478,0.0,0.3177335435419586,1.0,65/254,18.50%,NFIA;HLF;NFAT5;SMAD3;TCF4;PRRX1;NFKB1;RBPJ;MDM4;FOXC1;FOXO3;MEOX2;HOXB3;NFIB;ELF1;RREB1;GMEB1;MEF2A;NR3C1;HOXA5;SMAD2;ZBTB16;PLSCR1;HOXA7;TFDP2;STAT3;FOXC2;ELF4;HOXC4;VEZF1;CEBPG;RUNX1;AR;CDC5L;NFYC;ATF2;UBP1;JUN;GABPA;HIF1A;CREBRF;SMAD4;GLIS2;MEF2C;NRF1;TFCP2;TCF3;IRF1;ATF6;HINFP;KLF15;PRDM2;PRDM15;ZNF112;FOXK2;KLF6;MYBL1;NR4A1;SIX1;NFYB;SMARCD2;NR4A2;NFIC;TFCP2L1;NFATC3
prerank,methylation-dependent protein binding (GO:0140034),-0.41645575565737225,-1.4458449477797524,0.01937984496124031,0.31690672802257314,1.0,30/57,31.14%,KDM7A;CBX5;PYGO1;PHF8;CHD8;ZCWPW2;PHF2;MPHOSPH8;TDRD3;KAT8;ING5;PHF1;L3MBTL2;MSL3;MORC3;RRP8;BPTF;MORC4;MSH6;ZMYND8;ING1;NCAPD3;SPIN1;CXXC1;KMT2E;ATRX;ZMYND11;WDR5;GLYR1;CDYL
prerank,chemokine binding (GO:0019956),-0.4717997090689055,-1.4438738159297027,0.04672897196261682,0.3171881292063399,1.0,9/30,22.07%,ITGAV;PDPN;CCR9;HMGB1;ITGB1;ITGA4;CX3CR1;ITGB3;FGF2
prerank,tau-protein kinase activity (GO:0050321),-0.5257550945658545,-1.4393367782328816,0.07224334600760456,0.3222320971725491,1.0,9/20,17.75%,ROCK2;ROCK1;GSK3B;MARK3;MARK4;BRSK1;MARK1;SIK3;PRKAA1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.4615756410376212,1.4377309297308527,0.047619047619047616,0.23887375445881612,1.0,17/34,21.57%,NDUFC1;NDUFA4;NDUFA1;NDUFA2;NDUFC2;NDUFA3;NDUFA13;NDUFB2;NDUFB9;NDUFA7;NDUFA12;NDUFB8;NDUFB4;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.4615756410376212,1.4377309297308527,0.047619047619047616,0.23887375445881612,1.0,17/34,21.57%,NDUFC1;NDUFA4;NDUFA1;NDUFA2;NDUFC2;NDUFA3;NDUFA13;NDUFB2;NDUFB9;NDUFA7;NDUFA12;NDUFB8;NDUFB4;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.43877473951988055,-1.4364355648526121,0.03874538745387454,0.32385840014190903,1.0,21/44,24.70%,SETD7;KMT5B;SETD5;KMT2C;KMT2D;NSD1;NSD3;SMYD3;SETD3;SETD2;N6AMT1;SETDB1;KMT5C;EHMT1;ASH1L;KMT5A;KMT2A;EZH2;PRDM9;CXXC1;KMT2E
prerank,RNA polymerase binding (GO:0070063),-0.5377733318046297,-1.4328531373619384,0.06153846153846154,0.32707490822627716,1.0,9/18,15.26%,CCNT2;PABPN1;CCNT1;SCAF8;DHX9;STOM;PHRF1;TCERG1;ANP32B
prerank,transcription cis-regulatory region binding (GO:0000976),-0.31240682546755294,-1.4290880759993467,0.002044989775051125,0.33042448043877354,1.0,93/406,17.19%,ZBTB20;PBX1;BNC2;FOXP1;AEBP1;SMAD3;GLI3;TCF7L2;SOX5;TEAD1;NFKB1;CREB3L2;PRDM5;SMAD6;FOXC1;PER3;FOXO3;HDAC4;BCOR;NCOR1;CUX1;OSR1;ARNT;TFEB;MXI1;TBL1X;BRD7;FOXN3;TBL1XR1;RREB1;YAP1;MEF2A;KMT2D;HMGB1;NR3C1;SMAD2;GABPB2;TFDP2;STAT3;HOXC8;FOXC2;REST;VEZF1;RUNX1;AR;ZBTB8A;DHX36;FOXK1;TAF4;CDC5L;TBP;NFYC;ATF2;CHD3;JUN;NR1H3;GABPA;HIF1A;CREBRF;SMAD4;GLIS2;CALCOCO1;MEF2C;ZBED4;XRN2;RB1;TBX18;TFCP2;ARID5B;TCF3;SOX13;IRF1;ATF6;SOX6;GLI1;ZFP3;HINFP;RORA;HDAC1;RXRA;KLF15;PRDM2;SFPQ;VSX1;MNT;SNAPC3;BBX;TRPS1;FOXK2;SIX1;NFYB;ZFP37;TWIST2
prerank,retinoic acid binding (GO:0001972),-0.5978540011558343,-1.42214351788984,0.07317073170731707,0.3422829839976982,1.0,2/12,3.47%,NR2F2;CYP26B1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6228122395184238,-1.4214723966480363,0.08644400785854617,0.3390548154409676,1.0,3/10,10.71%,SLC6A13;SLC6A12;SLC6A1
prerank,neuropeptide receptor activity (GO:0008188),0.47941106165894154,1.4194051950796598,0.06756756756756757,0.2631792884569513,1.0,7/29,11.57%,SORCS3;TACR1;SORCS1;TACR3;HCRTR2;OPRM1;GRPR
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.5171770659498154,1.418388611288488,0.07894736842105263,0.26127110224096434,1.0,6/20,11.88%,SLC39A10;SLC39A2;SLC30A1;SLC30A3;SLC39A8;SLC30A5
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.3371194221289696,-1.4177434788786096,0.011320754716981131,0.3422906483651045,1.0,50/181,15.27%,SMAD3;TCF7L2;PRRX1;RBPJ;MDFIC;PIAS1;EP300;HDAC4;NCOR1;RERE;ARNT;WWP2;RBBP8;GSK3B;MEF2A;ANXA4;BAZ2A;BCAS3;CREBBP;TRIP4;STAT3;DHX9;AR;PPARGC1A;TAF4;TBP;PIAS3;NCOA1;DACT1;MED1;JUP;CHD4;ATF2;MIER1;TEAD3;JUN;TADA3;HIF1A;PARP9;ID2;HES1;RB1;PIAS4;BHLHE41;TCF3;DTX3L;TCERG1;STAT1;HDAC1;RXRA
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.46828548499626516,1.416042512809364,0.06798245614035088,0.26190262905783485,1.0,7/32,9.70%,SLC7A5;SLC6A6;SLC1A1;MFSD12;SLC7A8;SLC43A2;SLC36A1
prerank,GTPase binding (GO:0051020),-0.3350763456604406,-1.4150936920924602,0.004016064257028112,0.3435042753959998,1.0,74/194,24.65%,AKAP13;RNF152;AFDN;PLCE1;ABCA1;ERC1;LRRK2;FLNA;DOCK7;MAPKAP1;SGSM2;RADIL;DNM1L;STRN3;RANBP2;PDE6D;PAK2;TMEM127;RAB3GAP1;BRAF;BRK1;UNC13B;USP6NL;IQGAP2;TNFAIP1;LZTR1;CDC42EP5;RUSC2;USP33;TBC1D20;GGA3;EXOC2;NCKAP1;ARFIP2;YBX3;FGD1;BECN1;YBX1;ARHGDIB;WASF1;FGD4;ANKRD27;RCC1;RANBP9;WHAMM;RASA1;STOML2;GNB1;PICALM;CCDC186;RABGGTB;CDC42EP4;RHOH;ANKFY1;AMBRA1;CHM;TRIOBP;TBC1D7;RTKN;RABGAP1;TRIP11;CHML;BNIP3;DVL3;GGA2;ATG14;XPO5;ALS2;TNPO3;RGP1;GCC1;RAPGEF4;RAB8A;KIF3A
prerank,lipoprotein particle binding (GO:0071813),0.5027508316618539,1.4148587675623274,0.08731808731808732,0.26015992080831624,1.0,7/20,14.60%,PLTP;SCARF1;HSPD1;CD36;SORL1;SCARB1;STAB2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5744459083964795,-1.4093522534716223,0.06813996316758748,0.3521038623594688,1.0,6/13,24.60%,SLC9A1;SLC9A8;SLC9A2;LETM1;SLC9B2;SLC9A9
prerank,sequence-specific DNA binding (GO:0043565),-0.29851958704381754,-1.4091134480672427,0.00199203187250996,0.3480761508472272,1.0,120/590,17.45%,ZBTB20;PBX1;FOXP2;FOXP1;HLF;NR2F2;ZIC4;PKNOX2;NFAT5;ZIC1;SMAD3;GLI3;TCF4;TCF7L2;MAF;TEAD1;FOXD1;PRDM5;HOXB6;ZNF148;SMG6;RBPJ;THRB;ZNF423;GLI2;NR1D2;RARB;FOXC1;FOXO3;CREB5;HDAC4;SMG1;NR3C2;ABL1;CUX1;OSR1;ARNT;TFEB;MBNL2;MEOX2;NFIB;ELF1;NR6A1;NFIX;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;HOXA5;PRRX2;TBX15;ZIC5;TEF;HOXA7;JDP2;HOXC8;FOXC2;ELF4;HOXC4;BCL2;KDM5B;CEBPG;HOXB5;ZBTB37;HNRNPD;PPARGC1A;FOXK1;SAFB2;SP2;MBD2;ZEB2;MAFG;SMG7;HOXB4;ATF2;UPF1;RFX2;UBP1;JUN;GABPA;HIF1A;SMAD4;GLIS2;CALCOCO1;MEF2C;NFATC4;TEAD2;FBXL19;HES1;TELO2;TBX18;TFCP2;IRF9;BHLHE41;TCF7L1;SOX13;ATF6;YBX1;RORA;CTC1;HOXB9;RXRA;KLF15;PRDM2;VSX1;BBX;KDM2A;FOXL1;FOXK2;KLF6;PRMT5;NR4A1;SIX1;UPF3A;TBX2;RUNX2;NR4A2;HNRNPU
prerank,small GTPase binding (GO:0031267),-0.3376579013007619,-1.405523038612955,0.00398406374501992,0.35159754866323994,1.0,65/169,24.65%,AKAP13;RNF152;AFDN;PLCE1;ABCA1;ERC1;LRRK2;FLNA;DOCK7;MAPKAP1;SGSM2;DNM1L;STRN3;RANBP2;PDE6D;PAK2;TMEM127;RAB3GAP1;BRAF;BRK1;UNC13B;USP6NL;IQGAP2;TNFAIP1;LZTR1;CDC42EP5;RUSC2;USP33;TBC1D20;GGA3;EXOC2;NCKAP1;ARFIP2;YBX3;FGD1;ARHGDIB;WASF1;FGD4;ANKRD27;RCC1;RANBP9;WHAMM;PICALM;CCDC186;RABGGTB;CDC42EP4;RHOH;ANKFY1;CHM;TRIOBP;TBC1D7;RTKN;RABGAP1;TRIP11;CHML;DVL3;GGA2;XPO5;ALS2;TNPO3;RGP1;GCC1;RAPGEF4;RAB8A;KIF3A
prerank,DNA binding (GO:0003677),-0.2954044733908082,-1.4035196879074436,0.0,0.3518421964649081,1.0,267/694,30.78%,PBX1;RBMS1;FOXP2;DENND4A;HLF;EGFR;NR2F2;ZIC4;SMAD3;TCF4;TCF7L2;TEAD1;FOXD1;PRDM5;ZNF148;HIVEP2;RBPJ;THRB;INO80;ZNF423;GLI2;RARB;FOXC1;ZIC2;EP300;FOXO3;HDAC4;ABL1;CUX1;ARNT;RAD23B;MEOX2;NFIB;RBBP8;NUPR1;NR6A1;TOP1;BCLAF3;CCNT1;EZH1;HUWE1;KHDRBS1;RARG;MEF2A;KMT2D;ZKSCAN3;HMGB1;SMC6;HOXA5;RBM6;SMAD2;ZBTB16;NBN;WDR48;CREBBP;HOXA7;STAT3;TDP2;MLH1;DNMT3A;FOXC2;CHD8;DHX9;BCL2;RAD51B;KDM5B;HDGFL2;CEBPG;DHX36;PCBP2;WRN;PPARGC1A;AIFM1;ZNF496;FUBP1;SAFB2;TAF4;CDC5L;NFYC;ZEB2;DDB2;CHD4;CHD2;CHD3;RFX2;JUN;NR1H3;DDX60;SSBP2;HIF1A;SMAD4;XRCC4;CALCOCO1;MCM9;BCLAF1;RTF1;RAD51D;ERCC3;ZMYM4;XRN1;HES1;SPTY2D1;PDS5B;TFCP2;WDR76;ARID5B;NABP2;CCDC25;TCF3;TCF7L1;APTX;SOX13;PATZ1;IRF1;ATF6;ZMYM3;SOX6;YBX1;CGGBP1;GLI1;TSHZ3;PARP4;RBM5;PHF1;CRLF3;BRCA2;HINFP;PRKDC;MCM6;STAT1;RORA;MSH3;ILF2;CTC1;DDX3X;CARF;RXRA;TOPORS;PRDM2;SFPQ;SNAPC3;DMC1;MRE11;FOXL1;FOXK2;SPRTN;NR4A1;SIX1;CAMTA2;NFYB;TBX2;POGK;NR4A2;HNRNPU;ZDHHC1;WBP11;TAF6L;MSL3;POLR2H;SDE2;DCLRE1A;BPTF;PARK7;MSH6;GTF3C4;ELK4;H1-0;PCNA;NFYA;STN1;TAF12;TERT;RNF11;ZBTB49;ZIC3;SURF6;XRCC6;SMC1A;USF1;SSBP1;SPHK1;PRDM9;IRF2;CXXC5;DEDD;DRAP1;CLSPN;MYRF;ARID5A;MAFK;RAD51C;DNASE2;HDAC2;HSF1;ERCC1;TFAP4;ARID3B;MAFB;TSHZ2;GTF3C1;SNAPC1;MBD3;NR2F1;ZNF35;CRY2;SIRT3;FOXE1;QRICH1;CREBZF;ZBTB7A;ATAD5;SPO11;OGG1;KIN;ZNF219;TIPIN;PPARA;ORC1;NR2C1;GTF3C6;HOXB2;ENDOV;MBD6;SOX12;GTF2H4;ZBTB4;MAFF;DNASE1L1;LONP1;APP;MCM4;SLTM;SOX10;POLR2D;MCMDC2;SAP30L;SUPV3L1;SAFB;ZMYND11;TIMELESS;CGAS;SAMHD1;IGHMBP2;ZFPL1;CDK9;EGR1;FOXO4;ZNF292;MPG;E2F1;HIC1;POLRMT;NFE2L2;ZNF76;GLYR1;MLX;MLXIPL;KLF12;GTF2A1;CR2;CALR;PSIP1;FOXD2;NR5A2;SOX8;FANCG;THRAP3
prerank,voltage-gated ion channel activity (GO:0005244),0.540763696244278,1.4034079818759422,0.08096280087527352,0.273918190972086,1.0,5/14,14.28%,KCND2;HCN1;CACNA1E;VDAC2;VDAC3
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.6221300534665465,-1.402660115013839,0.07992565055762081,0.3496844636019566,1.0,4/10,16.10%,KDM7A;KDM4B;PHF8;KDM2A
prerank,histone acetyltransferase binding (GO:0035035),-0.5010797106629402,-1.400448329711279,0.08037383177570094,0.35035280590196743,1.0,14/21,28.95%,GLI3;KANSL1L;MEF2A;BCAS3;TRIP4;HIF1A;STAT1;CITED2;PCNA;EID1;TRIM68;ZBTB7A;TAF7;EGR1
prerank,phospholipase activator activity (GO:0016004),-0.6070658787526939,-1.3910462802997625,0.09532710280373832,0.3662214205086209,1.0,3/10,11.22%,ARHGAP6;PDPK1;STX4
prerank,monocarboxylic acid binding (GO:0033293),-0.5224028505468742,-1.3900165723802442,0.08955223880597014,0.3642827657323702,1.0,4/18,15.27%,NR2F2;CYP26B1;NAPEPLD;RXRA
prerank,methylated histone binding (GO:0035064),-0.3911037907505458,-1.3887535230751802,0.044145873320537425,0.3628629053932279,1.0,31/62,31.14%,KDM7A;CBX5;PYGO1;PHF8;CHD8;ZCWPW2;PHF2;MPHOSPH8;TDRD3;KAT8;ING5;PHF1;L3MBTL2;MSL3;MORC3;RRP8;BPTF;MORC4;MSH6;ZMYND8;ING1;NCAPD3;SPIN1;CXXC1;KMT2E;TAF7;ATRX;ZMYND11;WDR5;GLYR1;CDYL
prerank,cytochrome-c oxidase activity (GO:0004129),0.5359695404870759,1.3885111420915321,0.1038961038961039,0.2944716758803762,1.0,8/15,21.57%,COX7A1;NDUFA4;COX4I1;COX6A1;COX6B1;COX10;COX8A;COX5B
prerank,active ion transmembrane transporter activity (GO:0022853),0.4340360224074592,1.3880769182915684,0.07188160676532769,0.291136573287372,1.0,9/37,9.62%,SLCO1C1;SLC4A1;SLCO4C1;COX7A1;NDUFA4;COX4I1;COX6A1;SLCO5A1;SLCO2B1
prerank,sodium:proton antiporter activity (GO:0015385),-0.5978635682911068,-1.3824819005059057,0.08941605839416059,0.37281971729396923,1.0,5/11,24.60%,SLC9A1;SLC9A8;SLC9A2;SLC9B2;SLC9A9
prerank,four-way junction DNA binding (GO:0000400),-0.516278872873665,-1.3791493331248306,0.10160427807486631,0.37581815622228526,1.0,8/17,22.97%,ABL1;HMGB1;RAD51B;WRN;RAD51D;FANCM;MSH6;RAD51C
prerank,manganese ion binding (GO:0030145),-0.4074597499495175,-1.3762421064990031,0.06407766990291262,0.37821309791752056,1.0,20/48,23.55%,LARGE1;MPPED2;B4GALT1;ABL1;XPNPEP1;TDP2;WRN;ME1;ABL2;FAM20C;PPM1M;PCK2;XYLT2;SOD2;GALNT1;NEK4;B4GALT7;MPPE1;XXYLT1;PRIMPOL
prerank,poly-purine tract binding (GO:0070717),-0.4615144070164321,-1.3761993832263353,0.08382066276803118,0.3740312324569258,1.0,6/27,5.14%,RBMS1;RBMS3;RBPMS;ATXN1;KHDRBS1;RBMS2
prerank,muscle alpha-actinin binding (GO:0051371),-0.5338325663912042,-1.371183405528991,0.10861423220973783,0.3814140576641917,1.0,6/15,12.91%,PDLIM5;PDLIM7;SYNPO2;PALLD;PDLIM2;PKD2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.4025130698751764,1.3705671466468439,0.059548254620123205,0.3166220633178567,1.0,11/51,9.62%,SLCO1C1;SLC7A5;SLC4A1;SLCO4C1;MFSD2A;SLC35A1;SLCO5A1;SLC7A8;SLC35C1;SLC25A14;SLCO2B1
prerank,double-stranded DNA binding (GO:0003690),-0.29572894596744026,-1.3691595641460248,0.002008032128514056,0.38173863644747424,1.0,103/531,17.45%,ZBTB20;PBX1;RBMS1;FOXP1;HLF;EGFR;ZIC4;PKNOX2;NFAT5;ZIC1;GLI3;TCF4;MAF;TEAD1;HOXB6;THRB;GLI2;NR1D2;RARB;FOXO3;CREB5;NR3C2;ABL1;CUX1;OSR1;ARNT;TFEB;MBNL2;MEOX2;NFIB;ELF1;RBBP8;NR6A1;TOP1;NFIX;GMEB1;RARG;HMGB1;NR3C1;KLF3;HOXA5;SMAD2;PRRX2;TBX15;ZIC5;WDR48;TEF;HOXA7;JDP2;HOXC8;FOXC2;ELF4;HOXC4;DHX9;RAD51B;KDM5B;HDGFL2;CEBPG;HOXB5;ZBTB37;FOXK1;SP2;MAFG;HOXB4;ATF2;RFX2;UBP1;JUN;GABPA;DDX60;GLIS2;MEF2C;NFATC4;TEAD2;HES1;TBX18;TFCP2;IRF9;BHLHE41;TCF7L1;APTX;ATF6;YBX1;CGGBP1;PRKDC;STAT1;MSH3;HOXB9;RXRA;KLF15;VSX1;BBX;DMC1;MRE11;KLF6;SPRTN;NR4A1;SIX1;CAMTA2;TBX2;RUNX2;NR4A2;HNRNPU
prerank,low-density lipoprotein particle binding (GO:0030169),0.519343615648733,1.3668329161765713,0.1,0.31863382890838343,1.0,6/16,14.60%,PLTP;SCARF1;CD36;SORL1;SCARB1;STAB2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.38620430580073045,1.3603849934504888,0.07053941908713693,0.3257756372909672,1.0,15/60,8.39%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK;ACVRL1;EPHA10
prerank,peptidase inhibitor activity (GO:0030414),-0.43729226961189743,-1.3563204889575888,0.08795411089866156,0.40783396015683926,1.0,9/33,11.83%,CAST;PROS1;GPC3;TFPI;ITIH2;RECK;RENBP;SERPIND1;PSMF1
prerank,pentosyltransferase activity (GO:0016763),-0.4354335208278192,-1.3547641839087228,0.07692307692307693,0.4068162910919654,1.0,12/36,13.72%,LARGE1;TNKS2;UPP2;ZC3HAV1;PARP10;PARP9;PARP14;PPAT;PARP1;QTRT2;SIRT5;PARP4
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.3894241254397561,1.3545958462641048,0.06134969325153374,0.33202428091100894,1.0,25/57,21.57%,NDUFC1;COX7A1;NDUFA4;NDUFA1;COX4I1;COX6A1;NDUFA2;NDUFC2;NDUFA3;NDUFA13;COX6B1;NDUFB2;UQCRH;NDUFB9;NDUFA7;NDUFA12;COX10;NDUFB8;NDUFB4;COX8A;NDUFA10;NDUFS3;NDUFA6;COX5B;NDUFB7
prerank,transcription coregulator binding (GO:0001221),-0.39764622250932663,-1.3498487987744727,0.06422018348623854,0.41405352140363505,1.0,16/50,14.92%,SMAD3;THRB;PER3;CCNT2;VGLL4;LCOR;ZBTB16;AR;UBE2I;SMAD4;TEAD2;USP11;EHMT1;PHF1;RORA;CNOT2
prerank,miRNA binding (GO:0035198),-0.4400061309447894,-1.3440183971957023,0.09003831417624521,0.42352609386265266,1.0,12/30,29.05%,PUM2;ZC3H7A;RC3H1;PUM1;TUT4;RBM10;YBX1;RBM4;ZNF346;AGO1;ZC3H7B;ZC3H10
prerank,lipoprotein particle receptor binding (GO:0070325),0.447239310828493,1.3431989354809075,0.09090909090909091,0.3491801369738311,1.0,6/27,9.26%,SYT1;AP2M1;APBB1;APBB3;CLU;RELN
prerank,CXCR chemokine receptor binding (GO:0045236),0.5463941526100952,1.3402520871207788,0.1490280777537797,0.35080639964947546,1.0,1/11,2.42%,CXCL12
prerank,metallopeptidase activity (GO:0008237),-0.34207544613382634,-1.3397723787898874,0.03917910447761194,0.42939626461519104,1.0,27/113,14.04%,TRABD2B;ADAMTS2;ADAMTS10;THSD4;ADAMTSL3;ADAMTS12;ADAMTS6;ADAMTSL5;PAPPA;ADAMTS5;BRCC3;MYSM1;ECE1;ANPEP;ADAMTSL4;ADAMTS9;NRDC;ADAM9;LAP3;MBTPS2;MMP14;ADAM19;ADAMTS15;ADAM33;NLN;MMP2;ADAMTS17
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.5771598810041482,-1.3376913988179084,0.13345521023765997,0.4300751191503803,1.0,6/10,18.02%,EP300;HAT1;ATF2;KAT8;BRCA2;MSL3
prerank,water transmembrane transporter activity (GO:0005372),0.5512704853262178,1.3351444620534156,0.12684989429175475,0.3559284696326839,1.0,3/11,12.16%,AQP9;AQP11;AQP4
prerank,phospholipase binding (GO:0043274),-0.5331225654451959,-1.3334300858880748,0.1431297709923664,0.4359087628523714,1.0,3/13,7.95%,ARHGAP6;PRKN;PDPK1
prerank,protein serine/threonine kinase activity (GO:0004674),-0.29899367961007856,-1.3317379363796138,0.010141987829614604,0.43510676331797415,1.0,108/334,22.00%,ROCK2;GRK5;EGFR;TGFBR1;BMPR1A;CDK8;TLK1;CLK1;MAPK4;MYLK;ARAF;STK3;ROCK1;FAM20A;SMG1;CAMK1D;PRKAA2;TGFBR2;LRRK2;CSNK1A1;TOP1;GSK3B;STK17B;TBK1;NRK;IRAK3;MARK3;CDK16;BCR;CDK7;SLK;PAK2;ALPK1;TAOK3;MAP4K4;EIF2AK3;IRAK2;MTOR;CAMK2D;BRAF;MAP3K5;PDPK1;CAMK2G;MARK4;WNK4;GRK3;MAP2K1;HIPK1;CSNK1E;CCNK;CDK13;CLK2;WNK1;MAP3K20;BRSK1;PRKCD;DMPK;ULK2;PRKAB2;FAM20C;CLK3;CDK11B;RIOK3;MKNK2;SIK1;EIF2AK4;RPS6KC1;STK33;CPNE3;MAPK6;BMP2K;EIF2AK2;ERN1;PRKDC;PRKCZ;LATS1;ACVR1;GRK6;CSNK2A1;PIK3R4;DAPK1;MARK1;SIK3;TRIO;PRKD1;PRKACA;IKBKE;DAPK2;MAP3K14;PRKAA1;STK16;MAP3K1;NEK4;CSNK1D;IRAK1;CDK2;FASTK;CDK10;NRBP2;BCKDK;AKT2;NEK6;SIK2;CDK6;MAST2;MKNK1;MAP3K12;TAOK1
prerank,GTPase activator activity (GO:0005096),-0.30056965640145844,-1.3278669623946826,0.012096774193548387,0.44039362215144073,1.0,100/313,21.26%,AKAP13;RANBP3L;ALDH1A1;ARHGAP29;DENND4A;DOCK5;ARHGAP10;ARHGAP42;DOCK11;PLCE1;ERRFI1;ASAP3;SIPA1L1;DENND2A;FARP1;ARHGAP28;ASAP1;STXBP5;ARHGAP20;ARHGEF17;ARHGEF10L;LRRK2;ARAP1;TBC1D16;SMAP1;SBF2;IQSEC2;BCR;SGSM2;ARHGAP24;DNM1L;RANBP2;ARFGEF1;SEC23A;RAB3GAP1;GMIP;NRP1;CYTH3;RAPGEF3;VAV2;ARHGAP17;USP6NL;RAB3IL1;IQGAP2;ARFGAP1;ARFGAP3;HERC2;RAB3IP;TBC1D2B;JUN;TBC1D20;RCC1L;TBC1D8B;RP2;ARHGEF18;FNIP1;DENND4C;ARHGAP32;SEC23B;MON1A;SERGEF;FGD1;TBCK;DNMBP;GRTP1;TBC1D22B;DENND5A;TBC1D9;RAPGEF2;FGD4;ANKRD27;RCC1;ACAP2;ARHGAP18;RASA1;NGEF;ARHGEF11;SH3BP5L;FARP2;ARHGEF6;ARRB1;TBCD;RIC8B;DOCK1;NPRL3;TBC1D17;RANBP3;DENND2C;ARHGAP15;HPS1;RALGAPB;TBC1D7;SIPA1L3;EIF2B4;RAPGEF1;RABGAP1;TBC1D10A;RALGAPA2;LARS1;CCZ1
prerank,ATPase binding (GO:0051117),-0.3729788345236231,-1.3277040097127486,0.055876685934489405,0.43634132710652707,1.0,27/71,22.16%,EGFR;ANK2;ABCA1;TMTC4;SNTA1;ATP6V0A4;PTPN3;AR;CHMP4A;NCSTN;SELENOS;RALA;PKD2;SNX10;NOP58;METTL21A;SNU13;CLPP;DERL1;TCIRG1;SYVN1;ATP5IF1;ATP1B3;PEX26;S100A1;PIH1D1;WFS1
prerank,anion transmembrane transporter activity (GO:0008509),0.5477972228917191,1.3260304604461328,0.13304721030042918,0.3690942826508247,1.0,4/12,10.94%,SLC4A1;ABCG2;SLCO2B1;SLC39A8
prerank,transcription corepressor binding (GO:0001222),-0.45628479013713436,-1.3199303732757908,0.10536044362292052,0.4508554261725281,1.0,13/27,27.43%,PER3;LCOR;ZBTB16;USP11;EHMT1;PHF1;RORA;CNOT2;NEK6;EZH2;ZBTB7A;ESR1;HDAC3
prerank,SH3 domain binding (GO:0017124),-0.37571712279434505,-1.318092495188892,0.0658682634730539,0.45089473451229495,1.0,19/62,17.60%,DPYSL3;AFAP1;CBLB;PRKN;ABL1;WASF2;KHDRBS1;SYNJ2;PLSCR1;VASP;PTPN22;PTPN12;ADAM9;ABI1;WIPF1;CYBA;SOCS7;AFAP1L2;MICAL1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.49323060492128473,-1.3150463852970846,0.14538310412573674,0.4538847307367583,1.0,5/18,12.41%,ALDH1A1;ALDH1A2;ALDH2;AKR1B1;ALDH6A1
prerank,DNA secondary structure binding (GO:0000217),-0.42422885975677443,-1.3143597319075282,0.11310592459605028,0.45130919991895846,1.0,12/31,22.97%,ABL1;RBBP8;HMGB1;RAD51B;WRN;MEF2C;RAD51D;FANCM;MSH6;KMT2A;CLSPN;RAD51C
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.5612817540980414,-1.3134499800268218,0.14821763602251406,0.44919324494809765,1.0,7/11,39.82%,SLC22A5;SLC22A4;SLC25A47;SLC25A29;SLC25A20;SLC22A3;SLC25A45
prerank,pre-mRNA binding (GO:0036002),-0.4357980849553804,-1.3129292763204166,0.1169811320754717,0.4462290147010368,1.0,8/28,10.06%,CELF2;DDX5;CELF1;U2AF2;SRSF6;RNPC3;SLU7;SLBP
prerank,CoA-ligase activity (GO:0016405),-0.5203547379610884,-1.3109994299557928,0.15414258188824662,0.44672316975521303,1.0,2/14,3.04%,ACSL1;ACSS3
prerank,poly(A) binding (GO:0008143),-0.4714097098812353,-1.309103005006088,0.11798839458413926,0.4475022584059015,1.0,5/21,5.14%,RBMS1;RBMS3;RBPMS;KHDRBS1;RBMS2
prerank,5'-3' exonuclease activity (GO:0008409),-0.5163666908115202,-1.3083011453585276,0.15369649805447472,0.44536359259565345,1.0,6/14,22.82%,CPSF3;XRN2;XRN1;MRE11;DCLRE1A;EXOG
prerank,mRNA binding (GO:0003729),-0.3004226706040961,-1.3078636460776725,0.01593625498007968,0.44243884698113245,1.0,60/249,15.01%,SAMD4A;RBMS1;CELF2;SRRM2;RBFOX2;RBMS3;RBPMS;DDX5;CELF1;EIF4G3;LUC7L2;HNRNPR;PUM2;YTHDF3;PCF11;SYNCRIP;KHDRBS1;DDX6;RBMS2;EIF4ENIF1;RC3H1;ZC3H12C;SCAF8;NYNRIN;HNRNPM;DHX9;DENR;SRBD1;LARP1;SF3B1;SRSF6;PTBP3;HDLBP;PUM1;DCP1A;DHX36;PCBP2;FUBP1;CSDC2;GEMIN5;HNRNPK;SLBP;LSM14A;SF3B6;DAZAP1;YTHDC1;DCP1B;KHNYN;SNRNP70;TPR;YBX3;SERBP1;RBM5;NSRP1;ACO1;ZC3H12B;SRSF1;EDC3;CCT5;DDX3X
prerank,transcription coactivator binding (GO:0001223),-0.46642801410472917,-1.2994340922655048,0.12641509433962264,0.4597802911253255,1.0,10/20,20.76%,SMAD3;THRB;CCNT2;VGLL4;AR;SMAD4;TEAD2;RORA;TERT;ZBTB49
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5429130486646425,-1.2986344881388645,0.16544117647058823,0.4575994136283583,1.0,4/12,9.15%,CDK8;CDK7;CCNK;CDK13
prerank,Tat protein binding (GO:0030957),0.5503473101878984,1.2973991854608014,0.18902439024390244,0.42233691857575195,1.0,3/10,4.17%,ACTB;GABARAPL1;SMARCB1
prerank,lipase activator activity (GO:0060229),-0.57061876587744,-1.295985420597628,0.12969924812030076,0.46019520696792227,1.0,2/10,7.95%,ARHGAP6;PDPK1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.5648080272914253,-1.2958382441911442,0.15860735009671179,0.45659621708706144,1.0,3/10,9.22%,DSE;GLCE;RENBP
prerank,RNA cap binding (GO:0000339),-0.4979914492234082,-1.2951143154855778,0.15185185185185185,0.4545196470621066,1.0,8/16,30.74%,CYFIP2;LARP1;GEMIN5;EIF4E;EIF4E3;NCBP3;NCBP2;LSM1
prerank,acid-thiol ligase activity (GO:0016878),-0.5295045208626373,-1.2945281922020535,0.14705882352941177,0.45200950353711394,1.0,2/13,3.04%,ACSL1;ACSS3
prerank,phosphotyrosine residue binding (GO:0001784),-0.4020009558875794,-1.2940182544531402,0.1225296442687747,0.4493580616010399,1.0,16/37,25.38%,ABL1;IRS1;SHB;SHC1;PTPN3;VAV2;ABL2;YES1;RASA1;NCK2;PTPN11;SHF;CRKL;PIK3R1;SYK;SHC3
prerank,alpha-actinin binding (GO:0051393),-0.4456602172893702,-1.2927002968544101,0.12431444241316271,0.44858763001846813,1.0,9/24,12.91%,CACNA1C;DAG1;PDLIM5;PDLIM7;CACNA1D;SYNPO2;PALLD;PDLIM2;PKD2
prerank,tropomyosin binding (GO:0005523),-0.5029110331196723,-1.290050992732282,0.13584905660377358,0.45115686875888,1.0,3/16,10.56%,CALD1;TMOD3;S100A6
prerank,receptor ligand activity (GO:0048018),0.2995324266888956,1.2893145500877476,0.023076923076923078,0.4348028981947685,1.0,37/245,10.81%,NRG3;KITLG;IL17F;SEMA3C;SEMA6A;MIF;AMH;IL7;NRG1;SEMA4A;SEMA4F;GAS6;FGF10;SEMA6D;TAFA2;SEMA4D;SEMA7A;BMP8A;IL12A;TGFB2;SCGB3A1;TAFA1;AMELX;WNT7B;FGF5;ENDOU;TNFSF13B;EPO;TIMP1;NMB;GPNMB;SST;POMC;THPO;BMP3;PDGFB;SCG2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4851154631026696,1.2831821996839043,0.16424116424116425,0.44319151806935075,1.0,6/18,21.62%,SRD5A2;HSD17B7;HSD11B1;HSD17B2;HSD17B10;HSD3B7
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5372132021296961,-1.2818433510644573,0.16129032258064516,0.4668603782563467,1.0,6/12,16.42%,IGF1;IRS1;SHC1;IGF2;GNAS;ARRB1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.5202343129194426,-1.2783249182706349,0.18574108818011256,0.47142041716138633,1.0,10/13,42.22%,TRMT11;METTL1;THUMPD3;TRMT1L;FTSJ1;TRMT1;TRMT10C;TRMT5;WDR4;TRMT10B
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.36090202455415393,1.2780513680025425,0.109979633401222,0.44959374314639056,1.0,13/60,6.02%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK
prerank,nuclear localization sequence binding (GO:0008139),0.4656217437577007,1.2760557450225316,0.18444444444444444,0.44913566544333466,1.0,3/18,2.67%,IPO5;IPO4;CABP1
prerank,mRNA 3'-UTR binding (GO:0003730),-0.34155025440237013,-1.275022643438554,0.09090909090909091,0.4755430888002029,1.0,34/79,28.93%,RBMS1;CELF2;RBMS3;DDX5;CELF1;PUM2;RBMS2;RC3H1;LARP1;PUM1;DHX36;CSDC2;GEMIN5;DAZAP1;YBX3;SERBP1;EXOSC9;CCT5;RNF20;CPEB1;HNRNPU;RBM4;ANGEL2;NUDT21;AUH;PABPC4;FXR1;CPSF1;RSL1D1;PCBP4;ZFP36L2;PARN;PABPC4L;CRYZ
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5068049257768847,1.274375626034972,0.19658119658119658,0.44763401646252615,1.0,5/14,22.94%,CAPN11;CAPN6;CAPN5;CAPN2;CAPN15
prerank,kinase binding (GO:0019900),-0.2764220372039421,-1.2736722599253958,0.01603206412825651,0.47485853197878164,1.0,141/434,23.14%,PRKAG2;EGFR;SASH1;SMAD3;TCF7L2;ANK2;ERRFI1;PTN;GSN;PKD1;MAPK4;LIMS1;KIF13B;NBEAL1;NISCH;KAT2B;PDGFRB;IL31RA;PPP1R12A;FOXO3;GHR;PRKN;TAX1BP1;WWC2;TNS2;DLG4;IBTK;GSK3B;RPTOR;CNTLN;FLNA;IRAK3;IL15RA;MAPKAP1;DLG1;NR3C1;RND3;EIF4ENIF1;RBBP6;AXIN1;SLC12A7;SKI;PAK2;UBQLN1;UFL1;TRIP4;STAT3;SHC1;TPCN2;ADCY6;CDC42;PTPRK;VDAC1;SP100;PTPN22;CCNK;PLCG1;WNK1;TOM1L2;ATF2;SLC12A2;RB1CC1;PTPN2;TRAF2;RHOA;PRKCD;HIF1A;EXOC2;MAVS;PRKAB2;DNAJC3;WWC1;KIZ;PARP1;TRIM5;RB1;TELO2;RHOBTB2;SIK1;SUFU;BECN1;MAML1;MOB1B;MAPRE1;RICTOR;ERCC6L2;CDK5RAP1;LATS1;CDC25B;CCND3;PPP1CB;RAB11FIP2;MAP2K7;ADRA2A;TNIP2;TTC28;PRKACA;RHOBTB1;LRRC14;CACUL1;BLNK;RHOH;FBXW5;PTPN1;TRAF6;MYOM1;MAP3K1;MTCP1;RHOC;PARK7;PTPN11;IRAK1;MAP2K6;TRIP6;LRBA;CARD16;CAB39;PRKAG3;MVP;PFKM;DGKD;SPRED2;NBEAL2;NEK6;PIH1D1;PRKAB1;SMAD1;CDK5RAP3;USF1;MSN;PFKL;MAP3K12;TBL2;CIR1;GATA6;CHP1;TICAM1;NSF;PRKRIP1;CSPG4;HSF1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.40436145553526137,-1.2732692806298447,0.13211009174311927,0.47188892026408474,1.0,15/34,22.27%,SETD7;KMT5B;NSD3;SMYD3;SETD3;SETD2;N6AMT1;SETDB1;EHMT1;METTL21A;EEF2KMT;KMT5A;EZH2;PRDM9;CAMKMT
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5048179747194799,1.2572701522859067,0.17802197802197803,0.4813148017780367,1.0,3/14,0.51%,SPOCK2;SPOCK1;SPOCK3
prerank,vitamin D receptor binding (GO:0042809),-0.5017299024980593,-1.2572505584852682,0.1926070038910506,0.5061636528629291,1.0,10/14,30.78%,MED17;MED12;MED1;RXRA;MED16;MED13;MED14;TAF7;SNW1;THRAP3
prerank,alkali metal ion binding (GO:0031420),-0.5215424698887802,-1.2554985609878446,0.18923933209647495,0.5064137088107341,1.0,2/13,2.71%,ATP1A2;HDAC4
prerank,calcium channel activity (GO:0005262),0.3327553371608305,1.2547247475505703,0.11022044088176353,0.4818256766295315,1.0,19/84,13.50%,SLC24A4;SLC24A2;CACNA1A;GRIN1;TRPC5;CACNA1B;RYR2;CACNA2D1;CACNG2;CACNA1E;TRPM2;CACNB2;CACNG3;OPRM1;CACNB4;CACNG8;TRPC1;TMCO1;PSEN1
prerank,ATP binding (GO:0005524),-0.28572724373029557,-1.2490115579273562,0.028169014084507043,0.5188248073758271,1.0,96/266,27.72%,ATP1A2;PRKAG2;TGFBR1;BMPR1A;TLK1;ABCA1;MYO1B;KSR1;STK3;ABL1;ENPP1;TOP1;ABCD3;STK17B;N4BP2;IRAK3;MAP4K4;CHD8;DHX9;SMC4;MAP3K5;SYN3;DHX36;ABCD2;MARK4;WNK4;ABCF1;WNK1;MAP3K20;BRSK1;HSPA14;DMPK;CARS2;CDK11B;HSPA9;AK6;PNPLA8;MKNK2;ABCD4;PEX6;SIK1;MYO1F;PGK1;TBCK;ERN1;MCM6;LATS1;ACVR1;P2RX4;PDXK;DAPK1;PTPA;MARK1;MTREX;TAP2;SIK3;TARS1;OAS2;DAPK2;HNRNPU;PFKP;PXK;MSH6;EIF4G1;MLKL;BCKDK;NME1;PFKM;AKT2;NEK6;SIK2;CDK6;MAST2;MKNK1;PFKL;SPHK1;TAOK1;CDC42BPG;GSS;TRNT1;GALK1;RRM1;CLPX;MVK;RPS6KA4;TAP1;TWF2;TWF1;ABCF3;PRKCI;ABCB8;PRPS1;PRPS1L1;PIM1;LONP1;MINK1
prerank,3'-5' DNA helicase activity (GO:0043138),-0.4801613155073027,-1.2488409237780431,0.2087912087912088,0.5152766182825745,1.0,6/16,14.41%,DHX9;WRN;ASCC3;ERCC3;FANCM;MCM6
prerank,organic anion transmembrane transporter activity (GO:0008514),0.31303519866669133,1.2481842198607571,0.06639004149377593,0.491677040873407,1.0,25/134,11.08%,SLCO1C1;SLC7A5;SLC6A6;SLC4A1;SLCO4C1;SLC7A1;ABCG2;MFSD2A;SLC35A1;SLC17A6;SLC1A1;SLC52A2;SLC25A42;SLC25A23;MFSD12;SLC1A2;SLCO5A1;SLC7A8;SLC6A8;SLC52A3;SLC66A1;SLCO2B1;SLC36A1;SLC39A8;ABCC4
prerank,solute:sodium symporter activity (GO:0015370),-0.4146914443752653,-1.2481028145496438,0.15398886827458255,0.513243115674782,1.0,4/27,10.69%,SLC5A3;SLC20A2;SLC4A10;SLC5A6
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5346836251000674,1.2446534907923275,0.20666666666666667,0.49462352540118326,1.0,4/10,9.62%,SLCO1C1;SLCO4C1;SLCO5A1;SLCO2B1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.543769858471848,-1.2421214751306275,0.241635687732342,0.5245648698482854,1.0,3/10,19.41%,NOX4;CYBA;NCF2
prerank,kinesin binding (GO:0019894),0.42240379618243307,1.240626353905641,0.18724279835390947,0.4993124450575843,1.0,11/27,20.66%,ACTB;MAPK8IP2;SNCA;SPTBN5;MAPK8IP1;RAB29;ATCAY;TTBK2;CLSTN1;KIF1B;CROCC
prerank,ubiquitin binding (GO:0043130),-0.3450144434202586,-1.2398410388916652,0.10909090909090909,0.5263274385250437,1.0,18/73,17.09%,SMAD3;UBE2N;PRKN;RAD23B;UBXN2B;WDR48;DDI2;NBR1;RNFT1;MARK4;USP33;GGA3;FBXW7;ILRUN;USP13;FAF2;SPRTN;AUP1
prerank,phospholipid transfer activity (GO:0120014),0.44973578268838493,1.2396863144151349,0.18510158013544017,0.49648888570895605,1.0,9/21,17.95%,PLTP;CERT1;PITPNM1;PRELID3A;PLEKHA3;PRELID2;CPTP;MTTP;PITPNB
prerank,mannose binding (GO:0005537),0.5096478192862754,1.2396401878996512,0.2021505376344086,0.4914325925802301,1.0,1/12,0.94%,MBL2
prerank,phosphatase inhibitor activity (GO:0019212),-0.45386751579541207,-1.2395020952400773,0.19573643410852712,0.5232939748070555,1.0,8/20,26.98%,PTN;STYX;CABIN1;ANP32E;BOD1L1;PPP1R2;BOD1;SAG
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4757012294488143,1.238903125467696,0.20638297872340425,0.4881683174759211,1.0,5/15,14.30%,SLA2;PIK3R5;SOCS1;PIK3R3;CCKBR
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4914878956411744,1.2354817392851707,0.2203742203742204,0.4914701145302516,1.0,2/13,2.92%,PRKAR2B;RYR2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.3955395892755245,-1.2350026763515354,0.18290258449304175,0.5307112261741537,1.0,11/34,19.14%,UBE2N;UBE2E2;BIRC6;UBE2H;UBE2K;UBE2I;UBE2R2;UBE2B;UBE2E1;UBE2S;UBE2D3
prerank,cadherin binding (GO:0045296),-0.2785059587882562,-1.2312123854082297,0.02976190476190476,0.5364347944437085,1.0,88/315,16.18%,PHLDB2;CALD1;PARVA;EGFR;AHNAK;AFDN;VCL;PI4KA;PDLIM5;CAST;MPP7;MPRIP;ASAP1;MYO1B;CTNNA1;ERC1;LIMA1;BAIAP2L1;CDH11;TLN1;NIBAN2;PACSIN2;FLNA;WASF2;DDX6;DLG1;ITGB1;SLK;SNX9;PAK2;ANXA2;CDH1;RAB10;ARVCF;TMOD3;TES;ANXA1;ZC3HAV1;LARP1;HDLBP;CNN3;ZC3H15;CHMP4B;ATXN2L;VASP;GCN1;KTN1;JUP;HNRNPK;CHMP5;PLCB3;PDXDC1;BAG3;GOLGA3;NOTCH3;HCFC1;GIPC1;PLIN3;TXNDC9;ARGLU1;ABI1;ARFIP2;CAPZA1;ATIC;GLOD4;CEMIP2;TRIM25;CCT8;SERBP1;STX5;MAPRE1;CAPZB;PCMT1;CTTN;NUDC;LASP1;STAT1;NUMB;YWHAE;ACVR1;DDX3X;EMD;P2RX4;NCK1;ARHGAP18;PAICS;MRE11;VASN
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.3739075360064277,-1.2307650490204811,0.14940239043824702,0.5337719805195071,1.0,10/42,15.49%,CCNL2;KAT2B;CCNT2;CCNL1;CCNH;CCNT1;CCNK;CCNYL1;CCND3;CNPPD1
prerank,glucuronosyltransferase activity (GO:0015020),0.44378442479392816,1.2301587228128303,0.208955223880597,0.49947673069972437,1.0,3/19,5.76%,B3GAT1;B3GAT2;CSGALNACT1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5314306455498035,-1.2295674863322918,0.20708955223880596,0.5330416497955283,1.0,4/11,9.06%,AKAP13;KSR1;SH3RF1;MAP2K1
prerank,phosphatidylinositol binding (GO:0035091),-0.32504772388126457,-1.2277247383706646,0.11764705882352941,0.5338206164111683,1.0,29/91,20.58%,ITPR1;PARD3B;APPL2;ITPR2;SNX24;NUMA1;EEA1;PIGK;BCAS3;SNX9;ZFYVE1;FCHO2;PITPNC1;PITPNA;TULP3;PITPNM2;PLEKHF2;APPL1;PARD3;SNX10;ZFYVE16;SNX8;RUBCN;PICALM;ANKFY1;GPAA1;PLEKHF1;C2CD2L;MPPE1
prerank,NAD binding (GO:0051287),-0.4278541833194033,-1.2265978602388592,0.19180633147113593,0.5331827153199257,1.0,9/26,15.10%,ALDH1A1;CRYL1;ALDH2;GLUD1;ZC3HAV1;ME1;PARP9;SIRT5;BDH2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5153048711048299,1.225433584482311,0.25379609544468545,0.5056775561975044,1.0,1/10,0.14%,ADARB2
prerank,protein heterodimerization activity (GO:0046982),-0.2913665052798244,-1.221799496076826,0.06613226452905811,0.5424038627047499,1.0,54/178,23.14%,ATP1A2;BMP6;TCF4;TPM1;ZHX2;ARNT;ADRA1B;IRAK3;MEF2A;EXT1;SAE1;ITGB1;MIGA2;BCL2;IRAK2;ZBTB1;HIF1A;PAFAH1B2;MEF2C;PSMF1;AGTR1;QTRT2;BHLHE41;TCF3;SRI;ATF6;KATNA1;HEXA;GCA;MICU1;YWHAE;RCC1;BDKRB2;CYBA;ADRA2A;PRMT5;BUD23;NR4A1;TLR4;NR4A2;TOP2B;IRAK1;RALGAPB;TPM2;P4HB;DGKD;RALGAPA2;PPP2CA;NAE1;SMC1A;USF1;KCNB1;VAPA;HSF1
prerank,tRNA methyltransferase activity (GO:0008175),-0.4679699649775199,-1.2205650978968912,0.22332015810276679,0.5415436166277228,1.0,10/16,32.96%,TRMT9B;METTL2A;METTL2B;THUMPD3;FTSJ1;LCMT2;TRMT44;TYW3;ALKBH8;TRMT12
prerank,estrogen receptor binding (GO:0030331),-0.39184740739694984,-1.2204064318672065,0.20037105751391465,0.5381373046254773,1.0,13/32,16.87%,PPARGC1B;LCOR;DCAF1;TRIP4;NSD1;NCOA6;NCOA1;MED1;PRMT2;WIPI1;MMS19;LATS1;CNOT1
prerank,FMN binding (GO:0010181),0.5259320628441474,1.2174196871970084,0.25,0.5194043206330635,1.0,3/11,7.88%,NDOR1;NOS3;DUS2
prerank,cAMP response element binding (GO:0035497),-0.5204896848788152,-1.215337116902919,0.21960072595281308,0.5472645471999791,1.0,4/10,10.07%,CREB3L2;CREB5;ATF2;JUN
prerank,pyridoxal phosphate binding (GO:0030170),-0.43827586415228315,-1.215142389998157,0.20872865275142316,0.5438579370652588,1.0,14/20,42.30%,ABAT;PYGB;PYGM;PLPBP;PDXK;OAT;PSAT1;CBS;ACCS;CTH;PYGL;SHMT2;SHMT1;GLDC
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.3801831005418765,-1.2136428069240044,0.1836734693877551,0.5437834610910682,1.0,16/38,23.59%,SORBS1;GAB2;LRRK2;IRS1;AXIN1;SHC1;FRS2;MMS19;NCK1;NCK2;SH2B1;BLNK;PTPN11;PIK3R1;DLG5;SPAG9
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.4031452252901105,-1.2136242876655399,0.19553072625698323,0.5400801679680732,1.0,7/27,11.74%,ITPR1;ITPR2;SLC41A1;CNNM2;SLC12A2;ZDHHC13;ATP2B1
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.4063985716895391,-1.2133391529235615,0.18613861386138614,0.5372123101206623,1.0,8/26,26.98%,PTN;PPP1R1A;CABIN1;BOD1L1;PPP1R2;PPP1R14A;BOD1;SAG
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.36351897407796385,-1.2109861897494247,0.19215686274509805,0.5391754209485746,1.0,18/42,25.38%,ABL1;IRS1;SHB;SHC1;PTPN3;VAV2;ABL2;YES1;FBXW7;YWHAE;RASA1;NCK2;PTPN11;SHF;CRKL;PIK3R1;SYK;SHC3
prerank,Wnt-activated receptor activity (GO:0042813),-0.4729862512281269,-1.20618646118003,0.229126213592233,0.5480252626522629,1.0,4/15,5.97%,ROR1;PKD1;RYK;FZD2
prerank,magnesium ion binding (GO:0000287),-0.299250237614675,-1.204556186310725,0.10318949343339587,0.5484049317517654,1.0,40/135,22.99%,EYA2;OPA1;CLYBL;DIS3L2;STK3;ABL1;LRRK2;IRAK3;PLSCR1;NUDT5;TDP2;MAP3K5;DHX36;WRN;MAP3K20;BRSK1;ABL2;RP2;SIK1;PPA1;ERN1;LATS1;PDXK;MAP2K7;FOXK2;EPHX2;MARK1;SIK3;XYLT2;PSPH;MSH6;NME1;PGM1;NEK6;SIK2;MAST2;SPHK1;CDC42BPG;GSS;XXYLT1
prerank,tubulin binding (GO:0015631),0.27523066842776467,1.2013459680094563,0.06924643584521385,0.5534849092814773,1.0,65/295,14.97%,DNM3;NAV3;EML5;SYBU;GIT1;PACRG;S100A9;S100A8;TTLL7;UNC5C;AGBL4;MAP1B;STMN1;FGF13;MAP2;REEP1;GABARAPL1;KIF1A;SNCA;HOOK1;KIF21B;DST;MTUS1;MAP6D1;PAK1;GABARAP;SPAG5;CEP44;TRIM36;NEFM;MTCL1;SNPH;TERF1;MAPRE3;CLIP2;KIFC2;STMN4;RMDN1;CAMSAP1;TPPP;KIF26B;STMN2;NUSAP1;ARHGEF2;TUBGCP3;REEP2;MID2;DIP2B;APC;CCDC88A;KIF19;EML6;DCTN1;RPS3;SGIP1;MACO1;DIXDC1;EFHC2;DCX;STMN3;GOLGA2;NDRG1;ARHGEF7;CAPN6;TPPP3
prerank,RNA binding (GO:0003723),-0.24224245156471105,-1.2008061973876503,0.0,0.5544360461255837,1.0,508/1321,30.86%,BICC1;SAMD4A;RBMS1;ROCK2;FNDC3B;CELF2;SRRM2;AHNAK;RRBP1;LRP1;RBFOX2;NSA2;SON;RBMS3;ERI3;HOXB6;TNS1;SMG6;RBPMS;ANKRD17;DDX5;DCN;CELF1;FARS2;ANKHD1;CAST;HNRNPH1;EIF4G3;UBE2N;DIAPH1;RBM39;VIM;NUFIP2;CTNNA1;SMG1;DICER1;SNTB2;LUC7L2;TNRC6B;PABPN1;MBNL2;NUDT4;HNRNPR;TOP1;KMT2C;ZCCHC24;PUM2;PRRC2C;ZC3H7A;YTHDF3;WDR33;FLNA;PCF11;RSRC2;TNRC6A;SYNCRIP;CASC3;EIF4A2;MAP4;ACIN1;HUWE1;KHDRBS1;DDX17;TRMT9B;DDX6;PPARGC1B;HMGB1;BAZ2A;RBMS2;SRSF10;SCAF4;EIF4ENIF1;MOV10;RBBP6;RBM6;GOLGB1;DDX46;FUS;CCT6A;SEC23IP;RC3H1;NUDT5;ANXA2;ZC3H12C;SCAF8;MEX3C;STAT3;CS;NYNRIN;U2AF2;HNRNPM;TBCA;YLPM1;GFM1;IFIT2;PDCD11;PUS10;ADK;STXBP1;DHX9;ANXA7;TES;DENR;SRBD1;ZC3HAV1;LARP1;AKAP8L;SF3B1;CPSF3;SRSF6;PTBP3;HDLBP;SIDT1;HNRNPD;PUM1;TUT4;HNRNPUL1;NUP42;PRPF6;RBM10;ZC3H15;DCP1A;DHX36;PCBP2;PPARGC1A;KNOP1;SPATS2L;ATXN2L;FUBP1;SAFB2;CAVIN1;DDX42;CDC5L;CSDC2;HLTF;GCN1;NSUN6;KTN1;ABCF1;LAS1L;UBE2I;CSNK1E;CDK13;PNISR;GEMIN5;SMG7;HNRNPK;CHD2;UBAP2L;MAP3K20;ALG13;EIF4E;CHD3;UPF1;FAM120A;PRPF3;ARCN1;CSDE1;SPATS2;SLBP;JUN;RCC1L;DHX40;LSM14A;SF3A1;DDX60;SF3B6;RPGR;RBM45;DAZAP1;RPL11;YTHDC1;CLK3;PRRC2B;AKAP1;CDK11B;FCF1;SCAF11;BCLAF1;DUSP11;ZBED4;RTF1;XRN2;ZC3H4;ASCC3;LGALS1;PARP1;XRN1;ACAA2;DCP1B;SF3A3;KHNYN;DYNC1LI1;WDR43;HSPA9;SNRNP70;TPR;ARF1;ZCRB1;ZYX;ALDH6A1;ALKBH1;TRIM25;DIMT1;EIF2AK4;YBX3;TDRD3;CWC22;STRAP;SRFBP1;APTX;DDX23;SERBP1;HTATSF1;GTPBP10;MAPRE1;DDX19B;CPNE3;YBX1;URB1;TXN;KIF1C;RBM5;TCERG1;RBM42;CCAR1;NSRP1;EIF2AK2;RARS2;APOBEC1;ACO1;NAA15;PRKDC;OTUD4;ZC3H12B;BMS1;SRSF1;EDC3;SEC63;EXOSC9;ILF2;NOP58;YWHAE;DDX3X;RRP36;FAM32A;R3HDM2;SFPQ;RPP14;BRIX1;NOM1;TYW5;EFTUD2;SNU13;DDX27;HELZ;EXOSC10;NOP53;PRR3;DNTTIP2;SREK1;MAK16;MTREX;MRPL39;NXF1;BUD23;GANAB;NSUN2;HELB;OAS2;CNOT1;DYNC1H1;EWSR1;PRPF40B;SLC25A11;DDX50;HNRNPU;HSPE1;ARHGEF1;KRR1;TENT5A;WBP11;MSI2;DDX31;CSTF3;TRMT1L;RPN1;CDC42EP4;SHFL;CHCHD1;PTPN1;EIF1AX;MRPL3;RRP8;VCP;SNRPF;HNRNPA3;GPATCH4;EIF3A;COL14A1;ZRANB2;PARK7;ELP5;UTP3;UTP6;RBM4;SRSF7;EIF4G1;ESF1;MRPL1;PKM;SIDT2;H1-0;NFX1;RRP7A;KARS1;TRIP6;NUP98;EIF3L;ALDH18A1;SRSF11;RBM33;IFIT3;UPF3B;RBPMS2;P4HB;TERT;PSMC1;NME1;SRRM1;CCDC9B;ERAL1;ASS1;SURF6;XRCC6;SMC1A;CRKL;FBRSL1;EBNA1BP2;PYM1;MRPL32;SSBP1;MSN;SRSF2;ZNF346;DHX57;TBL2;LBR;LUC7L3;DALRD3;MRPL10;XPO5;LRRC47;NAP1L4;UTP18;PRKRIP1;GTF2F1;RPUSD4;CPSF4;CSTF1;HDAC2;DDX41;NUDT21;MRPL43;APEH;IMP3;CCAR2;TRNT1;AGO1;GAR1;BOP1;ZC3H13;AATF;EXOSC3;ALDOA;GNL3L;PARP12;WDR6;PPP1R10;USO1;BCCIP;PPHLN1;RTRAF;NOA1;PRPF38A;TRMT1;NONO;NCBP3;EIF3H;DHX15;UNK;IREB2;FAM50A;DUS3L;CNOT4;PABPC4;NAP1L1;CLUH;NKRF;FXR1;PSTK;ARL6IP4;KDM1A;RPL7L1;TWF2;EDF1;KIN;PRRC2A;RBM28;TDRD7;MTO1;PCBP3;HARS2;RSL1D1;ELAC2;TRMT2A;LUC7L;TSR1;NCBP2;GTF2E2;CRNKL1;PRPF8;ENDOV;RBM19;FYTTD1;NOL12;MRPL22;LSM6;PES1;DHX37;NIP7;CACTIN;PNLDC1;EIF3C;CCT3;NAT10;DHX58;RBM22;SRP72;PCBP4;GRN;ISY1;LONP1;ZC3H7B;SUGP1;SLTM;POLR1G;RBM34;NELFE;PIN4;RRS1;HNRNPL;GNL3;POLR2D;ZFP36L2;CCDC124;RPL22;PARN;SUPV3L1;FASTKD1;MRPL12;SAFB;SAMHD1;IGHMBP2;PABPC4L;HNRNPUL2;ZNF106;PNO1;CCDC47;NUDT1;RBM18;ZC3H10;POP4;KPNA2;TBL3;ZC3H18;RBM27;THOC2;SNRNP200;UTP4;MRPS24;POLRMT;MPHOSPH10;GDI2;MTPAP;RBM47;DDX25;PEF1;IFIH1;SNW1;RPP38;ENO1;USP36;FLYWCH2;SF3A2;NUDT7;CALR;TBRG4;RDX;PSIP1;ADARB1;SNRPA1;TRMT10C;LSM1;THRAP3;YWHAZ;DHX33;C1QBP
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.31229759600214374,-1.1970849335558915,0.1557377049180328,0.560424838665846,1.0,29/100,17.30%,GAB2;FCHSD2;ADAP2;MYO1B;SNX24;SH3PXD2B;GBF1;ARAP1;OSBPL8;MAPKAP1;OSBPL5;CYTH3;ZFYVE1;DAPP1;IQGAP2;PLA2G4A;KIF16B;SNX21;WIPI1;ARFIP2;GSDMD;PARD3;OGT;ATG2A;PLEKHA8;ZFYVE16;RUBCN;WDR45B;ATG2B
prerank,phospholipase inhibitor activity (GO:0004859),-0.5184181952779303,-1.196392142032946,0.24807692307692308,0.558402009344869,1.0,4/10,7.19%,ANXA5;ANXA4;ANXA2;ANXA1
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.37505354144919345,-1.1962056467540372,0.2,0.5552268124738072,1.0,18/34,28.30%,ERI3;DIS3L2;PAN3;CNOT8;XRN2;ERI2;EXOSC9;PAN2;CNOT2;EXOSC10;CNOT1;USB1;ANGEL2;EXOSC3;PNLDC1;PDE12;DIS3;PARN
prerank,myosin binding (GO:0017022),-0.3498098923804671,-1.1947739356741494,0.16865079365079366,0.5552527611163985,1.0,12/55,12.56%,CALD1;KIRREL1;TRAK1;GSN;STXBP5;RAB10;ARFGEF1;SPATA6;RHOA;GIPC1;RAB11A;RALA
prerank,death domain binding (GO:0070513),-0.5083953085209211,-1.193873215057186,0.23552123552123552,0.5537781368274275,1.0,6/11,27.92%,BCL2;DAP;DAPL1;IRGM;CRADD;TRADD
prerank,death receptor activity (GO:0005035),0.49985410337010194,1.1936403181786976,0.23390557939914164,0.5662740261448199,1.0,5/11,22.51%,TNFRSF19;TNFRSF25;TNFRSF1A;TNFRSF10B;EDA2R
prerank,GABA receptor binding (GO:0050811),0.4993532690585905,1.1935492107015162,0.2360248447204969,0.5610750468701566,1.0,4/11,9.32%,GABARAPL1;GABARAP;SHISA7;LHFPL4
prerank,endopeptidase regulator activity (GO:0061135),-0.3652832345448107,-1.1905722083762316,0.20758483033932135,0.5587866240574237,1.0,8/40,11.83%,CAST;PROS1;TFPI;ITIH2;RECK;RENBP;SERPIND1;PSMF1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.41962765074272507,-1.19057197017074,0.210727969348659,0.5552274735857203,1.0,11/25,24.59%,TNKS2;ZC3HAV1;PARP10;PARP9;PARP14;PARP1;SIRT5;PARP4;PARP6;SIRT4;SIRT3
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.3872736920502364,-1.1879855084934368,0.220703125,0.5577583301370941,1.0,10/31,19.14%,UBE2N;UBE2E2;BIRC6;UBE2H;UBE2K;UBE2R2;UBE2B;UBE2E1;UBE2S;UBE2D3
prerank,fibroblast growth factor receptor binding (GO:0005104),0.41564832663027795,1.1874966941822378,0.226890756302521,0.5715343427267493,1.0,4/21,6.99%,FGF10;FRS3;NPTN;FGF5
prerank,amino acid:sodium symporter activity (GO:0005283),-0.5078617030724464,-1.1836761643978764,0.2689393939393939,0.5653867901559889,1.0,4/11,10.71%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,protein tyrosine kinase activity (GO:0004713),0.30560302147987595,1.1827414532481209,0.14285714285714285,0.5777903404141105,1.0,16/108,6.02%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;WEE2;FLT3;AATK;SRMS;ALK
prerank,GTPase regulator activity (GO:0030695),-0.2778999072102716,-1.182178126406376,0.1285444234404537,0.5654191612624776,1.0,67/212,21.11%,RANBP3L;ALDH1A1;ARHGAP29;ARHGAP10;ARHGAP42;ERRFI1;ASAP3;SIPA1L1;ARHGAP28;ASAP1;STXBP5;ARHGAP20;ARHGEF10L;LRRK2;ARAP1;TBC1D16;SMAP1;BCR;SGSM2;ARHGAP24;DNM1L;RANBP2;PDE6D;ARFGEF1;SEC23A;RAB3GAP1;GMIP;NRP1;ARHGAP17;USP6NL;IQGAP2;WASL;ARFGAP1;ARFGAP3;TBC1D2B;JUN;TBC1D20;TBC1D8B;RP2;ARHGAP32;SEC23B;TBCK;GRTP1;TBC1D22B;TBC1D9;RAPGEF2;ACAP2;ARHGAP18;RASA1;ARHGEF6;ARRB1;TBCD;RIC8B;DOCK1;NPRL3;RHOH;TBC1D17;RANBP3;ARHGAP15;RALGAPB;TBC1D7;SIPA1L3;RTKN;RABGAP1;TBC1D10A;RALGAPA2;LARS1
prerank,voltage-gated calcium channel activity (GO:0005245),0.3660386425078526,1.1809502595873311,0.2,0.5770123949636073,1.0,10/37,10.91%,CACNA1A;CACNA1B;CACNA2D1;CACNG2;CACNA1E;CACNB2;CACNG3;OPRM1;CACNB4;CACNG8
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.32481095294821843,-1.180313863099875,0.18026565464895636,0.5666700026848531,1.0,20/69,22.05%,KAT2B;EP300;CERS5;KAT6B;SOAT1;CREBBP;PLA2G4A;ZDHHC13;MOGAT3;MBOAT7;KAT8;ESCO1;NAA15;ASPG;GTF2B;ZDHHC1;ZDHHC16;HHAT;SPHK1;LPCAT3
prerank,fibroblast growth factor binding (GO:0017134),-0.4242974388313115,-1.1800663777344067,0.22879684418145957,0.5637322008787152,1.0,13/21,28.35%,ITGAV;THBS1;FGFR2;GLG1;KL;FIBP;CEP57;ITGB3;FGFR4;GPC1;FGFRL1;S100A13;FGFBP3
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.46219692852842814,-1.1794450347894776,0.2514177693761815,0.5618743043488474,1.0,7/15,29.22%,KMT2C;KMT2D;SETD3;KMT2A;PRDM9;CXXC1;WDR5
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.49573649140970055,-1.1790335762361301,0.26703499079189685,0.5596033177663177,1.0,9/12,42.99%,NQO2;CBR4;NDUFS7;DHRS4;CRYZ;CBR1;NQO1;DCXR;AIFM2
prerank,signal sequence binding (GO:0005048),0.3655151300971747,1.178657395546777,0.18336886993603413,0.5774410186938408,1.0,8/35,13.19%,IPO5;IPO4;CABP1;AP2M1;PEX5L;AP2B1;TIMM22;NFKBIA
prerank,general transcription initiation factor binding (GO:0140296),-0.40746852386134946,-1.1785579568261435,0.22287968441814596,0.5574767282841473,1.0,13/25,30.25%,AR;TBP;TAF13;GTF2B;TAF12;PSMC1;DRAP1;YEATS2;ESR1;THRA;BRF2;RUVBL2;GTF2A1
prerank,actin binding (GO:0003779),-0.28611320630801346,-1.1779421716451866,0.10462776659959759,0.5555534259389875,1.0,32/170,11.80%,CALD1;SYNE2;PARVA;PAWR;PHACTR1;MICAL3;SORBS1;DAG1;VCL;GSN;TPM1;PDLIM5;PHACTR2;PRKN;LIMA1;ABL1;LRRK2;SHROOM2;MICAL2;NCALD;ITGB1;PDLIM7;PLEKHH2;CORO7;SMTN;MAEA;IQGAP2;SYNPO2;ABL2;GIPC1;PDLIM2;CAPZA1
prerank,phosphatase binding (GO:0019902),-0.30092967908207924,-1.1735228452319113,0.14345114345114346,0.5630673868393887,1.0,38/105,24.65%,EGFR;SMAD3;JAK1;DLG4;SHOC2;TBK1;DLG1;CTSC;SMAD2;STAT3;EIF2AK3;ANAPC5;MAP3K5;AP3B1;ANAPC7;ANAPC4;JUP;WNK1;TRAF2;MTMR3;SH3RF2;TRPC4AP;MAP2K7;TRAF3;CDC27;IKBKE;VCP;MVP;PPP1R3C;KIFAP3;MAST2;PIK3R1;STX17;PPP1R3F;GTF2F1;SIRPA;CRY2;KIF3A
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.40145586075456774,-1.17313512741316,0.22580645161290322,0.5605260283768673,1.0,5/25,4.67%,MICAL3;CYP26B1;MICAL2;CYP27A1;POR
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3486799065198038,-1.1708892997619984,0.18267419962335216,0.5627332744075146,1.0,10/47,12.28%,SLC7A11;SLC7A2;SLC6A13;SLC47A1;PDPN;SLC1A5;SLC38A11;SLC6A1;SLC38A6;SLC22A4
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.2551882917808778,-1.169987436579647,0.05465587044534413,0.5616650413955893,1.0,148/431,28.10%,ATP1A2;PRKAG2;RHOQ;TGFBR1;BMPR1A;TLK1;ABCA1;MYO1B;KSR1;STK3;ANXA6;ABL1;LRRK2;ENPP1;ATL3;RHOJ;TOP1;ABCD3;STK17B;N4BP2;ARL3;IRAK3;RND3;RAP1B;RAB10;MRAS;RAB22A;MAP4K4;GLUD1;CHD8;DHX9;SMC4;MAP3K5;SYN3;CDC42;DHX36;ABCD2;MARK4;WNK4;ABCF1;WNK1;MAP3K20;BRSK1;ATL2;RHOA;HSPA14;DMPK;RHOT1;CARS2;CDK11B;ARFIP2;DYNC1LI1;HSPA9;AK6;PNPLA8;MKNK2;ARF1;ABCD4;RHOBTB2;PEX6;SIK1;MYO1F;RALA;RASL12;GTPBP10;PGK1;TBCK;GBP3;ERN1;RAB21;MCM6;BMS1;LATS1;ACVR1;P2RX4;PDXK;DAPK1;PTPA;MARK1;MTREX;TAP2;SIK3;TARS1;OAS2;GBP2;DAPK2;RHOBTB1;HNRNPU;PFKP;GBP7;PXK;RHOH;TUBB2A;GBP6;RHOC;MTG2;MSH6;EIF4G1;MLKL;BCKDK;NME1;PFKM;AKT2;NEK6;SIK2;CDK6;MAST2;MKNK1;PFKL;SPHK1;TAOK1;RIT1;RABL3;CDC42BPG;GSS;TUBB6;ARL5A;TRNT1;GALK1;RRM1;RHOT2;CLPX;NOA1;RAB8A;MVK;RAB9A;RPS6KA4;TAP1;RAB7A;RAB5A;TWF2;TWF1;ABCF3;RRAGA;TSR1;PRKCI;ABCB8;DIRAS2;PRPS1;PRPS1L1;PIM1;LONP1;MINK1;TUBA1C;RAB39A;ARL4C;NIM1K;GNL3
prerank,cation transmembrane transporter activity (GO:0008324),0.3510879734681049,1.1692751864256052,0.22107438016528927,0.5968239674166498,1.0,8/48,9.70%,SLC7A5;SLC6A6;SLC7A1;SLC1A1;MFSD12;SLC7A8;SLC66A1;SLC36A1
prerank,calcium:sodium antiporter activity (GO:0005432),0.5091098652677472,1.1674475345773094,0.27956989247311825,0.5960957465120693,1.0,3/10,4.67%,SLC24A4;SLC24A2;SLC8A1
prerank,telomeric DNA binding (GO:0042162),-0.3783336508557535,-1.166961442349875,0.2200392927308448,0.5665462737208662,1.0,13/32,21.18%,SMG6;SMG1;HNRNPD;WRN;SMG7;UPF1;TELO2;CTC1;UPF3A;TERF2;STN1;TERT;XRCC6
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3721259717881241,-1.1666210646092128,0.21850393700787402,0.5640833600561669,1.0,9/35,16.49%,CLK1;ABL1;FRK;LYN;FER;ABL2;YES1;TEC;STYK1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.2867518799109883,-1.166117911257169,0.1533980582524272,0.5620554409732569,1.0,39/147,17.03%,AKAP13;DENND4A;DOCK5;DOCK11;PLCE1;DENND2A;FARP1;ARHGEF17;SBF2;IQSEC2;BCR;ARFGEF1;RAB3GAP1;CYTH3;RAPGEF3;VAV2;RAB3IL1;HERC2;RAB3IP;RCC1L;ARHGEF18;FNIP1;DENND4C;MON1A;SERGEF;FGD1;DNMBP;DENND5A;RAPGEF2;FGD4;ANKRD27;RCC1;NGEF;ARHGEF11;SH3BP5L;FARP2;ARHGEF6;RIC8B;DOCK1
prerank,microtubule binding (GO:0008017),0.27560853134259156,1.1650364283102654,0.13141683778234087,0.5968785852658504,1.0,56/222,17.65%,DNM3;NAV3;EML5;SYBU;S100A9;S100A8;MAP1B;FGF13;MAP2;REEP1;KIF1A;HOOK1;KNSTRN;KIF21B;DST;MTUS1;MAP6D1;SPAG5;CEP44;NEFM;MTCL1;SNPH;TERF1;MAPRE3;CLIP2;KIFC2;RMDN1;CAMSAP1;TPPP;KIF26B;NUSAP1;ARHGEF2;TUBGCP3;REEP2;MID2;APC;CCDC88A;KIF19;EML6;DCTN1;RPS3;SGIP1;MACO1;DCX;GOLGA2;NDRG1;CAPN6;REEP3;MACF1;CAMSAP3;CLASP2;DNM1;CCDC61;STARD9;KIF21A;FHDC1
prerank,PDZ domain binding (GO:0030165),-0.3264507081290403,-1.1645237526226997,0.18164435946462715,0.5631082972269648,1.0,17/61,14.54%,TGFBR3;ARHGAP29;CRIM1;PLEKHA2;SDC2;ERC1;PRKN;DLG4;SYNJ2;CXADR;FZD2;SLC22A5;ATP2B1;SLC22A4;FZD7;GNG5;RAPGEF2
prerank,insulin-like growth factor I binding (GO:0031994),-0.4727380566584678,-1.1614053272270146,0.26692456479690524,0.5673835714759997,1.0,6/13,8.53%,IGFBP2;IGFBP5;ITGAV;IGFBP3;IGFBP6;IGFBP4
prerank,sterol binding (GO:0032934),-0.3342397822565939,-1.1599011573074753,0.22376237623762377,0.5681815037898071,1.0,17/56,15.63%,ABCA1;ANXA6;OSBPL8;SOAT1;GRAMD1C;INSIG2;OSBPL5;OSBPL11;SIDT1;VDAC1;NR1H3;OSBPL9;ERLIN1;NPC2;APOD;RORA;PTCH1
prerank,actinin binding (GO:0042805),-0.41821898069044683,-1.1598305445528991,0.27599243856332706,0.5651444716336813,1.0,8/21,14.45%,CACNA1C;DAG1;NFKB1;PDLIM5;CACNA1D;SYNPO2;PKD2;CSRP2
prerank,diacylglycerol kinase activity (GO:0004143),0.48674354911070233,1.1598299778950436,0.2857142857142857,0.6047428998848654,1.0,3/11,7.33%,DGKI;DGKH;DGKB
prerank,lysine-acetylated histone binding (GO:0070577),-0.425010943651717,-1.1525584696976165,0.2884250474383302,0.5767701086591622,1.0,7/20,21.58%,MLLT3;BRD7;BAZ2A;BRD3;PHIP;ZMYND8;KMT2A
prerank,acetylation-dependent protein binding (GO:0140033),-0.425010943651717,-1.1525584696976165,0.2884250474383302,0.5767701086591622,1.0,7/20,21.58%,MLLT3;BRD7;BAZ2A;BRD3;PHIP;ZMYND8;KMT2A
prerank,adenylyltransferase activity (GO:0070566),-0.4093782566370755,-1.1490153765250424,0.27416173570019725,0.5824072741983479,1.0,9/21,19.94%,TENT2;NMNAT2;ABL1;NMNAT3;NMNAT1;PAPOLG;OAS2;FLAD1;KARS1
prerank,nuclear import signal receptor activity (GO:0061608),0.4471229653936938,1.1487264582049401,0.2828507795100223,0.6286008927754321,1.0,2/15,1.47%,IPO5;IPO4
prerank,syntaxin binding (GO:0019905),0.32848528131720445,1.1474562026332729,0.2468354430379747,0.6262881123464582,1.0,11/61,7.15%,CACNA1A;SYT1;SYT6;SYT12;SNAP25;UNC13A;STXBP5L;SNPH;NAPG;SYNPR;SYT10
prerank,actin monomer binding (GO:0003785),0.4039076978202925,1.1452273205249273,0.26180257510729615,0.6270036159761553,1.0,4/22,4.79%,MRTFA;TMSB4X;TMSB10;NOS3
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.25934582113311255,-1.1450503049108591,0.094,0.5892794189020686,1.0,72/269,18.94%,FHIT;EGFR;SMAD3;VCL;SMAD6;UBE2N;PRKN;JAK1;ARIH1;SNCAIP;GSK3B;CASC3;HM13;USP7;SMC6;DNM1L;SMAD2;AXIN1;SNX9;SKI;TRIP4;BCL2;RNF8;MID1;PCBP2;PPARGC1A;JKAMP;UBE2K;UQCRC1;HLTF;TXNIP;PTPN22;HERC2;JUN;SPOPL;TRAF2;HIF1A;PARP9;RPL11;CCDC50;HSPA9;RB1;PIAS4;CUL3;RALA;SLF1;FBXW7;PATZ1;BECN1;LTBR;DTX3L;TRIB2;UBE2B;USP2;STAT1;USP13;CUL2;YWHAE;FAF2;TRAF3;NDUFS2;ARRB1;RNF20;AUP1;DERL1;PRKACA;IKBKE;TRAF6;VCP;AMBRA1;TANK;TRIOBP
prerank,NADPH binding (GO:0070402),0.464425146682648,1.144460318257781,0.31359649122807015,0.6236345360388942,1.0,3/13,7.88%,NDOR1;KCNAB1;DUS2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.4965152703735113,-1.1433678169855055,0.3103448275862069,0.5899556691510167,1.0,3/10,12.87%,CFLAR;CASP12;CASP2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4482722591576155,1.1418419164237326,0.28936170212765955,0.6252860397062223,1.0,3/14,12.95%,KCNJ3;KCND3;KCNJ8
prerank,growth factor activity (GO:0008083),0.3164497252562375,1.1405606982338043,0.21052631578947367,0.6232604015888442,1.0,10/74,10.53%,NRG3;IL7;NRG1;FGF10;IL12A;AMELX;FGF5;ENDOU;THPO;PDGFB
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3939118592725792,1.1388880815541973,0.29653679653679654,0.6226302180337105,1.0,6/24,15.58%,ZDHHC22;ZDHHC17;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14
prerank,ion gated channel activity (GO:0022839),0.3923127652017386,1.138414897536482,0.2670807453416149,0.6188343316583321,1.0,5/24,8.84%,ANO3;TMEM63B;TTYH2;ANO5;ANO4
prerank,damaged DNA binding (GO:0003684),-0.3423900088765903,-1.1382986967667743,0.2543689320388349,0.5991722667889677,1.0,20/44,32.61%,EP300;RBBP8;HMGB1;SMC6;NBN;CREBBP;DDB2;ERCC3;APTX;SDE2;DCLRE1A;PCNA;ERCC1;CRY2;OGG1;MPG;FANCG;NEIL3;RPA2;PNKP
prerank,ubiquitin protein ligase binding (GO:0031625),-0.25902744510163417,-1.1365688639934493,0.11823647294589178,0.6005888272580913,1.0,68/254,18.94%,FHIT;EGFR;SMAD3;VCL;SMAD6;UBE2N;PRKN;JAK1;ARIH1;SNCAIP;GSK3B;CASC3;HM13;USP7;SMC6;DNM1L;SMAD2;AXIN1;SNX9;SKI;BCL2;RNF8;MID1;PCBP2;PPARGC1A;JKAMP;UBE2K;UQCRC1;HLTF;TXNIP;PTPN22;HERC2;JUN;SPOPL;TRAF2;HIF1A;RPL11;CCDC50;HSPA9;RB1;PIAS4;CUL3;RALA;SLF1;FBXW7;PATZ1;BECN1;LTBR;TRIB2;UBE2B;USP2;USP13;CUL2;YWHAE;FAF2;TRAF3;NDUFS2;ARRB1;RNF20;AUP1;DERL1;PRKACA;IKBKE;TRAF6;VCP;AMBRA1;TANK;TRIOBP
prerank,protein kinase binding (GO:0019901),-0.24507007714287318,-1.1347081286420184,0.09387755102040816,0.601934890114656,1.0,153/479,24.50%,PRKAG2;GRK5;SASH1;SMAD3;TCF7L2;ANK2;ERRFI1;PTN;PKD1;MAPK4;LIMS1;PDLIM5;KIF13B;NBEAL1;ITGAV;NISCH;PARD6G;KAT2B;PDGFRB;IL31RA;PPP1R12A;FOXO3;GHR;PRKN;ABL1;PPM1D;IBTK;GSK3B;RPTOR;CNTLN;IRAK3;IRS1;IL15RA;KHDRBS1;MAPKAP1;DLG1;NR3C1;ITGB1;RND3;RBBP6;AXIN1;SLC12A7;SKI;PAK2;UFL1;TRIP4;STAT3;DUSP16;SHC1;NOX4;TPCN2;EPHA4;ADCY6;CDC42;PTPRK;NBR1;VDAC1;DACT1;CCNK;PLCG1;WNK1;TOM1L2;ATF2;SLC12A2;RB1CC1;PTPN2;TRAF2;RHOA;PRKCD;HIF1A;ADAM9;EXOC2;MAVS;PRKAB2;DNAJC3;KIZ;PARP1;TRIM5;TELO2;TPR;RHOBTB2;SIK1;TCF3;APPL1;SUFU;BECN1;MAML1;MAPRE1;RICTOR;TRIB2;ERCC6L2;CDK5RAP1;DUSP1;ROR2;LATS1;CDC25B;ACVR1;CCND3;PPP1CB;DUSP10;RAB11FIP2;MAP2K7;ADRA2A;TNIP2;CAVIN3;PRKACA;RHOBTB1;TOP2B;CACUL1;BLNK;RHOH;FBXW5;PTPN1;TRAF6;MAP3K1;DACT3;MTCP1;RHOC;PTPN11;IRAK1;MAP2K6;LRBA;PRKAG3;MVP;SPRED2;NBEAL2;NEK6;PIH1D1;PRKAB1;SMAD1;CDK5RAP3;USF1;MSN;MAP3K12;TBL2;CIR1;DUSP7;GATA6;TICAM1;NSF;PRKRIP1;PKIA;CSPG4;HSF1;MAPK7;SPAG9;AP2A1;BAG5;DACT2;MAP3K13;BORA;PTPN23;SIRPA
prerank,leak channel activity (GO:0022840),-0.4219570558171899,-1.1334363166923573,0.2868369351669941,0.601705255777657,1.0,3/18,6.12%,KCNK2;NALCN;KCNK5
prerank,adenyl ribonucleotide binding (GO:0032559),-0.25754284972138614,-1.1326412859574144,0.13319672131147542,0.6004832671250881,1.0,90/291,23.92%,ATP1A2;PRKAG2;TGFBR1;BMPR1A;MPPED2;TLK1;ABCA1;MYO1B;KSR1;STK3;ABL1;ENPP1;TOP1;ABCD3;STK17B;N4BP2;IRAK3;MAP4K4;GLUD1;CHD8;DHX9;SMC4;MAP3K5;SYN3;DHX36;ABCD2;MARK4;WNK4;ABCF1;WNK1;MAP3K20;BRSK1;ME1;HSPA14;DMPK;CARS2;CDK11B;HSPA9;AK6;PNPLA8;MKNK2;ABCD4;PEX6;SIK1;MYO1F;PGK1;TBCK;ERN1;MCM6;RAPGEF2;LATS1;ACVR1;P2RX4;PDXK;DAPK1;PTPA;MARK1;MTREX;TAP2;SIK3;TARS1;OAS2;DAPK2;HNRNPU;PFKP;HMGCR;PXK;MSH6;EIF4G1;MLKL;BCKDK;NME1;PRKAG3;PFKM;AKT2;NEK6;SIK2;CDK6;MAST2;MKNK1;PFKL;SPHK1;TAOK1;CDC42BPG;GSS;TRNT1;GALK1;RRM1;RAPGEF4;CLPX
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.3371526063797201,-1.1319799877854855,0.27184466019417475,0.5989846631068322,1.0,23/49,31.10%,ZFAND6;RNF169;RAD23B;UBQLN1;BRCC3;PARP10;ZBTB1;ABRAXAS2;TNIP2;SPRTN;ZRANB3;IKBKE;VCP;SHARPIN;WDR81;BAG6;UBQLN4;PRPF8;ABRAXAS1;ZFAND2B;TNFAIP3;FAAP20;UFD1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.47839124418355666,-1.1317591329109535,0.3225806451612903,0.5963915978634555,1.0,2/11,1.04%,ITPR1;ITPR2
prerank,calcium-release channel activity (GO:0015278),-0.4341547503502041,-1.1311782382690776,0.2857142857142857,0.5948706023374987,1.0,6/17,12.91%,ITPR1;ITPR2;TPCN1;TPCN2;RASA3;PKD2
prerank,cation channel activity (GO:0005261),0.29432297043376165,1.1303985269156587,0.2012072434607646,0.6353398322470937,1.0,14/94,8.25%,HCN1;SLC24A4;SLC24A2;GRIN1;TRPC5;RYR2;UNC80;TMEM63B;KCNK10;CACNA1E;TRPM2;KCNK9;CACNB2;KCNK1
prerank,solute:anion antiporter activity (GO:0140323),-0.45011472322215507,-1.1280109164779102,0.3052434456928839,0.5996488701466156,1.0,4/14,12.26%,SLC7A11;SLC26A7;SLC26A2;SLC4A3
prerank,nucleosomal DNA binding (GO:0031492),0.39144973735688243,1.126987812247045,0.3054393305439331,0.6390572357744284,1.0,5/21,8.83%,ACTB;HMGA2;SMARCB1;HNRNPC;H3-3A
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.41745673863110744,1.1262119513797464,0.2894168466522678,0.6359136088569217,1.0,3/18,7.93%,SNCA;GAS6;RPS6KA1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.465992318909588,1.1260219709724717,0.33399602385685884,0.6311497221252076,1.0,4/12,12.83%,PDE4B;PDE2A;PDE4D;PDE4A
prerank,nuclear export signal receptor activity (GO:0005049),-0.4793179170917128,-1.120091974807141,0.3339449541284404,0.6165241092771296,1.0,8/11,33.23%,XPO4;EIF4ENIF1;NUP42;NUP214;XPO5;XPO1;RANBP17;RAN
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.48614509081792756,-1.1156120324789673,0.3397312859884837,0.6245318914721019,1.0,1/10,0.40%,DPYSL3
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.36528317561797335,1.115517005616553,0.28662420382165604,0.653474729329514,1.0,7/31,11.77%,HCN1;SLC12A6;KCNK10;KCNK9;KCNK1;SLC12A3;KCNA2
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.3335628275823493,-1.1152191975609236,0.2840690978886756,0.6224879105964851,1.0,12/49,16.29%,ATP1A2;MPPED2;DUSP16;PRUNE1;PTPN22;DUSP11;PXYLP1;PPP1CB;DUSP10;SACM1L;ACP2;EPHX2
prerank,LRR domain binding (GO:0030275),-0.4464354709160786,-1.1141485097247155,0.31007751937984496,0.6219133411537299,1.0,5/14,11.40%,PAWR;ERC1;ROBO1;LRRFIP2;ZXDC
prerank,sodium channel regulator activity (GO:0017080),0.3487430273699623,1.1138918323325766,0.2851063829787234,0.6526194579885651,1.0,9/37,17.83%,FGF12;FGF14;FGF13;SCN4B;SGK3;ATP2B4;SCN2B;GPLD1;PKP2
prerank,insulin-like growth factor binding (GO:0005520),-0.43829556483625975,-1.1131554357596731,0.3178294573643411,0.6213619968028822,1.0,6/15,8.53%,IGFBP2;IGFBP5;ITGAV;IGFBP3;IGFBP6;IGFBP4
prerank,Hsp70 protein binding (GO:0030544),0.36713266240288966,1.1120247003407686,0.2979591836734694,0.6523349140364834,1.0,9/31,13.09%,PACRG;SNCA;SACS;FICD;CYP2E1;IQCG;MVD;RNF207;RPS3
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.46889857316780703,-1.1115361124404257,0.3405511811023622,0.6221233162900223,1.0,7/12,28.30%,PAN3;CNOT8;PAN2;CNOT2;CNOT1;PNLDC1;PARN
prerank,channel activity (GO:0015267),0.3389373641892649,1.1091169655259097,0.27593360995850624,0.6552856463092319,1.0,3/41,2.99%,AQP9;AQP11;ASIC4
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.30437779251707164,-1.1072722138159705,0.28316831683168314,0.6300610127301657,1.0,20/72,17.48%,GSN;SVIL;ADAP2;MYO1B;GSDME;SLC9A1;MAPKAP1;ANXA2;KCNJ2;FCHO2;ACTN2;PLCD1;SNX21;TULP3;GSDMD;FZD7;PARD3;MARK1;PICALM;FRMPD4
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.38956943854679904,1.1054534410868182,0.3108910891089109,0.6499318806896579,1.0,2/22,3.44%,CHRM3;HTR2C
prerank,serotonin receptor activity (GO:0099589),0.38956943854679904,1.1054534410868182,0.3108910891089109,0.6499318806896579,1.0,2/22,3.44%,CHRM3;HTR2C
prerank,G protein-coupled amine receptor activity (GO:0008227),0.38956943854679904,1.1054534410868182,0.3108910891089109,0.6499318806896579,1.0,2/22,3.44%,CHRM3;HTR2C
prerank,phosphate ion binding (GO:0042301),0.47727227350715207,1.1050764010300318,0.3325635103926097,0.6460093988018261,1.0,1/10,3.41%,PDE2A
prerank,ephrin receptor activity (GO:0005003),0.42265785055363836,1.099531989645007,0.3374485596707819,0.6513528723571539,1.0,6/17,12.35%,EPHA6;EPHB1;EPHA5;EFNB3;EPHA10;EPHA1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.42265785055363836,1.099531989645007,0.3374485596707819,0.6513528723571539,1.0,6/17,12.35%,EPHA6;EPHB1;EPHA5;EFNB3;EPHA10;EPHA1
prerank,endoribonuclease activity (GO:0004521),-0.35880976658732716,-1.0969662508111242,0.31679389312977096,0.6540731089546135,1.0,8/32,14.39%,SMG6;DICER1;ZC3H12C;NYNRIN;CPSF3;KHNYN;ERN1;ZC3H12B
prerank,MAP kinase kinase activity (GO:0004708),-0.41943225081408025,-1.0949205798352843,0.326171875,0.6561907936964654,1.0,9/15,37.08%,LRRK2;MAP2K4;MAP2K1;MAP2K7;MAP2K6;MAPK14;MAP2K3;MAPKAPK3;MAP2K2
prerank,adrenergic receptor binding (GO:0031690),0.42375230321067725,1.094058545598635,0.3596673596673597,0.6606571390295962,1.0,5/16,12.78%,MAGI2;ADRB1;GRK2;UCHL1;PDE4D
prerank,metalloexopeptidase activity (GO:0008235),-0.3190244936917368,-1.0938756562106466,0.30528375733855184,0.6555729244263621,1.0,11/51,15.32%,CPQ;AEBP1;XPNPEP1;ANPEP;LAP3;MMP14;AGBL3;CPM;NPEPPS;CPXM2;LNPEP
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3703765912368605,-1.0936450625811924,0.3378640776699029,0.6529845247312186,1.0,8/26,13.97%,SLC6A13;SLC16A12;SLC6A12;SLC16A6;SLC16A9;SLC5A6;SLC6A1;SLC27A1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.28885282911608834,-1.0934884268111815,0.2665330661322645,0.6501254723338846,1.0,25/91,17.48%,GSN;SVIL;ADAP2;MYO1B;SH3PXD2B;GBF1;GSDME;SLC9A1;MAPKAP1;ANXA2;KCNJ2;FCHO2;ACTN2;PLCD1;KIF16B;SNX21;TULP3;WIPI1;GSDMD;FZD7;PARD3;MARK1;WDR45B;PICALM;FRMPD4
prerank,histone deacetylase binding (GO:0042826),-0.2863215494504243,-1.0911889740854268,0.274703557312253,0.6529271587787857,1.0,25/88,18.44%,GLI3;KAT2B;HDAC4;PRKN;BCOR;NCOR1;MEF2A;LCOR;AKAP8L;DHX36;SP2;DACT1;CHD4;MIER1;MEF2C;NIPBL;HES1;BHLHE41;YWHAE;HDAC1;SFPQ;CAMTA2;ZMYND15;TOP2B;TRAF6
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.4652979059410117,-1.0910772487854545,0.35952848722986247,0.6500298798167371,1.0,10/11,47.92%,CFLAR;CASP12;CASP2;CASP6;PYCARD;CASP1;CASP7;CASP4;CASP3;CASP9
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.33889797626137,-1.0893849702749905,0.3254437869822485,0.6512575201836496,1.0,16/33,28.30%,ERI3;DIS3L2;CNOT8;XRN2;XRN1;ERI2;EXOSC9;PAN2;EXOSC10;USB1;ANGEL2;EXOSC3;PNLDC1;PDE12;DIS3;PARN
prerank,endopeptidase activity (GO:0004175),-0.2499683889860274,-1.0892709978118111,0.2215568862275449,0.6483798606292864,1.0,46/257,15.09%,TRABD2B;ADAMTS2;ADAMTS10;THSD4;ADAMTSL3;ADAMTS12;ADAMTS6;ADAMTSL5;USP24;PCSK5;HTRA3;PLAT;USP7;CTSC;CTSH;ADAMTS5;DPP4;F3;DDI2;ECE1;ADAMTSL4;ADAMTS9;NRDC;USP33;ADAM9;SENP1;MBTPS2;USP47;MMP14;ADAM19;ADAMTS15;ADAM33;USP46;CASP2;USP11;NLN;USP12;MMP2;USP35;RHBDF1;PSMB2;FAP;ADAMTS17;USP2;USP13;MBTPS1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.47331087693167917,1.0881235889599534,0.3595505617977528,0.6713042162051012,1.0,4/10,10.90%,CACNA1A;CACNA1B;CACNB2;CACNB4
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.3423351395650354,-1.0873038386119802,0.322,0.6502362346408378,1.0,19/33,33.47%,PRKN;ARIH1;RNF217;RNF19A;TCERG1;AUP1;TRAF6;DCUN1D3;RNF14;PARK7;ARIH2;RNF144A;SIAH2;PPARA;DCUN1D5;UBA2;RNF180;DCUN1D4;ANKIB1
prerank,protein homodimerization activity (GO:0042803),-0.22936531904840743,-1.0833521833644733,0.15876288659793814,0.6573774130612764,1.0,195/589,27.35%,CPQ;FOXP2;NR2F2;SMAD3;APPL2;BMPR1A;PDGFRA;AOX1;TPM1;LRP6;NADK2;MAPK4;RBPMS;ZHX2;CRYL1;GHR;NPR3;ARNT;LRRK2;ENPP1;TPST1;XPNPEP1;FBLN5;KIT;NR6A1;ABCD3;EEA1;FLNA;IRAK3;EXT1;HM13;SLK;DNM1L;EIF2AK1;ZBTB16;AXIN1;SNX9;DPP4;SNX6;NUDT5;VPS4B;STAT3;GLCE;FGFR2;MMUT;MIGA2;MKLN1;BCL2;IRAK2;TRIM8;CDADC1;CRPPA;CAMK2D;MAP3K5;ECE1;RNF8;S100A10;MID1;UBA5;CHMP4B;CHMP4A;CAMK2G;WRN;ABCD2;ZBTB1;JUP;PRMT2;PDGFC;TARS2;S100A6;SMAD4;PAFAH1B2;TRIM5;NRF1;ACSL6;PSMF1;ATIC;HES1;PAXX;TBX18;TPR;QTRT2;BHLHE41;TCF3;APPL1;IL6R;PKD2;UPB1;EFEMP2;SOX6;TPD52L1;TXN;FAP;GBP3;GCA;ERN1;VEGFA;STAT1;ZNF318;APOE;MSH3;IL17D;PGRMC1;ACVR1;DPYD;GLIPR2;PDXK;SFPQ;TYW5;RAB11FIP2;NECTIN3;CUBN;ADRA2A;PTPA;EPHX2;SMCHD1;CCDC66;GBP2;ANO1;S100A11;NQO2;ACOX1;ATP5IF1;CEP57;MGLL;PRMT8;MYOM1;PSPH;PARK7;IRAK1;MSH6;TPM2;TERF2;PEX7;NAGA;CARNMT1;KARS1;PML;SLC39A13;SNF8;GNPTG;RBPMS2;TERT;SPPL3;DGKD;S100A1;BNIP3;KMT2A;USF1;GALM;SSBP1;MAP3K12;PRDM9;F11R;RABL3;ALS2;GSS;HIP1R;SLC8B1;GSTM2;ST6GAL1;NUDT21;PTH1R;TFAP4;MAP3K13;CYP2R1;SLIT2;PON3;LDB1;TRIM68;MZF1;PHB2;CBS;PHETA1;GGCT;TAP1;FBXO4;FXR1;RPE;BCL2L2;ST3GAL2;TRPC6;RRAGA;NFS1;LPL;SPPL2A;WARS1;SMIM1;ADRB2;S100A13;ZBTB7B;PRPS1;PRPS1L1;CIP2A;ZBTB4
prerank,hormone receptor binding (GO:0051427),-0.43662233921263083,-1.0821564240476922,0.34766355140186916,0.6571908914514213,1.0,4/14,21.94%,JAK1;NCOA6;TYK2;PTHLH
prerank,N-acetyltransferase activity (GO:0008080),-0.38999035286076555,-1.081723155602619,0.33643122676579923,0.6552428247792371,1.0,4/19,14.14%,KAT2B;EP300;SAT1;ESCO1
prerank,cGMP binding (GO:0030553),0.46057416241348953,1.0778690495140868,0.3678646934460888,0.6949033706985179,1.0,3/11,6.26%,PDE10A;PDE2A;PDE11A
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.3822957608330116,-1.0771138537244198,0.37074148296593185,0.6636504877864421,1.0,9/21,17.28%,WASF2;ARFGEF1;AKAP8L;PRRC1;ACBD3;AKAP1;WASF1;AKAP9;PRKACA
prerank,mannosyltransferase activity (GO:0000030),0.38426976628888865,1.0764313874032316,0.3543788187372709,0.6938593359592962,1.0,6/21,12.19%,TMTC2;ALG3;PIGM;ALG1;DPY19L1;ALG8
prerank,Notch binding (GO:0005112),-0.37681189461179465,-1.0740971890828295,0.3557692307692308,0.6683419055311484,1.0,4/22,12.51%,SNED1;JAG1;CCN3;CUL3
prerank,phosphatidate phosphatase activity (GO:0008195),0.43621066572129,1.0734068567085253,0.3559322033898305,0.6973145229992633,1.0,4/13,8.81%,PLPPR1;PLPPR5;PLPPR4;PLPP4
prerank,protein phosphatase binding (GO:0019903),-0.27170543002585823,-1.0706589367699257,0.2845360824742268,0.6743941347440109,1.0,39/117,24.65%,EGFR;JAK1;DLG4;SHOC2;TBK1;SLC9A1;STRN3;STAT3;EIF2AK3;ANAPC5;MAP3K5;AP3B1;ANAPC7;ANAPC4;JUP;SMG7;ANKLE2;TRAF2;MTMR3;PPP1R3B;SH3RF2;BOD1L1;MAP2K7;TRAF3;PTPA;CDC27;IKBKE;VCP;MVP;PPP1R3C;KIFAP3;PIK3R1;STX17;SPHK1;PPP1R3F;GTF2F1;SIRPA;MASTL;KIF3A
prerank,calcium channel regulator activity (GO:0005246),0.3309485553102157,1.070120592968581,0.35390946502057613,0.701305040089056,1.0,8/37,13.46%,NRXN1;PRKG1;SLC30A1;NRXN2;SGK3;CACNG8;CALM1;CALM2
prerank,nuclease activity (GO:0004518),-0.3144238881224783,-1.0699134973210203,0.33268858800773693,0.6731356512796334,1.0,19/52,28.68%,DIS3L2;ENPP1;N4BP2;PLSCR1;WRN;RNASE12;REXO5;XRN2;REXO1;MRE11;RNASE4;NME1;EXOG;OGG1;PDE12;DNASE1L1;DIS3;PARN;SAMHD1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.4379204525728899,-1.0693519895384476,0.3931947069943289,0.6714739510708778,1.0,2/14,0.99%,SLC7A11;SLC1A3
prerank,lipid phosphatase activity (GO:0042577),0.4217713287343039,1.068758502830625,0.3731958762886598,0.699977782001579,1.0,7/14,19.67%,PLPPR1;PLPPR5;SGPP2;PLPPR4;PLPP6;SGPP1;PLPP7
prerank,sulfotransferase activity (GO:0008146),-0.3441870615844554,-1.0670053357333842,0.37450980392156863,0.6744850997171948,1.0,9/33,18.96%,UST;HS3ST3A1;TPST1;HS2ST1;CHST15;SULT1A1;CHST11;HS6ST1;CHST12
prerank,CoA hydrolase activity (GO:0016289),-0.4110827361563812,-1.0668217051501692,0.3752310536044362,0.6718854479099255,1.0,6/16,23.20%,HIBCH;ACAA2;ACOT11;ACOT9;ACOT8;ACOT6
prerank,C2H2 zinc finger domain binding (GO:0070742),0.4481712301878533,1.0664012462907035,0.38253638253638256,0.7015094585085889,1.0,2/11,3.56%,LEF1;HMGA2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.3079846447068548,-1.0649735193722074,0.3684210526315789,0.6740125890393778,1.0,11/55,12.28%,SLC7A2;SLC6A13;SLC16A12;SLC13A3;PDPN;SLC6A12;SLC16A6;SLC38A11;SLC16A9;SLC38A6;SLC22A4
prerank,bHLH transcription factor binding (GO:0043425),-0.39500408701581824,-1.0636639772221352,0.36801541425818884,0.6743724986971594,1.0,5/19,12.66%,FHL2;SMAD3;CREBBP;BHLHE41;TCF3
prerank,calcium channel inhibitor activity (GO:0019855),-0.45211077901190466,-1.0594170248484993,0.4148550724637681,0.6824435971513673,1.0,1/11,0.26%,ITPR1
prerank,retinoic acid receptor binding (GO:0042974),-0.4021953675252856,-1.0579934794673294,0.38146167557932265,0.6832119297536176,1.0,7/17,17.34%,RARG;NSD1;NCOA6;MED1;PRMT2;CNOT1;NR4A2
prerank,ribonuclease P RNA binding (GO:0033204),0.4499568289191358,1.0573180226635013,0.3760869565217391,0.7210749087296643,1.0,3/10,12.59%,RPP40;RPP30;POP5
prerank,N-methyltransferase activity (GO:0008170),-0.38877403343951134,-1.0566137758519827,0.3730769230769231,0.6837851648620501,1.0,9/20,24.92%,ZCCHC4;SETD3;TRMT11;N6AMT1;DIMT1;METTL15;TRMT1L;TRMT1;HNMT
prerank,potassium ion antiporter activity (GO:0022821),-0.41326396941159194,-1.0548628105584434,0.39676840215439857,0.6854065848634223,1.0,4/15,6.00%,SLC24A3;SLC9A1;SLC9A8;SLC9A2
prerank,protein tyrosine kinase binding (GO:1990782),0.2876062786446034,1.053939144776421,0.3352941176470588,0.7250145863003241,1.0,7/71,5.55%,NRG3;GRM5;GRB14;NRG1;DOCK4;GAS6;PITPNM1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.46953478483623023,-1.0535466678493377,0.4049904030710173,0.6857532296024139,1.0,3/11,9.48%,EGFR;MAP3K5;MAP3K20
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3518293375402568,-1.0495566147091715,0.38181818181818183,0.693279200689929,1.0,16/27,33.47%,PRKN;ARIH1;RNF217;RNF19A;AUP1;TRAF6;DCUN1D3;RNF14;ARIH2;RNF144A;SIAH2;PPARA;DCUN1D5;RNF180;DCUN1D4;ANKIB1
prerank,cytokine activity (GO:0005125),0.2615032790511269,1.049331833227965,0.31844660194174756,0.7327457714799444,1.0,16/131,10.81%,KITLG;IL17F;MIF;IL7;CXCL12;NRG1;BMP8A;IL12A;TGFB2;SCGB3A1;WNT7B;EPO;TIMP1;CCL2;BMP3;SCG2
prerank,nuclear receptor coactivator activity (GO:0030374),-0.30248378689148203,-1.0490124420330391,0.3657587548638132,0.6916842407830588,1.0,12/52,11.31%,ZMIZ1;PPARGC1B;SS18;MED17;MED12;ENY2;PPARGC1A;NCOA6;NCOA1;MED1;CALCOCO1;DCAF6
prerank,single-stranded RNA binding (GO:0003727),0.3177054292047462,1.0479203016317955,0.35714285714285715,0.7314763887013735,1.0,6/43,9.69%,ADARB2;ZFR2;SNRPC;RBM11;DDX11;STRBP
prerank,endopeptidase inhibitor activity (GO:0004866),-0.2857350817279953,-1.0459901098089135,0.35892514395393477,0.6969191802407237,1.0,15/82,11.83%,TIMP3;COL4A3;CAST;ROCK1;BIRC6;SERPING1;PROS1;TFPI;ANXA2;ITIH2;RECK;RENBP;NGF;SERPIND1;PSMF1
prerank,thioesterase binding (GO:0031996),-0.44602420376604485,-1.0438088814562636,0.4218455743879473,0.6995375901432461,1.0,7/11,22.56%,CDC42;TRAF2;TRAF3;ADRA2A;TRAF6;HAUS7;TRAF5
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.36119251817602305,1.0428569932924374,0.39959016393442626,0.7405607579731412,1.0,3/24,4.19%,CAMK2A;CAMKV;CAMK4
prerank,translation elongation factor activity (GO:0003746),0.4083979430743682,1.0411468941178121,0.4016393442622951,0.7402121012112759,1.0,6/14,17.97%,EEF1B2;EIF5A2;TUFM;EEF1A2;EEF1A1;EEF2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.34205840098957174,1.0384794598458997,0.38377192982456143,0.742946902412647,1.0,4/30,7.93%,SPOCK1;SNCA;GAS6;RPS6KA1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3276641503971383,-1.0380112846978289,0.37937743190661477,0.712238599719197,1.0,15/38,24.34%,SH3PXD2B;ZFYVE1;PLA2G4A;KIF16B;SNX21;WIPI1;PARD3;ATG2A;WDR45B;ATG2B;PLEKHF1;WIPI2;PLEKHA4;JPH2;SNX12
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.2856313467736371,-1.036164946134099,0.40119760479041916,0.7139086834091372,1.0,20/71,14.94%,EYA2;PTPN13;EYA1;EYA4;PTPN14;CDC14A;TNS2;PTPN9;PTPRS;PTPN21;PTPN3;PTPRK;PTPN22;PTPN12;PTPN2;DUSP11;MTMR3;DUSP1;CDC25B;CDC14B
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.282968063720552,-1.0347515174620232,0.4087301587301587,0.7145278302063196,1.0,24/78,25.33%,USP24;CFLAR;USP7;CTSC;CTSH;PIGK;CASP12;USP33;USP47;USP46;CASP2;USP11;USP12;USP35;USP2;USP13;USP34;CTSF;GPAA1;CTSL;USP18;USP28;CASP6;USP9X
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4106631279235886,1.0345471150481802,0.4118895966029724,0.7488285510834912,1.0,6/13,25.08%,RANBP1;CCDC88A;GDI1;ARHGDIG;SH3BP4;EIF5
prerank,filamin binding (GO:0031005),-0.4288843460068723,-1.0330678470124224,0.41714285714285715,0.7159741508950219,1.0,2/11,9.84%,DPYSL3;SYNPO2
prerank,semaphorin receptor activity (GO:0017154),-0.4470776631618286,-1.0307121671814625,0.4179389312977099,0.7194246900926701,1.0,5/11,15.86%,PLXNA2;NRP1;PLXNB2;PLXNB1;PLXND1
prerank,myosin V binding (GO:0031489),0.4045717103362054,1.030349149124494,0.3922018348623853,0.755575319269475,1.0,3/15,7.30%,RAB3C;RAB6B;RAB39B
prerank,TBP-class protein binding (GO:0017025),-0.3706252201402447,-1.0300059468801088,0.4027504911591356,0.7181927113967602,1.0,11/21,30.25%,TAF13;GTF2B;TAF12;PSMC1;DRAP1;YEATS2;ESR1;THRA;BRF2;RUVBL2;GTF2A1
prerank,zinc ion binding (GO:0008270),0.2351546997987569,1.0297494863731464,0.35070140280561124,0.7522256291156351,1.0,45/293,11.01%,MT2A;MMP12;MME;GLRA1;S100A9;S100A8;GRIN2A;SHANK3;PDE2A;TRIM2;PPARG;GRIN2B;PHEX;QPCT;MMP13;SNCA;RPS27;ENPP2;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;SNRPC;CA2;NUDT12;KLF4;MYT1;MMP16;TIMP1;PITRM1;MSRB2;ZDHHC15;TMEM163;RNF112;ARHGEF2;TRIM24;DPF3;SMPDL3A;SMPD1;ZNF22;IKZF5
prerank,chemokine receptor activity (GO:0004950),0.3604995188475792,1.0261513436892038,0.43312101910828027,0.7573461385169044,1.0,4/24,9.35%,GPR35;ACKR4;GPR17;GPR75
prerank,transition metal ion binding (GO:0046914),-0.22419148383527465,-1.0259935944810645,0.358,0.7256083956470378,1.0,102/397,20.79%,AGMO;SMAD3;LARGE1;MPPED2;AOX1;LIMS1;SEC24D;B4GALT1;GLI2;MOXD1;CBLB;MDM4;ZEB1;PAPPA;HDAC4;PRKN;ABL1;ARIH1;ENPP1;KDM7A;ZCCHC4;XPNPEP1;EEA1;PLSCR1;SKI;RC3H1;PHF8;TDP2;NSD1;ASAH2;SEC23A;TES;TRIM8;ZFYVE1;CDADC1;KDM5B;ECE1;ACO2;RNF8;UBA5;WRN;ANPEP;ACER3;SLU7;CHD4;PHF2;CHD3;USP33;MNAT1;ME1;ENPP3;ABL2;FAM20C;NAPEPLD;BBOX1;SOD3;PPM1M;FBXL19;MSRB3;PIAS4;ADAM33;NPEPPS;KDM1B;PCK2;UPB1;SIRT5;CZIB;GLO1;ESCO1;KDM3A;P2RX4;RXRA;LNPEP;PDXK;PRDM2;TYW5;KDM2A;GTF2B;LOXL3;TARS1;ZFP37;BAZ1B;NQO2;XYLT2;SOD2;RABGGTB;GALNT1;PTPN1;NEK4;APIP;RASSF1;PARK7;NFU1;B4GALT7;QPCTL;ZMYND8;ETHE1;TIMP2;NOS1;MPPE1;RNF11;FDX1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.27353419550832486,1.0240251400535414,0.40524193548387094,0.7582198367370359,1.0,11/85,10.56%,AARS2;ABHD2;ENPP2;LYPLA1;LIPE;CA2;PLAAT1;PTRH2;PLA2G12A;ABHD8;ESD
prerank,endonuclease activity (GO:0004519),-0.3096188173201659,-1.0210769683665273,0.41164658634538154,0.7357279165087225,1.0,11/49,16.69%,SMG6;DICER1;N4BP2;ZC3H12C;NYNRIN;CPSF3;KHNYN;ERN1;ZC3H12B;MRE11;ZRANB3
prerank,nucleotide diphosphatase activity (GO:0004551),-0.4010718406390179,-1.0203628255813637,0.4472168905950096,0.7344858606996062,1.0,3/14,3.51%,FHIT;ENPP1;NUDT4
prerank,protein kinase inhibitor activity (GO:0004860),0.31299546667851297,1.018903280906312,0.3972602739726027,0.7675594785961626,1.0,13/42,15.98%,YWHAB;CAMK2N1;INKA1;SNCA;DUS2;MAPK8IP1;SPRY4;SOCS1;CEP43;CIT;CIB1;CDKN1A;CDKN1B
prerank,growth factor receptor binding (GO:0070851),-0.2626511952450561,-1.016155051770212,0.41392649903288203,0.7425044166842081,1.0,18/95,15.52%,EFEMP1;PDGFRA;FGF1;PDGFRB;IL6ST;PIBF1;PLSCR1;SHC1;FER;NCSTN;PDGFC;FRS2;KL;IL6R;ERN1;VEGFA;VEGFD;ITGA5
prerank,"DNA binding, bending (GO:0008301)",0.39979370319802293,1.014949197767709,0.43776824034334766,0.7740409902238689,1.0,3/14,6.98%,LEF1;HMGA2;TERF1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.43261565501224053,1.0141597637293545,0.4476987447698745,0.7715167419718845,1.0,11/11,56.77%,DDAH1;ALLC;PADI6;PADI3;AGMAT;PADI4;PADI1;ARG1;ARG2;PADI2;DDAH2
prerank,syntaxin-1 binding (GO:0017075),0.35556240943254774,1.0129192041867274,0.43524416135881105,0.7699634655532359,1.0,6/22,10.59%,SYT1;SNAP25;UNC13A;SNPH;SYNPR;CPLX1
prerank,hormone activity (GO:0005179),0.2958033957659439,1.012779083565322,0.4258474576271186,0.7655713966404707,1.0,13/54,19.96%,AMH;TRH;ADCYAP1;NMB;SST;POMC;GRP;PNOC;VGF;EDN1;CCL25;METRN;AGT
prerank,store-operated calcium channel activity (GO:0015279),0.43595414135429783,1.011738389316449,0.44536082474226807,0.7635044697043257,1.0,1/10,0.53%,TRPC5
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.42959367687409916,-1.0111526981216277,0.46395563770794823,0.7528807739979195,1.0,7/12,30.25%,TBP;STAT1;HDAC1;GTF2B;TBPL1;RUVBL2;GTF2A1
prerank,cytokine receptor binding (GO:0005126),-0.268002108192821,-1.010995893391374,0.43418467583497056,0.7501898082410987,1.0,8/83,5.49%,TGFBR3;SMAD3;IL34;IL6ST;JAK1;PIBF1;IL13RA1;SMAD2
prerank,gap junction channel activity (GO:0005243),-0.3611079273611614,-1.0100792908506846,0.43243243243243246,0.7495225585756904,1.0,3/22,8.67%,GJB6;GJA1;GJB2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.28697698147799755,1.0093201053599539,0.39634146341463417,0.7654617772834914,1.0,13/55,14.39%,SLC24A4;SLC24A2;GRIN1;TRPC5;RYR2;ATP2B3;TRPM2;CACNB2;TRPC1;TMCO1;PSEN1;ATP2B4;ATP2B2
prerank,RNA stem-loop binding (GO:0035613),-0.41628279143263736,-1.008496266998276,0.4570383912248629,0.7505039401190439,1.0,4/12,15.01%,RC3H1;DHX9;CSDE1;DDX3X
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.3212413504305854,-1.0080423826977745,0.45596868884540115,0.7485810261893783,1.0,18/35,30.25%,FOXP1;BAZ2A;NR3C1;TAF4;TBP;STAT1;HDAC1;SNAPC3;GTF2B;PARK7;PIH1D1;DRAP1;AGO1;TBPL1;TAF1C;RRN3;RUVBL2;GTF2A1
prerank,ribonuclease P activity (GO:0004526),0.42183439283466717,1.006061823800045,0.4269911504424779,0.7697529290793277,1.0,3/11,12.59%,RPP40;RPP30;POP5
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.33249474934381884,-1.0047336145868704,0.4548802946593002,0.7539797973592837,1.0,4/29,6.73%,SLC13A3;SLC1A5;SLC26A7;SLC26A2
prerank,wide pore channel activity (GO:0022829),-0.3563099248524251,-1.0035341925948082,0.44313725490196076,0.7541794854769335,1.0,3/23,8.67%,GJB6;GJA1;GJB2
prerank,dipeptidyl-peptidase activity (GO:0008239),0.4410145535949421,1.000925146847733,0.45934959349593496,0.7794213322805066,1.0,2/10,6.15%,DPP10;DPP6
prerank,sequence-specific mRNA binding (GO:1990825),0.41970566915786683,1.0002528160069264,0.450199203187251,0.7764832923217565,1.0,2/10,7.07%,LARP6;ETF1
prerank,acetylcholine receptor activity (GO:0015464),0.34630256547617516,0.9991957739311748,0.43617021276595747,0.774660917079716,1.0,1/22,1.75%,CHRM3
prerank,nucleotidyltransferase activity (GO:0016779),-0.3684619934940446,-0.9982478442508848,0.4540441176470588,0.7654360907504113,1.0,5/19,14.06%,TENT2;NUDT5;CRPPA;TUT4;REV1
prerank,MHC class II protein complex binding (GO:0023026),0.415882494202416,0.9975497148589602,0.46652267818574517,0.7744066095425056,1.0,4/11,17.06%,HSPA8;HSP90AB1;ATP1B1;HSP90AA1
prerank,dynactin binding (GO:0034452),0.40699225789525695,0.9920376659890853,0.4910313901345291,0.7846886638918116,1.0,3/12,8.24%,BICD1;BICDL1;SPTBN5
prerank,myosin II binding (GO:0045159),-0.43958238160456087,-0.9908744142685548,0.4685185185185185,0.7822369576563372,1.0,2/10,2.41%,GSN;STXBP5
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2719596440196471,0.9897941071271261,0.450199203187251,0.7859358527420776,1.0,16/73,18.03%,HCRTR1;LGR5;SORCS3;SORCS1;APLNR;HCRTR2;F2R;GRPR;OPRK1;CCKBR;ADCYAP1R1;NPR1;CALCRL;NPSR1;CYSLTR1;EDNRB
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.36779681859625146,0.9880686486424834,0.4731182795698925,0.7861743380218813,1.0,5/18,14.30%,SLA2;PIK3R5;SOCS1;PIK3R3;CCKBR
prerank,hyaluronic acid binding (GO:0005540),-0.4363476044430641,-0.9878186576956308,0.48534798534798534,0.7872179495076874,1.0,6/10,34.17%,CEMIP;IMPG2;C1QBP;LYVE1;CHODL;CD44
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.3900247304540252,-0.9870388420259814,0.48823529411764705,0.7860881786591709,1.0,2/14,12.09%,DHRS3;AKR1A1
prerank,beta-tubulin binding (GO:0048487),0.31993638500077193,0.9865676132386869,0.4729458917835671,0.7857379108608049,1.0,5/31,6.03%,PACRG;TTLL7;FGF13;GABARAPL1;GABARAP
prerank,neuropeptide hormone activity (GO:0005184),0.34569136698866976,0.9859604444337446,0.46346555323590816,0.7827435835628137,1.0,4/22,11.79%,ADCYAP1;NMB;GRP;PNOC
prerank,organic cation transmembrane transporter activity (GO:0015101),0.372335412243872,0.9832810557062477,0.4799196787148594,0.7854156798912915,1.0,3/16,7.31%,SLC18A3;SLC25A42;SLC7A8
prerank,leucine zipper domain binding (GO:0043522),-0.42788550180282203,-0.9803033565573149,0.5019230769230769,0.8011688444645534,1.0,2/10,2.75%,PAWR;ERC1
prerank,acylglycerol lipase activity (GO:0047372),0.4182920022278119,0.9792601299077599,0.5160550458715596,0.7919604502142829,1.0,2/11,5.60%,ABHD2;LIPE
prerank,cholesterol binding (GO:0015485),-0.2920956242366617,-0.9780464889367323,0.48565965583174,0.8043364291704301,1.0,13/47,15.63%,ABCA1;ANXA6;OSBPL8;SOAT1;GRAMD1C;OSBPL5;SIDT1;VDAC1;NR1H3;ERLIN1;NPC2;APOD;PTCH1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.35861374091031806,-0.9759176161220333,0.47058823529411764,0.8038756666754386,1.0,8/21,21.54%,CDK8;CDK7;CCNK;CDK13;CDK11B;CDK2;CDK10;CDK6
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.35861374091031806,-0.9759176161220333,0.47058823529411764,0.8038756666754386,1.0,8/21,21.54%,CDK8;CDK7;CCNK;CDK13;CDK11B;CDK2;CDK10;CDK6
prerank,chemokine activity (GO:0008009),0.3119959304388664,0.9754120756978195,0.4978813559322034,0.7976410260059076,1.0,6/31,20.59%,CXCL12;CCL2;CCL25;CKLF;CCL13;CCL19
prerank,protein kinase C binding (GO:0005080),-0.29556207246775107,-0.9747505502884125,0.5183044315992292,0.8038726369014217,1.0,9/43,10.55%,GRK5;PDLIM5;ITGAV;PARD6G;ABL1;IRS1;ADCY6;DACT1;ADAM9
prerank,sterol transfer activity (GO:0120015),0.3640558214881783,0.9747194046223457,0.5,0.7949248503596225,1.0,2/17,5.55%,PLTP;GRAMD1B
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.29922753252265755,0.9744986259438219,0.4924078091106291,0.7909750654607688,1.0,5/37,6.15%,AARS2;VARS1;VARS2;GARS1;RARS1
prerank,outward rectifier potassium channel activity (GO:0015271),-0.4177976958550943,-0.974278247740473,0.5,0.8020263504363006,1.0,2/11,1.40%,KCNK2;KCNT2
prerank,iron ion binding (GO:0005506),-0.28644993329101787,-0.9733963606504712,0.5192697768762677,0.8012316564665927,1.0,15/48,21.43%,AGMO;AOX1;FTO;KDM7A;PHF8;ACO2;PHF2;EGLN3;ALKBH1;KDM3A;TYW5;NFU1;ETHE1;FDX1;FXN
prerank,phosphatidylcholine transporter activity (GO:0008525),0.3647504220433834,0.972813704565305,0.48822269807280516,0.7911213106565627,1.0,4/17,5.55%,PLTP;ATP10A;ATP10B;PITPNM1
prerank,tRNA binding (GO:0000049),-0.2964198826753651,-0.9716682820734034,0.5088757396449705,0.8025930670932712,1.0,21/43,34.29%,FARS2;TRMT9B;NSUN6;ALKBH1;EIF2AK4;TYW5;NSUN2;ELP5;KARS1;TERT;DALRD3;RPUSD4;TRNT1;PSTK;NAT10;IGHMBP2;TRMT10C;MRPS27;ALKBH8;PUS1;CARS1
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.4255220391353951,-0.9711874388968985,0.5218978102189781,0.8007512084170415,1.0,2/10,2.20%,B4GALT1;B3GALT1
prerank,endopeptidase activator activity (GO:0061133),0.419189854042,0.9678126359412198,0.5032822757111597,0.800209395608502,1.0,2/10,14.35%,PSENEN;PSME3
prerank,galactosyltransferase activity (GO:0008378),-0.4077681226328348,-0.9673358250430635,0.5321969696969697,0.8079763149247557,1.0,5/11,22.54%,B4GALT1;A4GALT;B4GALT5;B4GALT7;B4GALT3
prerank,E-box binding (GO:0070888),-0.3158389332800531,-0.966797632843699,0.5058365758754864,0.8063626328532464,1.0,7/34,16.43%,TCF4;ZEB1;HES1;BHLHE41;TCF3;ATOH8;PRMT5
prerank,exoribonuclease activity (GO:0004532),0.3988068507099957,0.9661768054175478,0.5085470085470085,0.8000213697932362,1.0,1/12,0.91%,EXOSC5
prerank,protein kinase regulator activity (GO:0019887),-0.24864436492548692,-0.9631195190588869,0.5275142314990512,0.8133942719960477,1.0,19/95,16.13%,PRKAG2;PARVA;CCNL2;CCNT2;CCNL1;CCNH;CCNT1;RPTOR;TAOK3;CCNK;GPRC5C;WNK1;CCNYL1;DNAJC3;GMFB;CCND3;NCK1;CNPPD1;SH3BP5L
prerank,neurexin family protein binding (GO:0042043),0.4103075627442299,0.9628012447860409,0.5245202558635395,0.804714615936517,1.0,2/10,6.46%,NLGN1;SYTL2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.2791350609906254,-0.9615176669220616,0.5236220472440944,0.8146792415769508,1.0,12/54,15.26%,NGLY1;HDAC8;HDAC4;ASPA;ASAH2;ACER3;MIER1;NTAN1;UPB1;SIRT5;HDAC1;ASPG
prerank,cardiolipin binding (GO:1901612),-0.42495011212602374,-0.9597657009873887,0.5445920303605313,0.8162380581338495,1.0,5/10,21.63%,OPA1;GSDME;GSDMD;STOML2;PLEKHN1
prerank,cholesterol transfer activity (GO:0120020),0.36460894605233296,0.9579420537279771,0.5267326732673268,0.8132142292888761,1.0,2/16,5.55%,PLTP;GRAMD1B
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.3328561403338079,-0.9576258376468315,0.5176252319109462,0.8191420212119555,1.0,6/23,10.23%,PLCE1;PLCD3;EDNRA;PLCG1;PLCB3;PLCD1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.35987509557610664,0.956517169300827,0.49290060851926976,0.8125315113104596,1.0,7/16,25.53%,MACROD2;RPS3;CD38;ADPRS;SARM1;ADPRH;TDG
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.3623944355011633,-0.9550980307562084,0.5517241379310345,0.8226808652515955,1.0,11/20,25.33%,USP7;SENP3;SENP1;USP47;SENP5;COPS2;USP50;DESI2;SENP2;EIF3H;USP9X
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.3245480784678018,0.9545545803800473,0.5225409836065574,0.8132354412056931,1.0,5/26,11.81%,B4GALNT1;CHSY3;CSGALNACT1;B3GALT5;B3GNT2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.40696622829104867,-0.9527035566200245,0.5242718446601942,0.8259467931193442,1.0,4/11,18.44%,SASH1;TCF3;ROR2;TRAF6
prerank,tau protein binding (GO:0048156),-0.2926860432075641,-0.9512537080755794,0.532520325203252,0.826530300017145,1.0,13/40,17.75%,ROCK2;EP300;ROCK1;GSK3B;MARK3;SMAD2;MARK4;PPP2CB;BRSK1;APOE;MARK1;PICALM;PRKAA1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.40702523997382895,-0.9510120439036374,0.5377532228360957,0.8240564860595,1.0,3/11,23.98%,PPP1R1A;PPP1R2;PPP1R14A
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.2929456515559875,-0.9504057625826584,0.5335820895522388,0.8224790492889915,1.0,13/40,19.90%,PCMTD2;DNMT3A;COMT;SETD3;N6AMT1;METTL2A;METTL2B;PCMT1;TPMT;THUMPD3;PRMT8;RRP8;CARNMT1
prerank,receptor tyrosine kinase binding (GO:0030971),0.27306485205000464,0.9502432344845562,0.5337301587301587,0.8200857923589548,1.0,6/56,5.55%,NRG3;GRB14;NRG1;DOCK4;GAS6;PITPNM1
prerank,omega peptidase activity (GO:0008242),0.25359135092073787,0.9493307135944682,0.5598290598290598,0.8178099277118552,1.0,27/89,18.98%,USP44;OTUD7A;USP29;USP14;USP53;ASRGL1;UCHL1;USP49;GGT7;YOD1;GGH;UCHL3;GGT1;USP32;USP22;OTUB2;USP48;USP31;USP42;USP30;OTUB1;OTULIN;USP8;UCHL5;OTUD7B;ATXN3;JOSD1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.27842705440923804,-0.9487103988355434,0.5438931297709924,0.8237846485611665,1.0,5/53,3.17%,SLC7A11;SLC7A2;SLC1A3;SLC47A1;SLC1A5
prerank,phosphatase activity (GO:0016791),-0.26074251607319954,-0.946654910485565,0.5696969696969697,0.8261732710392317,1.0,20/73,19.46%,ATP1A2;PLPP3;DUSP16;NT5M;PRUNE1;PTPN22;DUSP11;APTX;PXYLP1;PPP1CB;ENOPH1;DUSP10;SACM1L;ACP2;EPHX2;LPIN2;INPP5K;LPIN3;PSPH;HDDC2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.39041551573422395,0.945582928266297,0.5183585313174947,0.8233563642737406,1.0,3/11,6.44%,RYR2;RYR3;TRPM2
prerank,phosphatidylglycerol binding (GO:1901611),0.38273230986710316,0.945429706215132,0.5365344467640919,0.8193136090895331,1.0,2/13,1.61%,PLTP;MME
prerank,SUMO binding (GO:0032183),-0.38775685447796665,-0.9410928406114987,0.5239923224568138,0.8374070983353645,1.0,4/13,20.15%,HERC2;SERBP1;SIMC1;PML
prerank,phosphoric diester hydrolase activity (GO:0008081),0.29806001020058237,0.9404360243822936,0.567741935483871,0.8277456487672756,1.0,8/35,10.92%,GPCPD1;PLCXD3;ENPP2;PDE11A;PLCB4;SMPDL3A;SMPD1;APEX1
prerank,phospholipase C activity (GO:0004629),-0.32352270239802905,-0.9404045638867115,0.539622641509434,0.8360896165092327,1.0,8/25,17.22%,PLCE1;PLCD3;EDNRA;PLCG1;PLCB3;PLCD1;BDKRB2;PLCL1
prerank,deubiquitinase activity (GO:0101005),0.25221327233160223,0.9377295223920098,0.5859872611464968,0.8304942056337891,1.0,26/88,18.98%,USP44;OTUD7A;EIF3F;USP29;USP14;USP53;UCHL1;USP49;YOD1;UCHL3;USP32;USP22;OTUB2;MINDY2;USP48;USP31;MINDY1;USP42;USP30;OTUB1;OTULIN;USP8;UCHL5;OTUD7B;ATXN3;JOSD1
prerank,serine-type peptidase activity (GO:0008236),0.2464358849772636,0.9361719378122463,0.5813492063492064,0.8301352330308706,1.0,10/96,11.41%,MASP2;PCSK1;PCSK2;RHBDF2;PCSK6;ENDOU;PREP;PCSK7;TMPRSS4;PROC
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3084719976094684,0.9338473044354368,0.5504950495049505,0.8316371494145819,1.0,7/27,17.45%,POLR1H;POLR2J;POLR2B;POLR2I;MED20;POLR3A;POLR2G
prerank,ferrous iron binding (GO:0008198),0.33403668025576944,0.9304492891481968,0.5575757575757576,0.8358146691063423,1.0,7/21,18.34%,FTH1;SNCA;FTL;ISCU;ALKBH3;FECH;EGLN1
prerank,cytokine receptor activity (GO:0004896),-0.24642955419580598,-0.929681142680545,0.6085192697768763,0.8605701109275621,1.0,12/83,12.71%,LEPR;IL31RA;IL6ST;GHR;CCR9;IL15RA;IL13RA1;F3;IL17RA;CNTFR;IL17RD;IL6R
prerank,snRNA binding (GO:0017069),-0.2835454308788376,-0.9291553510533122,0.5553539019963702,0.8587919235641247,1.0,16/42,32.44%,CCNT2;CCNT1;RNPC3;GEMIN5;SNRNP70;COIL;EFTUD2;SNU13;HNRNPU;LSM11;NCBP2;PRPF8;RBM22;CDK9;SNRPA1;RBM41
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.3962382710525543,-0.9277278237026788,0.5679702048417132,0.8595573104793018,1.0,8/11,59.67%,CHRNA4;CHRNA7;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,cysteine-type peptidase activity (GO:0008234),-0.2523293443147311,-0.9242991318010912,0.598019801980198,0.8654869446776745,1.0,17/73,18.05%,USP24;USP7;CTSC;CTSH;USP33;USP47;USP46;CASP2;USP11;USP12;USP35;USP50;USP2;USP13;ATG4D;USP34;CTSF
prerank,lysine N-methyltransferase activity (GO:0016278),-0.339857669167344,-0.9215518213195232,0.5632183908045977,0.8695689079821433,1.0,7/20,20.19%,SETD7;SETD3;SETD2;EHMT1;METTL21A;EEF2KMT;KMT5A
prerank,chloride transmembrane transporter activity (GO:0015108),0.3595655376273448,0.9152673760302364,0.5855670103092784,0.8705611744604892,1.0,2/16,4.45%,SLC4A1;SLC1A1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.35688061850850816,-0.9151755128323931,0.5727969348659003,0.8826598649242569,1.0,6/15,17.26%,EEA1;SNX9;ZFYVE1;SNX10;ZFYVE16;PICALM
prerank,phospholipase activity (GO:0004620),-0.25392137037173473,-0.9142392492977541,0.6520076481835564,0.8819084818272663,1.0,15/67,19.06%,PLCE1;SEC23IP;DDHD1;PLA2G4A;PLCB3;ABHD3;NAPEPLD;PNPLA8;PNPLA7;ASPG;PLCL1;ABHD6;ABHD12;MGLL;SMPD4
prerank,telomerase RNA binding (GO:0070034),-0.32589124571150746,-0.9110631347011541,0.5985130111524164,0.8867777454936575,1.0,8/22,23.64%,SMG6;DHX36;SMG7;XRN1;EXOSC10;HNRNPU;TERT;GAR1
prerank,aminopeptidase activity (GO:0004177),-0.31278694369365945,-0.90925800533217,0.6118546845124283,0.8883418895478361,1.0,7/26,15.32%,XPNPEP1;CTSH;ANPEP;LAP3;MMP14;NPEPPS;LNPEP
prerank,methyltransferase activity (GO:0008168),-0.27638827615109673,-0.90920408808672,0.6041666666666666,0.8853736894263481,1.0,16/46,22.43%,COQ3;COMT;NSUN3;TRMT11;N6AMT1;EHMT1;PRMT5;BUD23;NSUN2;PRMT8;RRP8;CARNMT1;FTSJ1;NTMT1;COQ5;AMT
prerank,steroid hydroxylase activity (GO:0008395),-0.34705005943618306,-0.9090503903471732,0.5804597701149425,0.8826412437769797,1.0,3/16,10.15%,CYP7B1;CYP27A1;CYP1B1
prerank,chemoattractant activity (GO:0042056),0.30927598954286956,0.9058116099119685,0.6045548654244306,0.8903089899239656,1.0,5/26,10.81%,MIF;FGF10;GPNMB;PDGFB;SCG2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.3937365261754403,-0.9051941290746842,0.5801526717557252,0.8889509568583737,1.0,1/10,0.19%,PRKAG2
prerank,ion channel inhibitor activity (GO:0008200),-0.2926592198644935,-0.9045939301794712,0.6264150943396226,0.8872803675375553,1.0,5/35,9.33%,ITPR1;VTI1B;CAMK2D;WNK4;WNK1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.39124439360441127,0.9020322749977747,0.5895691609977324,0.8951664295148783,1.0,1/10,0.29%,MECOM
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.38420201538447263,-0.9019087065629663,0.6121323529411765,0.8906628300920496,1.0,7/11,32.38%,NUDT4;NUDT5;NUDT11;NUDT1;NUDT7;NUDT16;NUDT16L1
prerank,protein phosphatase regulator activity (GO:0019888),-0.266709590784676,-0.9007820852941706,0.6405622489959839,0.8902774300585213,1.0,20/53,27.10%,PTN;SHOC2;PPP1R7;PPP4R2;CABIN1;ANKLE2;DMPK;PPP2R5E;EIF2AK2;PPP2R5D;BOD1L1;PTPA;PPP2R5C;PPP2R1B;PPP4R1;PPP1R2;PPP2R2C;BOD1;SAG;PPP1R15B
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.35829368134832806,0.8996613332107781,0.5799180327868853,0.8968507370054883,1.0,1/13,1.06%,DNASE1
prerank,neuropeptide receptor binding (GO:0071855),-0.35444959616076954,-0.8984846513563932,0.6171875,0.8930121297554893,1.0,4/14,37.67%,AGRP;NMU;PPY;NPY
prerank,DNA polymerase binding (GO:0070182),-0.33653618013178527,-0.8984702095412209,0.6057142857142858,0.8899823398379836,1.0,10/18,35.77%,SMG6;HMGB1;NABP2;FANCI;PCNA;NAT10;LONP1;FANCD2;RAD51;SMARCA4
prerank,ATP hydrolysis activity (GO:0140603),-0.2734649387712849,-0.8967296397177622,0.6563706563706564,0.8910017144132292,1.0,11/41,18.62%,ABCA4;RNF213;VPS4B;VWA8;DHX9;ABCD2;CHD3;ATP2B1;DDX3X;SMCHD1;VCP
prerank,potassium ion leak channel activity (GO:0022841),0.3478955130875658,0.8963940542801603,0.5916666666666667,0.9004786593533285,1.0,4/15,8.25%,KCNK13;KCNK10;KCNK9;KCNK1
prerank,chloride channel inhibitor activity (GO:0019869),-0.39415728405134987,-0.8959564141748594,0.5813953488372093,0.8897725779955376,1.0,6/10,27.46%,VTI1B;WNK4;WNK1;STX8;STX1A;STX7
prerank,serine-type endopeptidase activity (GO:0004252),0.24431683734578727,0.8954472554894786,0.6762886597938145,0.8982347262497284,1.0,8/80,11.41%,MASP2;PCSK1;PCSK2;RHBDF2;PCSK6;PCSK7;TMPRSS4;PROC
prerank,microtubule plus-end binding (GO:0051010),0.33136060074359874,0.8934763854672891,0.6068376068376068,0.8985328003077971,1.0,10/20,19.98%,KNSTRN;DST;MAPRE3;CLIP2;APC;DCTN1;CLASP2;KIF18A;TTBK2;CLASP1
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.24399171478491946,-0.8930337918335782,0.6589147286821705,0.8936176892128668,1.0,12/70,18.87%,GXYLT2;LARGE1;B4GALT1;B3GALT1;EXT1;B3GLCT;POGLUT2;OGT;HEXA;CHPF2;CHSY1;GCNT2
prerank,proton transmembrane transporter activity (GO:0015078),0.2763532370381378,0.891783006742724,0.6637554585152838,0.8978217398164782,1.0,14/39,21.57%,COX7A1;NDUFA4;COX4I1;COX6A1;ATP6V1F;COX6B1;DMAC2L;UQCRH;NNT;COX10;COX8A;CLCN4;CLCN3;COX5B
prerank,O-acyltransferase activity (GO:0008374),0.2949527391409789,0.8894187073907468,0.6467991169977925,0.8989885439530512,1.0,8/30,16.54%,MBOAT1;LPCAT2;DGAT2;PLAAT1;GPAM;PIGW;MOGAT1;SOAT2
prerank,MAP kinase activity (GO:0004707),-0.35745207957184555,-0.888841623934813,0.6053639846743295,0.9006859040417095,1.0,5/14,26.06%,MAPK4;MAPK6;MAPK7;MAPK14;MAPK9
prerank,antiporter activity (GO:0015297),0.3235943102554248,0.8874641352330979,0.6222222222222222,0.8992531324854095,1.0,5/20,12.75%,SLC35A1;ATP1A3;SLC35C1;SLC25A14;SLC35E4
prerank,adenylate cyclase binding (GO:0008179),0.37506788372159205,0.8867976457005926,0.6106382978723405,0.8963018401933802,1.0,5/10,13.93%,AKAP6;CAP2;CALM1;CALM2;CALM3
prerank,exonuclease activity (GO:0004527),-0.25787540112560037,-0.8851368910015167,0.693050193050193,0.9061504940787715,1.0,11/46,16.02%,ENPP1;APEX2;CPSF3;WRN;REXO5;ENPP3;XRN2;REXO1;EXOSC9;EXOSC10;MRE11
prerank,U6 snRNA binding (GO:0017070),0.3529184993298307,0.8840252202991029,0.6239130434782608,0.8985414959060286,1.0,8/14,27.32%,LSM4;LSM2;LSM7;LSM3;DDX39B;PRPF4;EIF5A;LSM8
prerank,ribonuclease activity (GO:0004540),-0.256021650896617,-0.8819147098348832,0.6622137404580153,0.9104248627499552,1.0,12/56,15.81%,SMG6;DIS3L2;DICER1;ZC3H12C;NYNRIN;CPSF3;RNASE12;KHNYN;ERN1;ZC3H12B;EXOSC9;EXOSC10
prerank,cation:chloride symporter activity (GO:0015377),-0.3919426138578792,-0.8818960679143732,0.6398467432950191,0.9074344556548019,1.0,5/10,20.40%,SLC12A7;SLC12A2;SLC6A1;SLC12A8;SLC12A9
prerank,snoRNA binding (GO:0030515),-0.2865079266841458,-0.8818110549247018,0.6581818181818182,0.9046385630328669,1.0,16/30,32.38%,NUDT4;NUDT5;PRKDC;BMS1;NOP58;SNU13;UTP6;IMP3;GAR1;TSR1;DHX37;NUDT1;TBL3;NUDT7;NUDT16;NUDT16L1
prerank,retinoid X receptor binding (GO:0046965),-0.3800836042157732,-0.881099165005093,0.6108108108108108,0.9032943420169245,1.0,5/11,22.58%,RARG;NSD1;NCOA6;NR4A2;ARID5A
prerank,heme binding (GO:0020037),-0.24457797963142447,-0.8794183800102501,0.7167300380228137,0.9039224548348573,1.0,9/65,10.15%,PTGIS;CYP26B1;CYP27A1;CYB5B;CYB5R4;EIF2AK1;NOX4;PGRMC2;CYP1B1
prerank,epidermal growth factor receptor binding (GO:0005154),0.29944160663899216,0.8770703858980908,0.6373165618448637,0.9110995178080634,1.0,5/25,12.39%,ERBB4;HIP1;LINGO1;CCDC88A;ARF4
prerank,metalloaminopeptidase activity (GO:0070006),-0.3383666630880635,-0.8767064648063699,0.6242884250474383,0.9073108590011244,1.0,5/16,15.32%,XPNPEP1;ANPEP;MMP14;NPEPPS;LNPEP
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3434147236616568,0.8758538453204476,0.6122004357298475,0.9095658578094368,1.0,3/15,5.91%,SLC17A6;SLC1A1;SLC1A2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.318823029865319,-0.8751100397476137,0.6163265306122448,0.9077867985776025,1.0,2/21,0.53%,PDE1A;PDE5A
prerank,disordered domain specific binding (GO:0097718),-0.2986341844640099,-0.8736852214669388,0.6623134328358209,0.9080319954300772,1.0,6/23,13.15%,NUMA1;SMAD2;TEAD2;RB1;FN1;FKBP8
prerank,protein kinase activator activity (GO:0030295),-0.24509110971402848,-0.8716943075858321,0.6952380952380952,0.9094545400449413,1.0,14/60,16.14%,PRKAG2;STK3;FAM20A;CAB39L;RPTOR;PAK2;IGF2;MAP2K1;GPRC5C;WNK1;ABI1;RICTOR;DDX3X;AFAP1L2
prerank,palmitoyltransferase activity (GO:0016409),0.2879005947941273,0.8680006814454618,0.6596638655462185,0.9232385954382456,1.0,6/28,15.58%,ZDHHC22;ZDHHC17;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3764104913751716,-0.866892527839314,0.6290909090909091,0.9171473584896653,1.0,2/10,9.16%,CXADR;JUP
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.35677794356536274,0.865563705960881,0.6396396396396397,0.9242234387662879,1.0,4/11,17.38%,HMGA2;APEX1;RPS3;APLF
prerank,protein phosphatase 2A binding (GO:0051721),0.29881964296012425,0.8634774659995882,0.6575052854122622,0.9243339457156045,1.0,6/23,14.49%,ADCY8;DAB2IP;GRIN3A;FOXO1;CTTNBP2NL;MFHAS1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.23185151423508504,-0.8622060399966681,0.73767258382643,0.9243799298182981,1.0,35/74,34.61%,NADK2;PI4KA;FAM20A;GK5;DGKA;NADK;ADK;PANK2;FAM20C;PIK3C3;DCAKD;RFK;PDXK;PIK3CD;FCSK;SHPK;PKM;DGKD;SPHK1;GALK2;DGKK;GALK1;MVK;ETNK1;DOLK;POMK;SPHK2;PI4KB;PIK3C2A;TKFC;PAPSS1;HYKK;HK2;COASY;TRPT1
prerank,mRNA 5'-UTR binding (GO:0048027),0.2932411293023385,0.8618509533825759,0.670061099796334,0.9237450206571922,1.0,7/24,15.36%,LARP6;RPL41;RPL5;RPS7;RPS14;UTP23;MYH10
prerank,endodeoxyribonuclease activity (GO:0004520),-0.3031288487206816,-0.8614217401050471,0.666058394160584,0.9230949173555025,1.0,6/20,26.63%,RBBP8;MRE11;ZRANB3;EXOG;ERCC1;ENDOV
prerank,phosphatidic acid binding (GO:0070300),-0.3160758759931483,-0.8606905047383042,0.6776061776061776,0.9216163193724429,1.0,7/19,16.31%,OPA1;PACSIN2;MAPKAP1;PITPNC1;GSDMD;RAPGEF2;MARK1
prerank,protein kinase C activity (GO:0004697),0.3431650412068797,0.8600231838827747,0.6481481481481481,0.9233111986354244,1.0,3/14,6.58%,PRKCH;PKN1;PRKCQ
prerank,ADP binding (GO:0043531),-0.29987180015038584,-0.8599668235312515,0.6722846441947565,0.9201582380832366,1.0,5/25,14.29%,PRKAG2;GLUD1;ME1;PGK1;ERN1
prerank,kinase activator activity (GO:0019209),-0.27995083491660216,-0.858198961635547,0.681214421252372,0.921021954495142,1.0,5/30,13.12%,PRKAG2;RPTOR;GPRC5C;WNK1;MOB1B
prerank,nucleotidase activity (GO:0008252),0.33366963653972004,0.8558942532412955,0.6430107526881721,0.9282307839756843,1.0,3/15,12.81%,NT5DC2;NT5C;BPNT2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3054743680044662,-0.8557746234843593,0.6350806451612904,0.9229962823322033,1.0,2/23,0.53%,PDE1A;PDE5A
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.34927695549063115,0.8549909329136309,0.6490066225165563,0.9258384436996955,1.0,3/13,17.52%,MIF;IDI1;EBP
prerank,GTPase activity (GO:0003924),-0.2036246263719871,-0.854554355081537,0.8542094455852156,0.9225697483879712,1.0,58/192,26.55%,RHOQ;OPA1;LRRK2;ATL3;RHOJ;DNM1L;RND3;ABCA4;RAP1B;MRAS;RAB22A;GFM1;MMUT;TBC1D24;CDC42;ATL2;RHOA;RHOT1;GNA14;RAB11A;RHOBTB2;RALA;GNAS;RASL12;GTPBP10;ARHGDIB;GNG5;GFM2;GBP3;RAB21;BMS1;DNAJC27;DDX3X;EFTUD2;GNB1;GBP2;RHOBTB1;GBP7;RHOH;GBP6;RHOC;MTG2;RAB24;RIT1;RABL3;NKIRAS1;GNAZ;RHOT2;SAR1B;GPN3;RAB8A;RAB9A;IRGM;RAB7A;RAB5A;RRAGA;TSR1;MFN2
prerank,fatty acid synthase activity (GO:0004312),0.3663650070055775,0.8542488197707006,0.6367521367521367,0.9230660320961359,1.0,2/10,7.41%,ELOVL7;ELOVL4
prerank,O-methyltransferase activity (GO:0008171),0.3616119541080696,0.8526136337882695,0.6456521739130435,0.9221358015561083,1.0,5/10,19.15%,CMTR2;BCDIN3D;CMTR1;ASMT;MEPCE
prerank,hexosyltransferase activity (GO:0016758),0.2197956208154121,0.8522991505709292,0.8007662835249042,0.9184943161895206,1.0,12/101,10.22%,TMTC2;MFNG;B4GALNT1;CHSY3;CSGALNACT1;FUT9;PIGM;B3GALT5;B4GALT6;ALG1;DPY19L1;MGAT4C
prerank,NAD+ binding (GO:0070403),0.34202727438875496,0.8518293051377325,0.6844444444444444,0.9153657757192057,1.0,4/12,10.39%,HADH;SIRT1;HPGD;UXS1
prerank,ATPase activator activity (GO:0001671),0.31051639024017913,0.8497875336849603,0.6936170212765957,0.9155631993926256,1.0,8/20,22.13%,DNAJC15;ATP1B1;DNAJA2;DNAJB2;AHSA1;DNAJC19;DNAJA1;ATP1B2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3296975318453661,-0.849266469058799,0.6860902255639098,0.9280194160840893,1.0,3/16,7.10%,ATP6V1B2;ATP6V0D1;ATP6V0A4
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3296975318453661,-0.849266469058799,0.6860902255639098,0.9280194160840893,1.0,3/16,7.10%,ATP6V1B2;ATP6V0D1;ATP6V0A4
prerank,voltage-gated anion channel activity (GO:0008308),-0.327025146850555,-0.8452042245087926,0.7054409005628518,0.9335470179158428,1.0,6/15,23.80%,CLCN2;VDAC1;ANO1;GPR89B;GPR89A;CLCN6
prerank,ephrin receptor binding (GO:0046875),-0.30382925296492347,-0.8441222690431295,0.6772388059701493,0.9327705345278929,1.0,4/21,6.87%,EFNB2;ABL1;SHC1;LYN
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.32081053435790535,-0.8390368001937045,0.6894639556377079,0.9400176947258538,1.0,7/16,29.85%,SLC13A3;SLC1A5;SLC25A11;SLC38A7;SLC25A22;SLC1A6;SLC13A5
prerank,lipase activity (GO:0016298),-0.2598904016807347,-0.8384135157278191,0.7651515151515151,0.9384114983279722,1.0,13/43,26.52%,SEC23IP;DDHD1;ABHD5;ABHD3;PNPLA8;PLA1A;ABHD6;ABHD12;MGLL;SMPD2;DAGLB;PNPLA2;LPL
prerank,3'-5' exonuclease activity (GO:0008408),-0.24679662614898853,-0.8366225023631552,0.7887596899224806,0.9390024637015559,1.0,17/45,28.30%,ERI3;DIS3L2;WRN;CNOT8;XRN2;ERI2;EXOSC9;PAN2;EXOSC10;MRE11;USB1;ANGEL2;EXOSC3;PNLDC1;PDE12;DIS3;PARN
prerank,peptidase activator activity (GO:0016504),0.2965283060874567,0.836151059720688,0.7056277056277056,0.9391859057365937,1.0,2/22,4.93%,MAL;PSENEN
prerank,clathrin adaptor activity (GO:0035615),0.3257683128455887,0.8356884195828354,0.6700404858299596,0.9358238126028944,1.0,3/15,9.06%,AP2M1;HIP1;AP2B1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.3530462336890014,-0.8315452324808348,0.69921875,0.946077669872119,1.0,1/10,2.45%,KAT2B
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.3658251321369079,-0.8299338556797972,0.69009009009009,0.9463346771804396,1.0,5/10,24.39%,EHHADH;ECHDC2;ECHDC3;ECI1;AUH
prerank,thiol-dependent deubiquitinase (GO:0004843),0.22408056667566284,0.8293800689393009,0.8220338983050848,0.9441170456664931,1.0,23/83,18.98%,USP44;OTUD7A;USP29;USP14;USP53;UCHL1;USP49;YOD1;UCHL3;USP32;USP22;OTUB2;USP48;USP31;USP42;USP30;OTUB1;OTULIN;USP8;UCHL5;OTUD7B;ATXN3;JOSD1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.292013257153938,-0.8277302258720269,0.7369477911646586,0.9477314431811009,1.0,10/23,23.64%,SH3PXD2B;GBF1;MAPKAP1;KIF16B;WIPI1;WDR45B;WIPI2;PLEKHA4;HIP1R;JPH2
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3015112463449745,0.8237506547552096,0.7276507276507277,0.9508798759068823,1.0,1/20,0.24%,DLG2
prerank,chemokine receptor binding (GO:0042379),0.2565822824638649,0.8234971745346584,0.7422680412371134,0.9470746779266692,1.0,7/35,22.72%,CXCL12;CCL2;CCL25;CKLF;CCL13;CCL19;ITCH
prerank,G protein-coupled receptor binding (GO:0001664),-0.2045623839654078,-0.8199866418811081,0.8972746331236897,0.9592550034005881,1.0,24/132,18.89%,WNT4;LRP6;RNF43;PRKN;WNT5B;WNT6;FLNA;RYK;WNT9A;GRK3;USP33;TULP3;ARHGEF12;GNA14;AGTR1;GNAS;FZD7;USP4;PTCH1;ARHGEF11;ARRB1;WNT5A;MYOC;FZD1
prerank,MAP kinase phosphatase activity (GO:0033549),-0.34083318819402775,-0.8168196219377778,0.7216117216117216,0.9621984564648516,1.0,4/12,22.16%,DUSP16;DUSP1;DUSP10;DUSP7
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.30664254805197033,-0.8163140345846444,0.7358490566037735,0.960123768705098,1.0,5/17,23.20%,ACAA2;ACOT11;ACOT9;ACOT8;ACOT6
prerank,hydro-lyase activity (GO:0016836),-0.24633944105549885,-0.8137461272858921,0.7976653696498055,0.9618116380955514,1.0,21/41,32.71%,GMDS;ACO2;EHHADH;ACO1;ECHDC2;HACD4;ECHDC3;ECI1;APIP;PARK7;UROS;AUH;IREB2;CBS;ENO3;TBXAS1;ENO1;CDYL;CYP2S1;FAHD2A;ALAD
prerank,GTP binding (GO:0005525),-0.19705056189585005,-0.8132488657706765,0.9085365853658537,0.9597542385073371,1.0,57/172,30.22%,RHOQ;ANXA6;LRRK2;ATL3;RHOJ;ARL3;RND3;RAP1B;RAB10;MRAS;RAB22A;GLUD1;CDC42;ATL2;RHOA;RHOT1;ARFIP2;DYNC1LI1;ARF1;RHOBTB2;RALA;RASL12;GTPBP10;GBP3;RAB21;BMS1;GBP2;RHOBTB1;GBP7;RHOH;TUBB2A;GBP6;RHOC;MTG2;NME1;RIT1;RABL3;TUBB6;ARL5A;RHOT2;NOA1;RAB8A;RAB9A;RAB7A;RAB5A;RRAGA;TSR1;DIRAS2;TUBA1C;RAB39A;ARL4C;GNL3;RANBP17;TUBB2B;ADSS1;GNL1;ARF6
prerank,microtubule minus-end binding (GO:0051011),-0.33133163167274976,-0.8124701849539704,0.7168316831683168,0.9581920379824506,1.0,7/13,30.17%,NUMA1;TUBGCP6;TUBGCP2;TUBGCP4;HAUS7;CAMSAP2;HAUS4
prerank,GDP binding (GO:0019003),0.22635044781031716,0.8083964971003157,0.8562628336755647,0.9712018404639372,1.0,15/63,17.56%,RIT2;DIRAS1;NME2;RAB4A;RAB35;MIEF1;RASEF;HRAS;GNAI1;RAP1A;RAB29;RAP2B;RAB31;RALB;RERG
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2718973964977358,0.8081941692951972,0.7621052631578947,0.9672264569273843,1.0,6/28,12.97%,RPP40;APEX1;RPP30;POP5;RNASEH2A;DROSHA
prerank,double-stranded RNA binding (GO:0003725),0.22605150749458197,0.8078758397319271,0.8340248962655602,0.9635050812881505,1.0,10/70,12.97%,TFRC;ADARB2;ZFR2;DUS2;HSP90AB1;STRBP;LRRFIP1;RFTN1;HSPD1;DROSHA
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.2866179118390351,0.8072678485455694,0.7575757575757576,0.9603724206874146,1.0,2/22,3.78%,DUSP6;PPM1F
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.26342397476377477,-0.8072349906588607,0.7762096774193549,0.9645039682140454,1.0,3/29,4.25%,PRKAG2;KAT2B;RPTOR
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.26620809473492013,-0.8062264300482637,0.761252446183953,0.9633412395433179,1.0,7/28,19.86%,PRKAA2;LRRK2;MAP2K4;MAP2K1;MAP2K7;PRKACA;MAP2K6
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.3126506198863595,0.8058140988639755,0.7357293868921776,0.9588491718475437,1.0,1/16,2.38%,BCO1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.31815781266507714,0.8047568712182211,0.7373949579831933,0.9565200649265706,1.0,3/13,17.77%,PIP5K1B;PIP5K1A;PIP4K2B
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.27850988059747805,0.8047282556907379,0.7724425887265136,0.9524280129440547,1.0,2/21,11.32%,GRIK2;P2RX7
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.28999833728217916,-0.8043366776772665,0.7509363295880149,0.9637298391236533,1.0,6/22,20.27%,ATP6V1B2;ATP6V0D1;ATP6V0A4;ATP2A2;TCIRG1;ATP2A3
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.319031818108461,0.8028979734553031,0.734475374732334,0.9516418143524032,1.0,2/14,9.71%,MAL;NOD1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.18422098143006177,-0.7988660735820255,0.9749478079331941,0.9703838541181672,1.0,52/248,19.33%,RHOQ;OPA1;LRRK2;ATL3;RHOJ;DNM1L;RND3;ABCA4;RAP1B;RNF213;VPS4B;VWA8;MRAS;RAB22A;GFM1;MMUT;DHX9;TBC1D24;CDC42;ABCD2;CHD3;ATL2;RHOA;RHOT1;ATP2B1;GNA14;RAB11A;RHOBTB2;RALA;GNAS;RASL12;GTPBP10;ARHGDIB;GNG5;GFM2;KIF1C;GBP3;RAB21;BMS1;DNAJC27;DDX3X;EFTUD2;GNB1;SMCHD1;GBP2;RHOBTB1;GBP7;RHOH;VCP;GBP6;RHOC;MTG2
prerank,protein phosphatase activator activity (GO:0072542),-0.32033699661415893,-0.7982129383868258,0.7434094903339191,0.9686739709752934,1.0,5/13,18.18%,IGFBP3;PPP2R5E;PPP2R5D;PTPA;PPP2R5C
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.2745662700470825,-0.7971772578902493,0.7911025145067698,0.9675499244002647,1.0,6/24,14.11%,OSBPL8;OSBPL5;PLA2G4A;ARFIP2;GSDMD;PLEKHA8
prerank,Hsp90 protein binding (GO:0051879),0.25527405155552774,0.7966611702504262,0.7966457023060797,0.9582497733600307,1.0,10/33,19.16%,PACRG;KDR;NPAS2;CYP2E1;UNC45B;RPS3;PTGES3;CHORDC1;AHSA1;NOD2
prerank,titin binding (GO:0031432),0.317940617022958,0.7954339991864977,0.7388392857142857,0.9562010937048419,1.0,4/13,13.93%,TCAP;CALM1;CALM2;CALM3
prerank,kinase activity (GO:0016301),-0.20407096495195862,-0.7936375993096936,0.9071969696969697,0.9706390288901466,1.0,42/109,29.91%,NADK2;PI4KA;ABL1;LRRK2;GK5;GSK3B;DGKA;NADK;TRRAP;MAP4K4;LYN;MTOR;EPHA4;PANK2;PGK1;PIK3C3;DCAKD;RFK;PDXK;CSNK2A1;PIK3CD;PRKD1;FCSK;IRAK1;ITPKC;SHPK;BCKDK;DGKD;SPHK1;TAOK1;DGKK;MVK;MASTL;PSTK;IP6K2;ETNK1;DOLK;POMK;SPHK2;SCYL3;PI4KB;CERKL
prerank,kinase inhibitor activity (GO:0019210),-0.25524613797858287,-0.7925734434246088,0.8076190476190476,0.9694114776194952,1.0,9/33,20.25%,PARVA;LRP6;TAOK3;DNAJC3;GMFB;NCK1;SH3BP5L;RHOH;CDKN1C
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3414496546379285,-0.7886387576160846,0.7442273534635879,0.9703643503002248,1.0,4/10,22.16%,DUSP16;DUSP1;DUSP10;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3414496546379285,-0.7886387576160846,0.7442273534635879,0.9703643503002248,1.0,4/10,22.16%,DUSP16;DUSP1;DUSP10;DUSP7
prerank,motor activity (GO:0003774),0.22562775434422389,0.7866229558288841,0.8502994011976048,0.9667851076976192,1.0,15/60,20.39%,MYO1E;KIF1A;KIF21B;KIFC2;KIF26B;MYL6;MYO6;KIF19;KIFC3;STARD9;DNAH3;KIF21A;KIF18A;KIF1B;KIF26A
prerank,transaminase activity (GO:0008483),-0.335989217539714,-0.7859938352245136,0.7533460803059273,0.971640620015962,1.0,5/11,34.33%,ABAT;OAT;PSAT1;GOT1;GOT2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.32434285191153855,-0.784669402002787,0.7452107279693486,0.970993357379549,1.0,3/12,19.01%,PIEZO2;TMC4;TMC6
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.315246933773988,-0.7843323873909297,0.7566539923954373,0.9686351233653955,1.0,2/14,6.73%,SLC26A7;SLC26A2
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.26610462170404464,-0.7839986956566165,0.7985074626865671,0.966353474392568,1.0,4/27,6.00%,SLC41A1;SLC9A1;SLC9A8;SLC9A2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.33462618636693947,-0.7818834439227721,0.7569060773480663,0.9667197616769346,1.0,5/11,25.69%,PRMT2;PRMT5;PRMT8;FBXO11;PRMT9
prerank,NADP binding (GO:0050661),0.25458907402853326,0.7815149805596686,0.8105906313645621,0.9708059890977719,1.0,8/32,17.75%,NDOR1;NOS3;KCNAB1;DUS2;HSD11B1;DHCR7;TM7SF2;NNT
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.3068660464910099,-0.7808579330981199,0.7577981651376147,0.9655123081428676,1.0,6/15,31.70%,PI4KA;PIK3C3;PIK3CD;PI4K2B;PI4KB;PIK3C2A
prerank,nucleoside-diphosphatase activity (GO:0017110),0.32012017064649895,0.7793101089594856,0.7804295942720764,0.9701572905754746,1.0,5/12,22.74%,SLC25A42;ENTPD3;ENTPD1;ENTPD5;ENTPD7
prerank,N-acyltransferase activity (GO:0016410),-0.24960044545711435,-0.778574179558271,0.8057142857142857,0.9661936356694006,1.0,3/32,3.26%,EP300;CERS5;NMT2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.26677368996350864,-0.7773849914032999,0.7906976744186046,0.9652234843814572,1.0,7/27,17.42%,SLC26A7;SLC39A14;SLC26A2;SLC22A6;SLC5A5;SLC25A11;ANO1
prerank,guanyl ribonucleotide binding (GO:0032561),-0.18375026562709085,-0.7716462661328994,0.9816700610997964,0.9709996757613757,1.0,38/196,19.33%,PDE5A;RHOQ;MPPED2;ANXA6;LRRK2;ATL3;RHOJ;ARL3;RND3;RAP1B;RAB10;MRAS;RAB22A;GLUD1;RAB12;CDC42;ATL2;RHOA;RHOT1;ARFIP2;DYNC1LI1;ARF1;RHOBTB2;RALA;RASL12;GTPBP10;GBP3;RAB21;BMS1;RAPGEF2;GBP2;RHOBTB1;GBP7;RHOH;TUBB2A;GBP6;RHOC;MTG2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.3038950052268118,0.769515674638745,0.7782608695652173,0.9807715048625533,1.0,3/14,12.59%,RPP40;RPP30;POP5
prerank,anion:anion antiporter activity (GO:0015301),0.29121645138325136,0.7694073648819489,0.7829977628635347,0.976826166452404,1.0,1/17,0.55%,SLC4A1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.31108069561328866,-0.7684208828163215,0.7980952380952381,0.9730862695598963,1.0,5/13,20.62%,AGPAT4;ABHD5;GPAT4;LPCAT1;GPAT3
prerank,symporter activity (GO:0015293),0.3294881512448004,0.7639322738407373,0.7760532150776053,0.9808269316752672,1.0,1/10,3.79%,MFSD2A
prerank,5'-nucleotidase activity (GO:0008253),0.3100305935079384,0.7638807797024707,0.7695652173913043,0.9768218672622226,1.0,2/13,9.72%,NT5DC2;NT5C
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.31349654739485244,0.7606225856779399,0.7844444444444445,0.977534432762939,1.0,12/12,68.67%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;RHO;OPN1MW;OPN1MW3;RRH;GPR52;GPR88;OPN3
prerank,gamma-tubulin binding (GO:0043015),-0.27585328667490705,-0.7605543052754974,0.812992125984252,0.9816428049717486,1.0,7/21,15.01%,TUBGCP6;TUBGCP2;MARK4;BRSK1;RAD51D;BRCA2;DDX3X
prerank,exopeptidase activity (GO:0008238),0.22639217981766765,0.7541636835380933,0.8757637474541752,0.9826242698828402,1.0,4/50,6.15%,DPP10;MME;METAP2;DPP6
prerank,alpha-tubulin binding (GO:0043014),0.24067429685466354,0.751843744719876,0.8647540983606558,0.9816649079503568,1.0,4/31,6.30%,PACRG;TTLL7;SNCA;TRIM36
prerank,histone deacetylase activity (GO:0004407),-0.2753909694672839,-0.7492449840508532,0.8171206225680934,0.9945941714273536,1.0,13/19,38.11%,HDAC8;HDAC4;MIER1;HDAC1;HDAC2;SIRT3;HDAC3;MIER2;HDAC10;MIER3;SIRT6;SUDS3;HDAC5
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.2986260319429965,-0.7464213272901847,0.7963963963963964,0.9955808587328543,1.0,1/13,0.48%,SLC7A2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.2485284396339483,0.7441447281065584,0.8661257606490872,0.9878597855051309,1.0,7/27,17.45%,POLR1H;POLR2J;POLR2B;POLR2I;MED20;POLR3A;POLR2G
prerank,ATPase regulator activity (GO:0060590),0.23014829341865273,0.7389038536996914,0.8718487394957983,0.9903880642415728,1.0,14/38,22.86%,HSPBP1;DNAJC15;BRSK2;ATP1B1;PFN1;DNAJA2;DNAJB2;AHSA1;BAG2;DNAJC19;DNAJA1;BAG1;ATP1B2;FNIP2
prerank,NF-kappaB binding (GO:0051059),-0.25032703678546764,-0.7341089524924186,0.8454198473282443,1.0,1.0,3/24,4.81%,EP300;GSK3B;ANXA4
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3118337835503534,-0.7319444724347158,0.825187969924812,1.0,1.0,3/10,23.80%,CLCN2;ANO1;CLCN6
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.29046002712930014,0.7311280647496387,0.8226164079822617,0.9958766762347189,1.0,1/15,0.55%,SLC4A1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.2604973299803534,-0.731069722389924,0.8574144486692015,1.0,1.0,7/22,21.05%,RNF169;PARP10;ZBTB1;SPRTN;ZRANB3;IKBKE;WDR81
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.3026481904350579,-0.7307942300032323,0.8289473684210527,1.0,1.0,4/12,19.34%,VEGFA;VEGFD;ITGA5;ITGB3
prerank,CARD domain binding (GO:0050700),0.2886348237598829,0.7276288383528817,0.8390557939914163,0.9959113798263535,1.0,3/14,11.76%,CARD19;NOD1;BCL10
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.29714004879054534,-0.7242953012453979,0.8330206378986866,1.0,1.0,6/12,37.77%,CTSH;BCL2L13;ATP2A3;APAF1;PYCARD;CASP1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.23642993584044847,-0.7232079728303735,0.8820224719101124,1.0,1.0,7/29,17.53%,GANC;ACER3;HEXD;GUSB;PGGHG;GANAB;ABHD10
prerank,BMP binding (GO:0036122),-0.3101636096486379,-0.7221819928944675,0.8296146044624746,1.0,1.0,2/11,11.37%,NBL1;GREM2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.29306702459037315,0.7200765326246504,0.8154506437768241,1.0,1.0,3/12,8.65%,TENT5C;TENT4A;PAPOLB
prerank,mRNA methyltransferase activity (GO:0008174),0.2947353954013433,0.7195040788492674,0.8251028806584362,0.997322311043465,1.0,4/12,21.65%,CMTR2;CMTR1;METTL8;METTL3
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2408908163374133,-0.7169781163267277,0.864244741873805,1.0,1.0,6/26,21.92%,AEBP1;AGBL3;CPM;CPXM2;CPXM1;AGBL1
prerank,GTPase inhibitor activity (GO:0005095),0.2847408365215898,0.7148482505366712,0.823404255319149,0.9984933970966645,1.0,2/13,8.64%,IPO5;GPS2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.19586476684255544,0.7132901585851218,0.959915611814346,0.9962614464219154,1.0,21/75,21.97%,HADHA;HADH;KCNAB1;HSD17B7;PRXL2B;PHGDH;HPGD;ABCC4;BDH1;KDSR;RDH11;HSD17B10;LDHB;RDH10;IMPDH1;LDHA;NSDHL;UGDH;HSD17B4;HSD3B7;KCNAB2
prerank,receptor antagonist activity (GO:0048019),0.26591213289842947,0.7105600207702797,0.8418803418803419,0.9951942574662206,1.0,1/17,2.65%,FST
prerank,gated channel activity (GO:0022836),-0.27900846655624406,-0.7078501046290571,0.8444022770398482,1.0,1.0,1/14,1.08%,PIEZO2
prerank,deoxyribonuclease activity (GO:0004536),0.2773281573095606,0.7014918072311964,0.830316742081448,1.0,1.0,4/14,17.38%,APEX1;RPS3;DFFB;APLF
prerank,translation initiation factor activity (GO:0003743),-0.22153668970822865,-0.6995031531329088,0.9258589511754068,1.0,1.0,14/36,31.14%,EIF4G3;EIF4A2;EIF4E;EIF3A;EIF4G1;EIF3L;EIF2B4;EIF2B5;EIF4E3;EIF3H;EIF3C;EIF3M;COPS5;EIF2B1
prerank,phosphatase activator activity (GO:0019211),-0.2801877779053314,-0.6989461586476509,0.8705035971223022,1.0,1.0,6/14,22.90%,FRS2;PPP2R5E;PPP2R5D;PPP2R5C;BMP2;GTF2F1
prerank,carbohydrate kinase activity (GO:0019200),0.30050073106528974,0.6973193801319851,0.8426724137931034,1.0,1.0,3/11,19.45%,KHK;FGGY;XYLB
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.21028723240536434,-0.6961953222450769,0.9528688524590164,1.0,1.0,7/46,14.01%,LARGE1;B3GALT1;EXT1;B3GLCT;MGAT3;OGT;HEXA
prerank,MHC protein binding (GO:0042287),-0.25511716695441145,-0.6960750486929129,0.8884826325411335,1.0,1.0,7/20,35.45%,TAP2;DERL1;TAP1;CD81;ATP5F1A;LAG3;TAPBP
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.2862381820984917,0.6918857404580285,0.8763326226012793,1.0,1.0,6/12,21.68%,ISCU;ISCA2;ISCA1;CISD2;CIAPIN1;CISD1
prerank,DNA replication origin binding (GO:0003688),-0.24295216274520595,-0.691841988214426,0.8957952468007313,1.0,1.0,15/23,45.35%,DHX9;MCM9;MCM6;ORC1;MCM4;MCMDC2;CDC45;POLA1;MCM2;MCM7;MCM5;MCM10;ORC3;CDC6;GRWD1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.27994384417311163,0.6918083169950004,0.8658008658008658,0.997687035164405,1.0,4/14,15.49%,ISCU;ISCA2;ETFDH;RSAD2
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.23315291906037444,-0.6917524236483801,0.9085714285714286,1.0,1.0,11/29,25.45%,ABL1;PPM1D;DUSP16;NBR1;TPR;DUSP1;DUSP10;CDK5RAP3;DUSP7;MAPK7;MAPK14
prerank,histone methyltransferase binding (GO:1990226),-0.29434635455543806,-0.6912850753170223,0.8571428571428571,1.0,1.0,3/11,14.08%,CBX1;LCOR;PHF1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.2936862059805823,0.6912452067954891,0.8498942917547568,0.9942562042487014,1.0,2/11,5.48%,SLC25A42;SLC25A23
prerank,chloride channel regulator activity (GO:0017081),-0.2721408061734603,-0.6887569947843307,0.8512720156555773,1.0,1.0,7/14,31.04%,VTI1B;WNK4;WNK1;STX8;STX1A;STX7;SGK1
prerank,pyrophosphatase activity (GO:0016462),-0.2050392513420588,-0.6868304312593061,0.9530956848030019,1.0,1.0,22/50,32.38%,ENPP1;NUDT4;NUDT5;DHX9;PRUNE1;ENPP3;PPA1;DDX3X;ENTPD6;RNGTT;ALPL;PPA2;DOLPP1;NUDT11;NUDT1;PLPP1;PLPP5;CILP;NUDT7;FITM2;NUDT16;NUDT16L1
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.29342049944909,-0.6854310495807489,0.8942307692307693,1.0,1.0,1/11,2.67%,SLC5A3
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.28507746483794527,0.6843290371870981,0.8768898488120951,0.9964901846547232,1.0,2/12,5.48%,SLC25A42;SLC25A23
prerank,death receptor binding (GO:0005123),-0.26293685407695694,-0.6834495042743864,0.8820326678765881,1.0,1.0,2/15,9.66%,EDA;NGF
prerank,lysophospholipase activity (GO:0004622),0.25077893071191276,0.681633938970694,0.8877118644067796,0.9949933434846285,1.0,2/20,4.82%,ENPP2;LYPLA1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.2792827607546807,0.6724445347848512,0.8782961460446247,0.9987257176175769,1.0,1/12,1.47%,SPPL2B
prerank,P-type ion transporter activity (GO:0015662),0.2693426302159109,0.6720508117539604,0.8851351351351351,0.99518994043138,1.0,4/12,18.99%,ATP2B3;ATP2B4;ATP2B2;ATP2C1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.2818957911134667,-0.669604192056588,0.8874045801526718,1.0,1.0,5/12,22.56%,TRAF2;STAT1;TRAF3;TRAF6;TRAF5
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.2682295497627605,0.6614926521495169,0.8876889848812095,0.9995667493264973,1.0,4/12,19.28%,PIK3R3;ATM;IPMK;PIK3R6
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.2608187587908064,0.6547078808566025,0.9088983050847458,1.0,1.0,2/15,8.39%,ACKR4;GPR17
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.2379570970797223,-0.6540740448569696,0.9056974459724951,1.0,1.0,6/20,20.62%,AGPAT4;ABHD5;GPAT4;MOGAT3;LPCAT1;GPAT3
prerank,WW domain binding (GO:0050699),-0.22356783417347362,-0.653171805854127,0.9434306569343066,1.0,1.0,9/26,34.52%,PMEPA1;RAPGEF2;TCEAL9;WBP11;WBP1;TCEAL8;DAZAP2;TCEAL1;TRAF4
prerank,peptide hormone receptor binding (GO:0051428),0.2716314673885959,0.6529843926790517,0.8903225806451613,0.9978693181818182,1.0,1/11,7.63%,ADCYAP1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.25804673907207604,-0.6514292248640924,0.9206049149338374,1.0,1.0,6/14,35.78%,MTHFR;ALDH1L1;ALDH4A1;PYCR2;PYCR3;AASS
prerank,DNA polymerase activity (GO:0034061),-0.23289009427770693,-0.6509839813047552,0.9411764705882353,1.0,1.0,12/22,36.15%,POLM;REV1;POLE4;TERT;POLN;PRIMPOL;POLE2;POLH;POLA1;POLE;REV3L;POLD4
prerank,C-C chemokine binding (GO:0019957),-0.2306046502996001,-0.6481309171776982,0.9301397205588823,1.0,1.0,15/22,54.84%,CCR9;CX3CR1;CCR5;ACKR1;CCR2;CXCR4;CCRL2;CXCR6;ZFP36;CCR1;CCR10;CXCR5;ACKR3;CCR6;CXCR2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.24517203360550122,-0.6453941010754713,0.9251012145748988,1.0,1.0,3/16,15.71%,MTMR12;MTMR3;SACM1L
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.20012408777665236,0.6435771211045105,0.9615384615384616,0.9999598654685927,1.0,3/38,10.26%,SPOCK1;SERPINB8;SLPI
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.19937703598942164,-0.6365587831529299,0.9653767820773931,1.0,1.0,15/35,31.23%,FTO;TRMT9B;PUS10;TARS2;QTRT2;ALKBH1;FTSJ1;LCMT2;DTWD1;DUS3L;DTWD2;ELAC2;MRPL58;TYW3;QRSL1
prerank,glutathione transferase activity (GO:0004364),0.22357100480477204,0.6359740575073607,0.945823927765237,1.0,1.0,2/23,8.24%,GSTA4;GSTM5
prerank,ubiquitin-dependent protein binding (GO:0140036),0.2775631567392788,0.6352854692460039,0.9037199124726477,0.9974578244822753,1.0,6/10,25.90%,DNAJB2;ANKRD13A;DNAJC2;USP15;ANKRD13D;LAPTM5
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.2500787869207143,-0.634955826867914,0.940952380952381,1.0,1.0,5/15,20.62%,AGPAT4;ABHD5;GPAT4;LPCAT1;GPAT3
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.2652184259852344,0.6347811751152312,0.9156118143459916,0.9940636732345458,1.0,3/11,15.31%,SGMS1;AASDHPPT;SAMD8
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.26522178487942416,-0.6309426523417554,0.9348659003831418,1.0,1.0,1/12,2.20%,B3GALT1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.2248021603859447,-0.6284900544208811,0.9544592030360531,1.0,1.0,12/22,39.14%,RBMS3;DHX36;EXOSC9;CPEB1;NUDT21;CPSF1;ZFP36L2;EXOSC8;RBM24;ELAVL1;MEX3D;ILF3
prerank,carboxypeptidase activity (GO:0004180),-0.19686608148682072,-0.6257434481858533,0.9640831758034026,1.0,1.0,9/35,26.83%,AEBP1;AGBL3;CPM;CTSA;CPXM2;CPXM1;AGBL1;SCPEP1;VASH1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.26371451200116236,0.6254739734670436,0.920997920997921,0.9955381919408266,1.0,2/10,13.21%,APEX1;POLD1
prerank,MHC class I protein binding (GO:0042288),-0.2542981972734313,-0.6200111139831214,0.9323583180987203,1.0,1.0,5/13,35.45%,TAP2;DERL1;TAP1;ATP5F1A;TAPBP
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.2617222827559046,-0.6132157789858842,0.9171374764595104,1.0,1.0,4/11,20.36%,NABP2;CTC1;TERF2;STN1
prerank,C-C chemokine receptor activity (GO:0016493),0.22127453608631042,0.611436044657773,0.9722222222222222,0.9993892719004385,1.0,2/21,9.35%,ACKR4;GPR75
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.26210621554120134,-0.6087573813034647,0.9266917293233082,1.0,1.0,6/11,36.20%,NAA15;NAA16;NAA80;NAA25;NAA40;NAA10
prerank,transferrin receptor binding (GO:1990459),-0.2613857362933419,-0.6086621530113488,0.918918918918919,1.0,1.0,1/10,8.19%,RGMA
prerank,adenyl nucleotide binding (GO:0030554),0.257518656974086,0.6076479219899946,0.9429824561403509,0.993846481247983,1.0,1/11,1.65%,HSPBP1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.257518656974086,0.6076479219899946,0.9429824561403509,0.993846481247983,1.0,1/11,1.65%,HSPBP1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.22885059259004845,0.5956090777622436,0.9599198396793587,0.9955875384426872,1.0,4/17,16.81%,PECR;TECR;DHCR7;TM7SF2
prerank,purinergic nucleotide receptor activity (GO:0001614),0.2327599218209985,0.5941252530029953,0.9553191489361702,0.9924985975209344,1.0,2/15,11.32%,P2RY1;P2RX7
prerank,ribosome binding (GO:0043022),-0.1770781137067709,-0.5932449126905651,0.996031746031746,1.0,1.0,16/46,31.84%,YTHDF3;GEMIN5;SERBP1;NAA15;CPEB1;SHFL;PYM1;BAG6;NAA16;EIF3C;SRP72;IGHMBP2;CCDC47;C1QBP;MRPS27;SRP19
prerank,phospholipase A2 activity (GO:0004623),0.20047999726081475,0.5918899451664419,0.9688149688149689,0.9898165995047823,1.0,5/26,19.36%,PLAAT1;PLA2G12A;PLA2G4E;PNPLA3;PRDX6
prerank,ribosomal small subunit binding (GO:0043024),-0.22408545154732995,-0.5909596056978719,0.95703125,1.0,1.0,4/17,20.99%,LARP1;DDX3X;NME1;ERAL1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.19412438508167618,0.5906680295876826,0.9740820734341252,0.9866350180798809,1.0,6/28,18.81%,TRAF1;TRIM37;DAB2IP;MADD;TMBIM1;RIPK1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.2306637254657464,-0.58788127892259,0.946983546617916,1.0,1.0,5/15,28.17%,SH3PXD2B;PLA2G4A;PLEKHF1;JPH2;SAP30L
prerank,ribosomal large subunit binding (GO:0043023),-0.2514218656029637,-0.5855016784849291,0.9541284403669725,1.0,1.0,4/11,35.64%,MRRF;LTN1;DHX33;NPM1
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.20848602188696075,-0.5791558081843966,0.9556840077071291,1.0,1.0,11/21,36.15%,POLM;REV1;POLE4;POLN;PRIMPOL;POLE2;POLH;POLA1;POLE;REV3L;POLD4
prerank,aspartic-type peptidase activity (GO:0070001),-0.251967419056212,-0.5777421528745135,0.9581749049429658,1.0,1.0,1/10,7.30%,DDI2
prerank,pseudouridine synthase activity (GO:0009982),-0.22744990857153066,-0.5674686913411996,0.9694244604316546,1.0,1.0,8/13,43.82%,PUS10;PUS3;RPUSD4;PUS1;PUS7L;PUSL1;RPUSD2;RPUSD3
prerank,microtubule motor activity (GO:0003777),0.16533435237472788,0.5626361147937788,0.9937629937629938,0.9927449916035229,1.0,12/51,20.39%,KIF1A;KIF21B;KIFC2;KIF26B;KIF19;KIFC3;STARD9;DNAH3;KIF21A;KIF18A;KIF1B;KIF26A
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.22452864262162736,0.5625573456049067,0.9540481400437637,0.989198503798311,1.0,6/14,22.39%,YOD1;MINDY2;MINDY1;OTUD7B;ATXN3;USP15
prerank,methyl-CpG binding (GO:0008327),-0.20057156638204332,-0.5619065609990084,0.9822134387351779,1.0,1.0,10/22,33.57%,MBD2;PRMT5;CXXC5;MBD3;ZBTB4;CXXC4;TET3;ZBTB38;ERH;ZBTB21
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.2400965050165595,-0.556602441190616,0.9611992945326279,1.0,1.0,2/11,12.09%,AKR1B1;AKR1A1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.21555356516297572,-0.549208353221394,0.9797160243407708,1.0,1.0,2/14,12.93%,MTMR12;MTMR3
prerank,protein phosphatase 1 binding (GO:0008157),-0.19734104182970874,-0.5463033667018409,0.9924385633270322,1.0,1.0,5/21,22.81%,SHOC2;PPP1R3B;SH3RF2;PPP1R3C;PPP1R3F
prerank,copper ion binding (GO:0005507),0.16564897705977083,0.5326642441363113,0.9977827050997783,0.9931772913652909,1.0,6/42,16.69%,AOC2;SNCA;ATOX1;SNCB;COX17;COA6
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.228969294180271,-0.5235968758578093,0.9756554307116105,1.0,1.0,4/10,33.30%,PML;ANKRD13B;FAAP20;IDE
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.22794416456937616,-0.5211682924519923,0.9652014652014652,1.0,1.0,5/10,36.20%,NAA15;NAA16;NAA80;NAA25;NAA10
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.19924928340000375,-0.5007419310512837,0.9871086556169429,1.0,1.0,5/14,26.78%,DTYMK;NME6;NME1;CMPK2;AK1
prerank,triglyceride lipase activity (GO:0004806),-0.1850547248186225,-0.49978791166265946,0.9961538461538462,1.0,1.0,4/20,26.52%,ABHD5;DAGLB;PNPLA2;LPL
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.1735244637047501,-0.4972313255351159,0.9943074003795066,1.0,1.0,9/24,33.82%,DTYMK;NME6;ITPKC;NME1;CMPK2;IP6K2;AK1;AK7;PPIP5K2
prerank,single-stranded DNA helicase activity (GO:0017116),-0.1812798134609855,-0.4936797414690804,0.996415770609319,1.0,1.0,10/19,43.39%,DHX9;MCM6;HELB;HELQ;RAD51;MCM2;MCM7;MCM5;DSCC1;CHTF18
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.18584205796660863,-0.4913066195318741,0.9962825278810409,1.0,1.0,5/17,26.78%,DTYMK;NME6;NME1;CMPK2;AK1
prerank,RNA methyltransferase activity (GO:0008173),-0.17825662037149556,-0.48422850888957014,0.9981308411214953,1.0,1.0,7/19,32.96%,TRMT9B;TGS1;FTSJ1;LCMT2;TYW3;MRM2;TRMT12
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.20593976898772007,0.48049493149133826,0.9842696629213483,0.9980655990123388,1.0,2/10,13.71%,PIK3R3;ATM
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.18376986855861258,0.47672970226488154,0.9936440677966102,0.9949143079089188,1.0,2/15,17.08%,PLA2G12A;PLA2G4E
prerank,solute:proton symporter activity (GO:0015295),-0.16429738245126785,-0.4351725401239937,1.0,1.0,1.0,3/16,16.77%,SLC33A1;SLC25A3;CTNS
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.19143905529159955,-0.4306844013776289,0.996415770609319,1.0,1.0,4/10,33.82%,OTUD4;DESI2;TNFAIP3;OTUD5
prerank,CCR chemokine receptor binding (GO:0048020),-0.13284713095894635,-0.4045239071646995,1.0,0.9991534051924481,1.0,2/28,11.87%,NES;CNIH4
